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In The Netherlands, the contribution of cardiovascular diseases to the total 
mortality is 32% (Centraal Bureau voor de Statistiek (CBS), Mortality in 2006). 
Consequently, cardiovascular diseases are still the number one cause of death. 
Atherosclerosis is the underlying cause for more than 50% of cases. Already more 
than 50 years ago, in 1951, fatty streaks were generally considered to be the 
earliest atherosclerotic lesions.
1
 These lesions were mainly found in aortas in 
childhood and adolescence.
2-4
 In 1975, Sinzinger and colleagues reported the 
existence of lipid deposits even in fetal aortas.
5
 Although the process of 
atherosclerosis appears to start already early in life, decades of lesion progression 
follow until eventual atherosclerosis-associated events occur, such as myocardial 
infarction and ischemic stroke.  
 Atherosclerosis is a complex multifactorial process. Many risk factors that 
contribute to atherosclerosis have been identified. They can be divided into 
uncontrollable and controllable, genetic and environmental factors. Important risk 
factors are hypercholesterolemia, hypertension, diabetes mellitus, obesity, lack of 
physical activity, diet, alcohol consumption, smoking, genetically inherited traits, 
gender, age and family history. 
 
Fetal Origin of Cardiovascular Disease 
The “fetal origins hypothesis” postulated by Barker
6
 proposes that cardiovascular 
disease risk is at least partially determined by the intrauterine environment created 
by the mother during pregnancy. He stated that an embryo is capable of 
adjustment to unfavorable aspects of the maternal environment during 
development. As a result, the intrauterine environment becomes beneficial to the 
embryo and chances of survival increase. However, when the adult environment 
differs from the fetal environment, these adaptations may be detrimental for health 
in adult life.  
 A number of studies have reported an association between intrauterine 
growth restriction and increased cardiovascular disease risk in adult life.
6-8
 A 
unique study setting in this context is the Dutch Hunger Winter Families Study. 
During the harsh winter of 1944-1945, in the final year of the Second World War, 
there was severe food shortage in the Western part of The Netherlands. The cohort 
comprises individuals who were prenatally exposed to famine and controls that 
were not. Data revealed increased cardiovascular disease risk at adult age in the 






 Besides intrauterine growth restriction, more and more evidence is 
provided that maternal hypercholesterolemia during pregnancy may have adverse 
effects on cardiovascular disease risk in the offspring. Cholesterol is an essential 
component for adequate development of the embryo. It is an integral part of cell 
membranes, for example lipid rafts. In the third trimester of human pregnancy, in 
which fetal growth rate and subsequent fetal requirements are enhanced, the 
majority of mothers develop gestational hypercholesterolemia.
11,12
 Hence, 
gestational hypercholesterolemia is generally considered to be a natural 
phenomenon not directly posing a risk for cardiovascular disease in both mother 
and progeny. However, in 1997, Napoli and colleagues demonstrated that maternal 
hypercholesterolemia during pregnancy accelerated and aggravated fatty streak 
formation in fetal aortas.
13
 An extended study in neonates and young children 
demonstrated more rapid progression of atherosclerosis in children from 
hypercholesterolemic mothers compared with those from normocholesterolemic 
mothers.
14
 Based on these data one can speculate that offspring from 
hypercholesterolemic mothers acquire a long-term susceptibility for atherosclerosis 
and are at increased risk for myocardial infarction or ischemic stroke in adult life.  
 
Epigenetic Programming of Cardiovascular Disease 
The “fetal origins hypothesis” suggests that an adverse intrauterine environment 
induces changes that persist into adulthood. This so-called intrauterine 
programming is not achieved by alterations in the DNA sequence itself, but by 
epigenetic mechanisms. The word epigenetics was already introduced by 
Waddington in 1942
15
 and was used to describe cell differentiation. Later it was 
defined as the study of the mechanisms of temporal and spatial control of gene 
activity during the development of complex organisms.
16
 Nowadays, epigenetics is 
preferably defined as the processes that through chromatin remodeling alter gene 
expression patterns within a cell without changing the nucleotide sequence. The 
mostly stable epigenetic changes can be transmitted to the daughter cells. DNA 
methylation of CpG islands
17-19
 and covalent post-translational histone 
modifications
20
 are key players in the regulation of the transcription machinery. 
 A clear definition of epigenetics does not mean that the interpretation is 
simple. Epigenetic programming namely means different things to different people. 
Cancer researchers study the role of epigenetics in the context of dysregulation or 
defects of the normal epigenome, the overall epigenetic state of a cell. Aberrant 
epigenetic modifications of the chromatin surrounding the gene, for example loss or 
gain of methylation, are considered to be the cause of altered expression and 
subsequent development of disease.
21-23
 Geneticists on the other hand, study the 




comprises the effects of environmental factors on the epigenome. It has been 
reported that maternal behavior and care during the lactation period determine the 
extent of DNA methylation and histone acetylation on the glucocorticoid receptor in 
the rat offspring, thereby programming the stress response and social behavior.
24-28
  
 Intrauterine programming can be established by a number of, mainly 
environmental, cues (reviewed by Fowden and colleagues
29
). As mentioned earlier, 
maternal nutrition is very important during pregnancy to supply for the fetal needs. 
A shift in nutritional balance may induce programming. Physiological stress and 
dysregulation of the endocrine system have been reported to affect blood pressure, 
glucose tolerance, and the stress response in the offspring.
30,31
 Finally, 
environmental toxins and substances such as alcohol and nicotine may influence 
intrauterine programming.
32,33
 The role of epigenetic mechanisms in intrauterine 
programming becomes more and more apparent. Recently, it has been 
demonstrated that exposure to famine induces epigenetic changes in the IGF2 




Aim of This Thesis 
Although data indicate that an adverse intrauterine environment comprised of 
environmental atherosclerotic risk factors such as hypercholesterolemia, oxidative 
stress and inflammation, may induce accelerated and aggravated atherosclerotic 
lesion formation in fetuses, it is not known whether this actually results in increased 
cardiovascular disease development in adult life. Execution of a study in humans 
on the long-term consequences of intrauterine exposure is nearly impossible. 
Extensive genetic variation between individuals in combination with many 
environmental factors, prospective follow-up for decades and possible ethical 
objections are potential biases and have to be taken into account. To overcome 
this, often mouse models of atherosclerosis are used. The most frequently utilized 







mice spontaneously develop hypercholesterolemia on a regular chow diet. In 
addition, atherosclerotic lesions similar to that found in humans develop throughout 





 In this model, Western-type diet feeding is used 
to induce hypercholesterolemia and subsequent atherosclerosis development. In 
general, the atherosclerotic lesions in the murine arterial tree are initially 
characterized as fatty streaks containing lipid cores and cholesterol crystals.
39
 In 
more advanced lesions calcification can be detected, though limited.
39
 The 
aforementioned suggests that the apoE
-/-
 mouse model is a perfect model for 
mimicking human atherosclerosis and cardiovascular disease. The opposite is true. 






 never found lesions in the coronary artery. As a result, mice will 
not suffer from myocardial infarction. In addition, plaque rupture, an important 
feature that underlies human myocardial infarction can not be studied.
40,41
 
Vulnerable plaques and subsequent rupture can be detected in the brachiocephalic 
artery of mice. However, there is no consensus on whether or not this observed 
vulnerability meets the criteria set for the human situation.
41
  




 strain are good models for studying early 
pathogenesis of atherosclerosis, we used them in the experiments described in this 
thesis. Early atherosclerotic lesion development is studied in the aorta and 









 mice, heterozygous 
mice are athero-resistant. In this way, we were able to examine the effects of 
environmental risk factors. In addition, we addressed the challenging question how 
an adverse maternal environment can be translated into an increased 
atherosclerosis susceptibility of the offspring. Which maternal signals affect the 
offspring and what epigenetic mechanisms are involved to predispose the 






In Chapter 2 we demonstrate that intrauterine exposure to maternal atherosclerotic 
risk factors associated with apoE-deficiency induces susceptibility for 
cardiovascular disease in apoE
+/-
 offspring that persists into adult life. 
 
Chapter 3 shows that maternal apoE-deficiency is sufficient to allow collar-induced 
neointima formation in apoE
+/-
 offspring, even without cholesterol feeding, 
sustaining the hypothesis that the intrauterine environment poses a major risk 
factor for adult cardiovascular disease. 
 
ApoE-deficiency is characterized by hypercholesterolemia, high oxidative stress, as 
well as increased inflammatory status and altered innate immune function. Chapter 
4 more specifically describes the role of maternal hypercholesterolemia in prenatal 







In Chapter 5 we present data that adult vascular endothelial cells in vivo are 
capable of undergoing endothelial-to-mesenchymal-transformation. Through this 
transdifferentiation endothelial cells contribute to the total pool of mesenchymal 
cells that compose the neointima. The data indicate that endothelial-to-
mesenchymal-transformation could be important in development and progression 
of cardiovascular disease.   
 
Chapter 6 describes the role of a number of maternal signals that exert adverse 
effects on the intrauterine environment and subsequent cardiovascular disease risk 
in the offspring. Furthermore, we discuss several epigenetic mechanisms possibly 
underlying intrauterine programming leading to increased atherosclerosis 
susceptibility.  
 
In Chapter 7 the effect of maternal apoE-deficiency on DNA methylation and 
histone modifications in the vasculature of apoE
+/-
 offspring is investigated. We 
demonstrate that intrauterine exposure results in tissue-specific alterations in 
histone modification patterns in the vascular wall providing us with a first indication 
of an underlying epigenetic mechanism to explain the increased atherosclerosis 







Chapter 8 provides a general discussion on the fetal origin of adult cardiovascular 
disease, the prenatal risk factors involved and possible underlying mechanisms. 
Moreover, the implications of these data on prevention, lifestyle management and 
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Maternal hypercholesterolemia is associated with a higher incidence and faster 
progression of atherosclerotic lesions in neonatal offspring. We aimed to determine 
whether an in utero environment exposing a fetus to maternal 
hypercholesterolemia and associated risk factors can prime the murine vessel wall 
to accelerated development of cardiovascular disease in adult life. To investigate 
the epigenetic effect in utero, we generated genetically identical heterozygous 
apolipoprotein E-deficient progeny from mothers with a wild-type or apolipoprotein 
E-deficient background. A significant increase in loss of endothelial cell volume 
was observed in the carotid arteries of fetuses from apolipoprotein E-deficient 
mothers, but fatty streak formation was absent. Spontaneous atherosclerosis 
development was absent in the aorta and carotid arteries in adult life. We 
unilaterally placed a constrictive collar around the carotid artery to induce lesion 
formation. In offspring from apolipoprotein E-deficient mothers, collar placement 
resulted in severe neointima formation in 9 of 10 mice analyzed compared with 
only minor lesion volume (2 of 10) in the progeny of wild-type mothers. We 
conclude that the susceptibility to neointima formation of morphologically normal 
adult arteries is already imprinted during prenatal development and manifests itself 
in the presence of additional atherogenic risk factors in adult life. Future research 
will concentrate on the mechanisms involved in this priming process, as well as on 














Postnatal risk factors of atherosclerosis are well-defined and mechanisms 
contributing to lesion formation are increasingly understood. Previous studies 
showed that the atherogenic process in humans can already start during fetal 
development.
1
 In a morphometric postmortem analysis of atherosclerosis in fetuses 
and children (Fate of Early Lesions in Children Study),
2
 it was demonstrated that 
specifically maternal hypercholesterolemia was associated with a higher incidence 
of atherosclerotic lesions during the fetal period and a faster progression of these 
atherosclerotic lesions after birth, even under conditions of normocholesterolemia 
in the offspring. A causal role for maternal hypercholesterolemia in fetal lesion 
formation was demonstrated in a genetically nonhomogeneous rabbit model of 
diet-induced hypercholesterolemia and confirmed in a low-density lipoprotein 




 Raised cholesterol intake of pregnant 
Ldlr
-/-
 mice accelerated the progression of spontaneous atherosclerotic lesions in 
the Ldlr
-/-
 progeny. Because these mice have elevated plasma cholesterol levels 
independent of the maternal cholesterol levels during postnatal life, they are 
genetically prone to develop atherosclerotic lesions. The question remains whether 
solely environmental atherogenic risk factors present in utero can prime the 
developing vascular system.  
We hypothesized that the offspring without a genetic predisposition for 
spontaneous atherosclerosis, which had been exposed in utero to maternal 
atherosclerotic risk factors, would show increased susceptibility for atherosclerosis 
development in adult life compared with offspring from wild-type mothers. To solely 
investigate the epigenetic effect, we generated genetically identical heterozygous 
apolipoprotein E-deficient mice (apoE
+/-
) from mothers with a normocholesterolemic 
wild-type or a hypercholesterolemic apoE-deficient (apoE
-/-
) background and 
studied the morphology of the carotid arteries during the fetal and adult period. 
Homozygous apoE-deficiency is associated with hypercholesterolemia and 





 mice on the other hand, only develop hypercholesterolemia 
and atherosclerosis when fed a high-fat Western-type diet.
7,8
 To study the effect of 
maternal atherosclerotic risk factors in utero, we examined the morphology of the 
vascular wall in the late fetal stages. To investigate a possible increased 
vulnerability to atherosclerosis in adulthood, we studied neointima formation in both 
groups after induction of lowered shear stress levels by perivascular constrictive 









 mice used were generated by homologous recombination in embryonic 
stem cells as described and backcrossed ≥8 times to a C57Bl/6J background.
8
 
Wild-type C57Bl/6J mice were purchased from Charles River Laboratories 
(Maastricht, The Netherlands, import agency for Jackson Laboratories). The apoE
-/-
 
and wild-type mice were crossbred to generate genetically identical apoE
+/-
 fetuses 
(n=20 each group) from apoE
-/-
 mothers (n=5) as well as from wild-type mothers 
(n=5). To examine the long-term effects of prenatal exposure to risk factors for 
atherosclerosis, we used female apoE
+/-
 offspring (n=10 each group). After 
weaning (age 4 weeks), the animals received a Western-type diet (1% cholesterol, 
Hope Farms) for 16 weeks. Diet and water were provided ad libitum. The 
Committee on Animal Welfare, Leiden University Medical Center, approved all of 
the animal experiments. 
 
Lipid Measurements 
Total levels of cholesterol and triglycerides were enzymatically quantified in blood 
plasma of 4-hour fasted animals by using commercially available kits (Roche). 
Adult blood samples were obtained through tail bleeding. Maternal blood samples 
were acquired before pregnancy and at day 17.5 of pregnancy while fetal blood 
samples were acquired by decapitation at embryonic day 17.5 (E17.5). Samples of 
the offspring were acquired at the postnatal ages of 4, 8 and 16 weeks. 
 
Carotid Collar placement 





 offspring and C57BL/6J controls (n=5) at the age of 16 weeks 
as previously described.
9
 Mice were anesthetized by intraperitoneal injection of 
Domitor (0.5 mg/kg, Pfizer), Dormicum (5 mg/kg, Roche) and Fentanyl (0.05 
mg/kg, Janssen-Cilag). A constrictive silicone collar (0.31 mm ID, 0.64 mm OD, 
and 2.0 mm length, Helixmark) was placed around the left common carotid artery. 
After wound closing, anesthesia was antagonized with a subcutaneous injection of 
Antisedan (2.5 mg/kg, Pfizer), Anexate (0.5 mg/kg, Roche) and Naloxone (1.2 
mg/kg).  
 
Magnetic Resonance Microscopy 
Visualization of the arterial tree was performed 4 weeks after collar placement. For 
detailed information on MRI see Appendix. 
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Tissue Harvesting and Preparation 
At E17.5, fetal thorax tissue was removed and fixed in 4% paraformaldehyde  in 
0.1 mol/L of sodium phosphate buffer (pH 7.4) for 48 hours or embedded in 
TissueTek (Bayer) for nonfixated cryosections. Four weeks after collar placement, 
the mice were anesthetized and the thorax opened. Pressure-perfusion fixation (76 
mm Hg) was performed through the cardiac left ventricle with PBS for 5 minutes 
followed by 4% paraformaldehyde in 0.1 mol/L of PHEM buffer (60 mmol/L of 
Pipes, 25 mmol/L of Hepes, 10 mmol/L of ethyleneglycoltetraacetic acid, and 2 
mmol/L of MgCl2; pH 6.97) for 5 minutes. The aorta and common carotid arteries 
were harvested and the collar was removed. Pressure-perfusion with only PBS was 
used for cryosections. The specimens were fixed for 48 and 6 hours, respectively, 
in 4% paraformaldehyde in 0.1 mol/L of PHEM buffer. After fixation, the tissue was 
dehydrated in ethanol and xylene and paraffin embedded. Transverse 5-µm 
sections were cut and serially mounted.  
  
Immunohistochemistry 
Routine staining was performed with hematoxylin and eosin, Resorcin-Fuchsin for 
detection of elastin, Sirius red for collagen, and Oil Red O to assess lipid 
deposition. Unless indicated otherwise, the immunohistochemistry was performed 
as described.
10
 Sections were incubated overnight at room temperature with a 
mouse monoclonal primary antibody against α-smooth muscle actin to identify 
vascular smooth muscle cells (1:2000, Sigma Aldrich, Product No. A2547), a rat 
monoclonal anti-CD31 (1:50, PharMingen) and rabbit polyclonal anti-von 
Willebrand factor (vWF; 1:2000, DAKO) to study endothelial cells, and a rat 
monoclonal Mac-3 (1:400, PharMingen) against macrophages. Goat anti-rabbit 
biotin conjugate (1:200, Vector), goat anti-rat biotin conjugate (1:200, PharMingen), 
and rabbit anti-mouse peroxidase conjugate (1:200, DAKO) with normal goat and 
mouse serum diluted in PBS were used as secondary antibodies (1 hour at room 
temperature). Biotin labeling was followed by incubation with Vectastain ABC 
(Vector). The CD31 signal was enhanced with a colony-stimulating activity kit 
(DAKO). 3-3’ Diaminobenzidine tetrahydrochloride was used as chromogen and 
counterstaining was performed with Mayer’s hematoxylin.  
 
Morphometry 
To estimate the total volume of endothelial cells in the fetal carotid arteries at E17.5 
the Cavalieri principle,
11
 a point counting method using a grid, was used in 5 
equally spaced sections stained with vWF (n=5 each group). In addition,        




adult carotid artery. To exclude bias because of differences in maximum neointima 
area, the complete plaque was studied by volume measurements. Lumen and 
medial volume were also estimated. Contralateral noncompromised carotid arteries 
were assessed in a comparable region. Fifteen equally spaced sections were 
examined. The total intimal volume was measured between the endothelial cell 
monolayer and internal elastic lamina and total medial volume between the 
external and internal elastic lamina. The intima/media ratio was calculated by 
dividing the intimal volume by the medial volume. 
 
Statistical Analysis 
Data are represented as mean ± SEM. Paired and unpaired data were evaluated 
by 2-tailed Student’s t-test. The differences were considered to be significant if P < 
0.05. 
 






To study the effect of maternal hypercholesterolemia and associated risk factors on 
fetal lipid levels, we determined maternal and fetal plasma cholesterol and 
triglyceride levels. Maternal total plasma cholesterol and triglyceride levels are 
shown in Table 1. As expected, before and during pregnancy plasma cholesterol 
and triglyceride levels differed significantly between wild-type and apoE
-/-
 mothers. 
Plasma cholesterol concentrations in both groups significantly decreased during 
pregnancy. A striking reduction of 51% was observed in plasma cholesterol levels 
of apoE
-/- 
mothers at pregnancy day 17.5 but the cholesterol status remained 
hypercholesterolemic. Plasma triglyceride levels increased significantly in pregnant 
wild-type mothers, but not in the apoE
-/-
 mothers.  
 Maternal hypercholesterolemia in apoE
-/-
 mothers resulted in a significant 
plasma cholesterol elevation in apoE
+/-
 mice at E17.5 compared with fetuses from 
wild-type mothers (Table 2). The plasma cholesterol levels found in apoE
+/-
 
offspring at weaning and in adult life after a Western-type diet were similar. Plasma 
triglyceride levels were low in all of the fetuses.  
 
Table 1. Maternal plasma cholesterol and triglyceride levels 
Mother  TC (mmol/L)  TG (mmol/L) 
Wild-type   
Before pregnancy   1.98 ± 0.15* 0.50 ± 0.03* 
Pregnancy day 17.5   1.33 ± 0.04* 1.58 ± 0.12* 
   
ApoE
-/-
   
Before pregnancy  20.13 ± 0.44
‡*
 1.50 ± 0.10
‡
 
Pregnancy day 17.5     9.42 ± 0.79*
‡
 2.08 ± 0.21
‡
 
All data are shown as mean ± SEM. TC indicates total plasma cholesterol;  
TG, total plasma triglyceride.
 *
P < 0.05 versus before pregnancy,  
‡
P < 0.05 versus other group at same time point.
 
 
Fetal Carotid Artery Composition 
To examine the effect of intrauterine exposure to maternal atherosclerotic risk 
factors on fetal vascular remodeling, we studied the morphology of the vascular 
wall of the carotid arteries in apoE
+/-
 fetuses from wild-type and apoE
-/-
 mothers at 
E17.5. No fatty streaks were observed in the carotid arteries of all fetuses. 
However, in carotid arteries of fetuses from apoE
-/-
 mothers increased endothelial 





detected several areas in the carotid arteries where endothelial cells were absent. 
Morphometry revealed significantly less endothelial cell volume in the carotid 
arteries of apoE
+/-
 fetuses from apoE
-/-
 mothers compared with fetuses from wild-
type mothers (18.81 ± 1.54x10
4




; Figure 1B). We 
found no lipid deposition in the vascular wall. In addition, Mac-3 staining showed 
that macrophages were not present in the vascular wall (results not shown). 
Overall quantification of vWF staining intensity in individual endothelial cells 
showed no significant difference between the two groups. 
 
Table 2. Offspring plasma cholesterol and triglyceride levels 
Mother Offspring TC (mmol/L) TG (mmol/L) 
Wild-type ApoE
+/-
   
 E17.5 1.54 ± 0.04 0.30 ± 0.01 
 4 weeks 2.00 ± 0.03 0.93 ± 0.03 
 8 weeks 6.21 ± 0.14 0.70 ± 0.02 
 16 weeks 7.89 ± 0.31 0.44 ± 0.02 





   
 E17.5 2.11 ± 0.06* 0.37 ± 0.02 
 4 weeks 1.90 ± 0.06 0.81 ± 0.05 
 8 weeks 7.08 ± 0.21 0.56 ± 0.04 
 16 weeks 7.73 ± 0.36 0.47 ± 0.02 
All data are shown as mean ± SEM. TC indicates total plasma 
cholesterol; TG, total plasma triglyceride. *P < 0.000 at E17.5 versus 
other group at the same time point. 
 
Carotid Artery Visualization by MRI 
Four weeks after collar placement, the carotid arteries and the position of the collar 
could clearly be visualized with magnetic resonance microscopy in all of the 
C57BL/6J mice (Figure 2A). In 4 of 5 apoE
+/-
 mice born from wild-type mothers, the 
angiography revealed a normal carotid artery lumen proximal to the position of the 
collar (Figure 2B). In 1 case the left carotid artery could not be visualized as a 
result of thrombus formation within the collar (confirmed by histology). In the group 
of apoE
+/-
 mice from apoE
-/-
 mothers, only 1 angiography resembled the wild-type. 
In 2 cases the lumen of the left carotid artery was only partly visualized, whereas in 
the other 2 mice the left carotid artery lumen was completely absent (Figure 2C). 
Histology revealed that the lack of visualization was caused by severe lumen 
narrowing as a result of presence of intimal thickening proximal to the collar.  




Figure 1. Effects of in utero exposure of apoE
+/-
 fetuses to maternal atherosclerotic risk factors on 
endothelial cells of the carotid arteries. (A) Representative immunostaining for vWF and CD31 in cross-
sections from apoE
+/-
 fetuses from wild-type (Mat WT, left panels) and apoE
-/-
 mothers (Mat apoE
-/-
, right 
panels) at age E17.5. Region between broken lines indicates an area of decreased expression of vWF 
and CD31, respectively. Scale bars, 20 µm. (B) Morphometric analysis of endothelial cell volume in the 




Figure 2. Effects of a constrictive collar four weeks after placement around the left common carotid 
artery. Angiographies representative for 20 weeks old (A) wild-type (WT), (B) apoE
+/-
 from wild-type 
mothers (Mat WT) and (C) apoE
+/-
 mice from apoE
-/-
 mothers (Mat apoE
-/-
). The induced intimal 
thickening in Mat apoE
-/-
 reduces the flow to an undetectable level, only the trunk of the LCCA is visible. 
BA indicates basilar artery; VA, vertebral artery; RCCA, right common carotid artery; LCCA, left 









Spontaneous neointima formation was assessed in adult apoE
+/-
 offspring from 
wild-type and apoE
-/-
 mothers at the age of 20 weeks. No lesions were detected at 
the level of the aortic root and in the aortic arch (see Appendix). In addition, in 
noncompromised carotid arteries normal vascular wall morphology was observed 
(Figure 3A). We found that collar placement resulted in severe neointima formation 
proximal to the collar in apoE
+/-
 mice from apoE
-/-
 mothers (9 of 10) compared with 
minor lesions in the offspring from wild-type mothers (2 of 10) (Figure 3B-C). 









; P = 0.018; Figure 4A). A trend 
towards increased medial volume was observed as result of collar placement 
(Figure 4B). A significant increase in medial volume was detected between the 









; P = 0.04). Medial volumes 
between the contralateral arteries of both groups did not differ. The intima/media 
ratio was significantly increased in apoE
+/-
 mice from apoE
-/-
 mothers (0.15 ± 0.05 
versus 0.01 ± 0.01; P = 0.017; Figure 4C). Severe lesions were characterized by a 
cylindrical structure and maximal intima/media ratios of ≈ 1.0.  
  
Lesion Composition 
To assess the role of several cell lineages in intimal proliferation, neointimal lesion 
composition was studied. The endothelial cell lining was, in contrast to the findings 
in the fetuses, in all cases intact (Figure 5A). The vWF was absent in the 
endothelial cells and present subendothelially (Figure 5B). All lesions contained 
macrophages (Figure 5C). Extensive extracellular matrix deposition was 
demonstrated throughout the neointima by increased presence of elastin and 
collagen (Figure 5D-E). Enhanced medial volume in collared arteries appeared 
also to be the result of increased collagen production. All elastic lamina of the 
media were intact, thereby excluding major invasion of medial smooth muscle cells 
into the intima at this stage. Staining for α-smooth muscle actin was not restricted 
to the media, but positive cells were also detected in the intima (Figure 5F).  
 Oil red O staining revealed that Western-type diet alone did not result in 
lipid deposition in the carotid arteries (Figure 6A). A second trigger, collar 
placement, resulted in limited accumulation of lipids in the media only directly 
proximal to the collar in apoE
+/-
 mice from wild-type mothers (Figure 6B). On the 
contrary, massive lipid deposition was observed in the intima as well as in the 
media of collared arteries of apoE
+/-
 mice from apoE
-/-
 mothers (Figure 6C).  
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The vascular wall of all contralateral, noncompromised carotid arteries showed a 
normal morphology. In addition to immunohistochemical analysis of these arteries, 
we performed microarray analysis to detect changes in intrinsic gene expression 
patterns (see Appendix for preliminary data). 
                
Figure 3. Morphology of adult carotid arteries. Mice were euthanized at 20 weeks of age, 4 weeks after 
collar placement. Perfusion-fixation induced dilatation of the arteries. Presence of intimal thickening 
prevented dilatation. Representative HE staining in cross-sections from (A) noncompromised carotid 
arteries and the region proximal to the collar in apoE
+/-
 mice from (B) wild-type and (C) apoE
-/-
 mothers, 
respectively. I indicates intima; M, media; LEI, lamina elastica interna. Scale bars: 30 µm.  
 
Figure 4. Morphometric analysis of the effects of collar placement. (A) Estimation of intimal volume and 
(B) medial volume of noncompromised (control) and collared carotid arteries of apoE
+/-
 mice from wild-




) mothers. (C) Calculated intima/media ratio for the collared 
carotid arteries of both apoE
+/-





Figure 5. Neointima composition. Representative cross-sections from apoE
+/-
 mice from apoE
-/-
 mothers 
were stained to study (A and B) endothelial cells, (C) macrophages, (D and E) extracellular matrix 
production and (F) α-sm actin expression. I indicates intima; M, media; LEI, lamina elastica interna. 
Scale bars: 30 µm.   
 
Figure 6. Oil Red O staining. Representative staining in cross-sections from (A) noncompromised 
carotid arteries and the region proximal to the collar in apoE
+/-
 mice from (B) wild-type and (C) apoE
-/-
 
mothers. The collar induces deposition of lipids in the media in the low flow areas in B. Note the 
increase in lipid deposition in the Mat apoE
-/-
 offspring in C. I indicates intima; M, media; LEI, lamina 
elastica interna; L, lumen. Scale bars, 30 µm.                                                                                           




The present study has provided evidence 
that the susceptibility to atherosclerosis of 
morphologically normal adult vessels can 
already be imprinted during prenatal 
development. We showed that in utero 
exposure of apoE
+/-
 embryos and fetuses 
to environmental maternal atherosclerotic 
risk factors can prime the vasculature to 
severely aggravated neointima formation in 
morphological normal adult carotid arteries 
after collar placement compared with 
nonexposed offspring from wild-type 
mothers. In apoE
+/-
 mice the remaining 
apoE allele is sufficient to generate plasma 
apoE levels equal to those of wild-type 
animals (reviewed by Getz and 
Reardon
12
). Furthermore, plasma lipid 
levels of both groups of
 
mice are 




spontaneous atherosclerosis development 
in the aortic root is absent. Homozygous 






 and enhanced 
inflammatory status,
14
 and all of these 
factors may have a role in the process of 
programming of the vessel wall of apoE
+/-
 offspring. However, contribution of other 
factors associated with apoE-deficiency cannot be excluded.  
 Because apoE-deficiency is associated with hypercholesterolemia, we 
assessed the effect of increased maternal cholesterol status on fetal cholesterol 
levels. In our analysis we found that maternal hypercholesterolemia enhanced fetal 
plasma cholesterol levels. Neonatal plasma cholesterol levels did not differ 
between apoE
+/-
 mice from apoE
-/-
 and wild-type mothers. Our data are in 
concordance with previous studies in humans, rats, and mice that demonstrated 
that no correlation exists between maternal and fetal plasma cholesterol levels late 
in pregnancy and at and after birth.
1,15-17
 However, we have no data available on 




indicate that, during mid-pregnancy, fetal plasma cholesterol levels are very 
high,
1,18
 the slight significant difference observed at E17.5 may be a reflection of 
larger differences earlier in development.  
 Studies in human subjects revealed that fatty streaks are present in fetal 
aortas and carotid arteries, and the existence of maternal hypercholesterolemia 
throughout pregnancy leads to an increased number and size of the lesions.
1,19
 In 
human cerebral and coronary arteries on the other hand, no lipid accumulations 
and macrophages were detected prenatally.
19,20
 In rabbits, diet-induced maternal 
hypercholesterolemia results in extensive lesion formation in the aorta of the 
offspring at birth.
3
 Our data show that the presence of maternal atherosclerotic risk 
factors leads to endothelial cell activation and damage in carotid arteries of apoE
+/-
 
fetuses. Except for these early markers of atherosclerosis,
21
 no morphological 
abnormalities, e.g. fatty streaks, were observed in the murine fetal carotid arteries.  
 Furthermore, no intimal thickening was detected in the aorta of the fetuses 
(unpublished data). Anatomical and functional differences in arteries, as well as 
discrepancies between species, may explain the observed distinction in 
atherosclerotic lesion formation in fetal life. Because apoE
+/-
 mice from apoE
-/-
 
mothers lack atherosclerotic lesions in fetal vasculature and spontaneous lesion 
formation in the aortic root, aortic arch, and carotid arteries at the age of 20 weeks, 
our model is very useful to study the long-term consequences of imprinting of 
morphologically normal vessels.    
ApoE-deficiency leads to high levels of reactive oxygen species in the 
circulation and tissues.
22
 In addition, it has been described that atherosclerosis 
development in these mice is accompanied by a reduction in antioxidant enzymes 
in the athero-prone areas.
23
 It has been suggested that reactive oxygen species 
pass the placenta
24
 and as a result may influence the oxidative status of the fetus. 
Napoli and colleagues
3
 and Palinski and colleagues
25
 reported that addition of 
vitamin E or cholestyramine to the diet of rabbits significantly diminished 
atherosclerosis in the offspring. Oxidative stress has also been described to affect 
DNA methylation.
26,27
 As a consequence, embryonic development, as well as other 
physiological processes may be modulated by increased oxidative stress. We 
hypothesize that maternal hypercholesterolemia through oxidative stress affects 
signaling processes in the cell lineages of the fetal vascular wall and bone marrow 
leading to functional changes in these cells. That epigenetic changes are likely to 
be responsible for the aggravated atherogenic response to collar-induced shear 
stress changes in adult life is currently a focus of our ongoing investigations.  
There seems to be a paradox between our study and a previous study by 
Madsen and colleagues
15
 who did not observe an effect of in utero exposure to 
maternal atherosclerotic risk factors on atherosclerotic lesion formation in adult life.  
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In the latter study, spontaneous lesion formation was induced by a Western-type 
diet containing the strong atherosclerosis-inducing factor cholate. In long-term 
survivors, they detected equal degrees of advanced atherosclerosis. In our study, 
spontaneous expression of atherosclerosis was missing, and we studied the initial 
stages of neointima formation, which turned out to be different between the two 
groups of apoE
+/-
 mice. Therefore, our studies cannot be reliably compared. 
The striking differences in adult lesion formation between the in utero 
exposed and nonexposed apoE
+/-
 mice raise the question which cell types involved 
are affected during embryonic development. The most obvious vascular cell 
populations to be considered are the endothelial and smooth muscle cells of the 
carotid arteries and the circulating bone marrow-derived cells. Changes in the gene 
expression profiles of mural cells after in utero exposure to high cholesterol levels 




 Diet-induced maternal 
hypercholesterolemia in Ldlr
-/- 
mothers significantly altered the expression of 139 
genes in descending aortas of Ldlr
-/- 
offspring without signs of lesion formation. 
These data are in line with our gene set enrichment analysis of the microarray data 
of noncompromised carotid arteries showing changes in gene expression as a 
result of in utero exposure to maternal atherosclerotic risk factors (see Appendix). 
This method allows insight into the dynamics of genes contributing to a gene set 
without having to work within the fixed thresholds that genes have to meet to be 
differentially expressed and demonstrated altered regulations of various pathways 
in the vascular wall. Larger sample sizes of carotid arteries and descending aortas 
in combination with laser dissection microscopy will give us insight into the 
vulnerability of the individual cell populations for induction of changes in gene 
expression as a consequence of prenatal exposure to atherosclerotic risk factors. 
 In conclusion, the present study has provided evidence that the 
susceptibility to atherosclerosis of morphologically normal adult vessels is already 
imprinted during prenatal development and is not genetically determined in our 
model. In the presence of additional risk factors, neointima formation in adult life is 
severely accelerated. Our findings indicate that the basis for development of 
atherosclerosis in adult life is already laid down during embryonic development. 
Risk factors for atherosclerosis in human adults are mainly associated with 
lifestyle. Extensive lifestyle management can, thus, reduce the number of 
environmental triggers that induce aggravated atherosclerotic lesion formation. 
Future research will concentrate on the mechanisms involved in the priming 
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Magnetic Resonance Microscopy 
Mice were imaged in vivo using a vertical 9.4T (400 MHz), 89 mm bore magnet 
with a shielded 1T/m gradient and a transmit/receive birdcage radiofrequency coil 
with an inner diameter of 30 mm (Bruker Biospin, Rheinstetten, Germany). Bruker 
ParaVision 3.02 software was used for image acquisition and analysis. Mice (n=5 
each group) were initially anesthetized with 4% isoflurane (Abbott, Hoofddorp, The 
Netherlands) in air (0.3 l min
-1
) and O2 (0.3 l min
-1
) and maintained with ~1.5% 
isoflurane during all procedures. Anesthetized mice were mounted into a 
probehead and inserted head-up into the magnet. The respiratory rate was 
monitored via an air-pressure cushion connected to a laptop using Biotrig software 
(Bruker, Rheinstatten, Germany). The depth of the anesthesia was continuously 
regulated to maintain a stable respiration rate during the experiment. We used a 
3D FLASH (fast low angle shot) sequence with an echo time of 1.85 ms, a 
repetition time of 30 ms, a 0.8 ms sinc radio frequency pulse with a flip angle of 30 
degrees and a spectral band width of 100 kHz. With a field of view (FOV) of 
20x20x20 mm, a matrix of 256x256x256 an isotropic resolution of 78 µm was 
reached within a scan time of 32 minutes and 46 seconds. 3D angiograms were 
generated in ParaVision by maximum intensity projection. 
 
Microarray 
Total RNA was isolated from noncompromised contralateral carotid arteries at the 
age of 20 weeks of 3 apoE
+/-
 offspring from wild-type mothers and 4 offspring from 
apoE
-/-
 mothers. RNA was isolated with the RNAqueous
®
 Micro Kit (Ambion, 
Cambridgeshire, UK) according to the manufacturers protocol. The RNA 
concentration was determined by absorbency at 260 nm with a NanoDrop (Isogen 
Life Science B.V., IJsselstein, The Netherlands) and RNA integrity was verified by 
use of the RNA 6000 Pico assay on a Agilent 2100 Bioanalyzer (Agilent 
Technologies, Amstelveen, The Netherlands). All of the RNA was subjected to a 
first round of oligo-dT primed amplification with the MessageAmp™II aRNA 
Amplification Kit (Ambion). One µg of aRNA was used in a random primed second 
round of amplification (MessageAmp™II-Biotin Enhanced Kit, Ambion) to obtain 
biotin labeled aRNA. Hybridization, washing and scanning of mouse genome 430A 





protocols (http://www.affymetrix.com). After scanning, the images were quantified 
using the Affymetrix GeneChip Operating software. The scaled data were then 
imported into the R software environment (http://www.R-project.org) and analyzed 
with the Bioconductor (http://www.bioconductor.org) R/affy package. Normalization 
was performed by the Robust Multi-array Average method.
1
 Gene expression 
levels were analyzed with the R/limma package (http://www.bioconductor.org) and 














mice only develop atherosclerosis when fed a high fat Western-type diet. 
To examine the extent of spontaneous lesion development in our mouse model, 
the aortas of the apoE
+/-
 mice from apoE
-/-
 and wild-type mothers were examined at 
the termination of the experiment, at the age of 20 weeks. No atherosclerotic 
lesions were observed at the level of the aortic root (Figure 1A). Furthermore, no 
lesions were observed in the aortic arch and at the bifurcations (Figure 1B).  
 
 
Figure 1. Analysis of spontaneous atherosclerosis. Pictures representative for (A) aortic root and (B) 
aortic arch. No lesions detectable. AAo indicates ascending aorta; LV, left ventricle; BCA, 
brachiocephalic artery; LCCA, left common carotid artery; LSA, left subclavian artery; AoA, aortic arch; 
DAo, dorsal aorta. Scale bars: (A) 200 µm and (B) 300 µm. 
 
Gene Expression 
Given the effect of intrauterine exposure to atherosclerotic risk factors on fetal 
carotid arteries and atherosclerotic lesion formation in adult life, we performed 
microarray analysis on the noncompromised carotid arteries of the apoE
+/-
 mice 
from both wild-type and apoE
-/-
 mothers to detect changes in intrinsic gene 
expression patterns. Up to 3309 genes had an unadjusted P-value of < 0.05 and 
626 an unadjusted P-value of < 0.01. After correction for multiple testing no 
differentially expressed genes were detected. To exclude the possibility that 
relevant biological differences were not detected due to the relative noise inherent 
to the microarray technology, a gene set enrichment analysis was performed.
3
 This 
analysis revealed a number of upregulated pathways among which the CTLA-4 
and TCRA T-cell activating pathway, the pro-inflammatory IL-12/STAT-4 pathway 





(Table 1). The complete microarray analysis is available at 
http://www.ncbi.nlm.nih.gov/geo/, query GSE6134. Although the amount of 
samples available for the microarray analysis was limited, the nominal P-value was 
significant for the top ranked pathways. Therefore, the results may give rise to 
hypotheses for future research. 
 
Table 1. Top ranked pathways gene set enrichment analysis.  
ID Pathway nominal P-value 
1 TCA 0.000 
2 MAP00190_Oxidative_phosporylation 0.000 
3 FA 0.000 
4 Krebs-TCA_Cycle 0.000 
5 GO_0005739 0.000 
6 TcytotoxicPathway 0.037 
7 CR_immune_function 0.038 
8 TcraPathway 0.040 
9 Ctla4Pathway 0.040 
10 Il17Pathway 0.042 
11 Tob1Pathway 0.043 
12 IL12Pathway 0.047 
13 No2il12Pathway 0.049 
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We have previously shown that adult apoE
+/-
 offspring from apoE
-/-
 mothers exhibit 
increased susceptibility to cardiovascular disease, as compared to adult apoE
+/-
 
offspring from wild-type mothers. In this model, neointimal lesions, as a reflection of 
cardiovascular disease, were induced by placement of a constrictive collar around 
the carotid artery in combination with a high-cholesterol diet. The aim of the 
present study was to investigate whether adult apoE
+/-
 offspring from apoE
-/-
 
mothers are also more susceptible to neointima formation without feeding a 
cholesterol-containing diet. On a chow diet, both types of apoE
+/-
 offspring were 
normocholesterolemic. After placement of a constrictive collar, lesions could not be 
detected in apoE
+/-





 did develop neointimal lesions. These neointimal lesions were small 
and relatively a-cellular. The mesenchymal cells stained positive for α-smooth 
muscle actin and were negative for the macrophage marker Mac-3. We conclude 
that intrauterine exposure to maternal apoE-deficiency is sufficient to allow collar-
induced neointima formation, even without cholesterol feeding, sustaining the 
hypothesis that the intrauterine environment poses a major risk factor for adult 
cardiovascular disease. 




Although the exact cause of atherosclerosis is unknown, many risk factors have 
been identified, for example age, gender, smoking, hypertension, 
hypercholesterolemia, obesity, and lack of physical exercise. These factors 
accumulate throughout life and operate synergistically, thereby promoting earlier 
and more severe onset of disease.  
 In addition to adult onset risk factors for atherosclerosis, prenatal risk 
factors have been identified. The “fetal origins hypothesis” postulated by Barker
1
 
proposes that adjustment to an unfavorable maternal environment is beneficial to 
the developing embryo. However, these adaptations may lead to an increased 
disease risk as the adult environment differs from the fetal situation. Examples of 
prenatal risks are fetal undernutrition and maternal hypercholesterolemia. Fetal 
undernutrition leads to persisting changes in a range of metabolic processes in the 
fetus thereby enhancing cardiovascular disease risk in adulthood.
2-4
 Intrauterine 
exposure to maternal hypercholesterolemia on the other hand, has been reported 
to enhance fatty streak formation, as well as lesion size in aortas of fetuses from 
hypercholesterolemic mothers compared with fetuses from normocholesterolemic 
mothers.
5
 After birth, lesion progression remained accelerated in these children in 
relation to children from normocholesterolemic mothers.
6
  
 To study the long-term consequences of intrauterine exposure to 
environmental maternal atherosclerotic risk factors such as hypercholesterolemia, 
we have used a genetically homogeneous mouse model. We were able to 
demonstrate increased endothelial cell activation and vascular injury in 
heterozygous apolipoprotein E-deficient (apoE
+/-
) fetuses from homozygous 
apolipoprotein E-deficient (apoE
-/-
) mothers as compared to genetically identical 
apoE
+/-
 fetuses from wild-type mothers.
7
 Combined constrictive collar placement 
around the left common carotid artery and high-cholesterol feeding in adult apoE
+/-
 
offspring severely aggravated neointima formation in apoE
+/-
 offspring from apoE
-/-
 
mothers whereas almost no lesions were found in apoE
+/-
 offspring from wild-type 
mothers. However, it remained unclear whether solely intrauterine exposure to 
maternal apoE-deficiency was sufficient for increased development of 
cardiovascular disease in adult life.  





 mothers are also more susceptible for neointima formation in absence 
of a high-cholesterol diet. We generated genetically identical apoE
+/-
 offspring from 
normocholesterolemic wild-type mothers, as well as from hypercholesterolemic 
apoE
-/-
 mothers. Mice heterozygous for the apoE allele are comparable to wild-type 







Even when fed a diet containing cholesterol, these mice do not develop 
atherosclerosis spontaneously up to the age of 20 weeks.
7
 The probability that 
apoE
+/-
 mice will develop atherosclerosis spontaneously during their life time is 
quite low. To investigate the consequences of prenatal priming on the susceptibility 
for cardiovascular disease, neointimal lesions, as a reflection of cardiovascular 
disease, were induced by placement of a constrictive collar around the left common 
artery of both apoE
+/-
 offspring from wild-type mothers and apoE
+/-
 offspring from 
apoE
-/-
 mothers. With the collar technique we can mimic the normal aging process 
and at the same time accelerate the process of atherosclerosis. The high-
cholesterol diet that was used in our previous study
7
 was replaced by regular chow 
to maintain normocholesterolemic conditions throughout the experiment.  
 
 








 and wild-type C57Bl/6J mice were purchased from Charles River 
Laboratories (Maastricht, The Netherlands, import agency for Jackson 
Laboratories). ApoE
-/-
 mothers were crossed with wild-type fathers and vice versa 
to generate genetically identical apoE
+/-
 offspring from wild-type as well as from 
apoE
-/-
 mothers. Female offspring (n=5 each group) were used for experiments. 
Regular chow and water were provided ad libitum. The Committee on Animal 
Welfare, Leiden University Medical Center, approved all animal experiments. 
 
Lipid Measurements 
Total levels of cholesterol and triglycerides were enzymatically quantified in blood 
plasma of 4 hour fasted offspring at age 4, 8 and 16 weeks by using commercially 
available kits (Roche, Almere, The Netherlands). Blood samples were obtained 
through tail bleeding.  
 
Neointimal Lesion Induction 
Neointima formation was induced by placement of a constrictive collar around the 
left common carotid artery in all apoE
+/-





Tissue Harvesting and Preparation 
Mice were anesthetized 4 weeks after collar placement. Pressure-perfusion (76 
mm Hg) was performed through the cardiac left ventricle with sterile PBS for 5 
minutes. Both common carotid arteries were harvested and the collar was 
removed. The carotid arteries were fixed in 4% paraformaldehyde in 0.1M sodium 
phosphate buffer (pH 7.4) for 6 hours. Fixation was followed by dehydration in 
series of ethanol and xylene and tissues were paraffin-embedded. Transverse 5-
µm sections were cut and serially mounted.  
 
Immunohistochemistry 
Routine staining was performed with Mayer’s hematoxylin and eosin, Resorcin-
Fuchsin for detection of elastin and Sirius red for collagen. Unless indicated 
otherwise the immunohistochemistry was performed as described earlier.
7,12
 In 
short, for each staining all sections were stained in one batch. The sections were 
incubated overnight at room temperature with a mouse monoclonal primary 




(1:2000, Sigma Aldrich, Product No. A2547, Zwijndrecht, The Netherlands), a 
rabbit polyclonal anti-von Willebrand factor (vWF; 1:2000, DAKO, Glostrup, 
Denmark) and a rat monoclonal anti-CD31 (1:50, PharMingen, Alphen, The 
Netherlands) to study endothelial cells, and a rat monoclonal Mac-3 (1:400, 
PharMingen, Alphen, The Netherlands) against macrophages. Goat anti-rabbit 
biotin conjugate (1:200, Vector, Amsterdam, The Netherlands), goat anti-rat biotin 
conjugate (1:200, PharMingen) and rabbit anti-mouse peroxidase conjugate 
(1:200, DAKO) with normal goat and mouse serum diluted in PBS were used as 
secondary antibodies (1 hour at room temperature). Biotin labeling was followed by 
incubation with Vectastain ABC (Vector). The CD31 signal was enhanced with a 
CSA kit (DAKO). The 3-3’ diaminobenzidine tetrahydrochloride was used as 





 was used to estimate the volume of the neointimal lesions 
in the region proximal to the collar. The lesion area was counted in 20 equally 
spaced sections and the volume calculated. Medial volumes were estimated in 10 
equally spaced sections comprising a total length of 350 µm proximal to the collar. 
As a control, intimal and medial volumes were calculated in contralateral 
noncompromised carotid arteries. 
  
Statistical Analysis 
Data are represented as mean ± SEM. The data on offspring weight and plasma 
lipid levels were evaluated by general linear model repeated measures. The 
Fisher’s Exact test and ANOVA were used to statistically substantiate the results 
on neointima formation. The differences were considered to be significant if P < 









Body Weight and Lipid Levels 
Throughout the experiment, no significant differences were observed between the 
body weights of apoE
+/-
 offspring from apoE
-/-
 mothers and apoE
+/-
 offspring from 
wild-type mothers (Table 1). Intrauterine exposure to maternal apoE-deficiency did 
not affect the total plasma cholesterol (Table 2) and triglyceride levels (Table 3) of 
the offspring.  
 
Table 1. Weight offspring 
Offspring  Weight (g)  
 4 weeks 8 weeks 16 weeks 
    
Mat WT 10.3 ± 1.2* 19.8 ± 0.6 23.3 ± 0.6 
Mat apoE
-/-
 14.5 ± 1.0* 19.9 ± 0.3 24.1 ± 0.2 
All data are shown as mean ± SEM. Mat WT indicates apoE
+/-









P = 0.027 versus Mat WT at 4 weeks. 
 
 
Table 2. Total plasma cholesterol levels offspring 
Offspring  TC (mmol/L)  
 4 weeks 8 weeks 16 weeks 
    
Mat WT 1.30 ± 0.11 1.84 ± 0.20 1.74 ± 0.17 
Mat apoE
-/-
 1.54 ± 0.10 1.74 ± 0.12 1.69 ± 0.08 
All data are shown as mean ± SEM. TC indicates total plasma cholesterol; TG, total plasma 
triglycerides; Mat WT, apoE
+/-




 offspring from apoE
-/-
 
mothers. No significant differences were found between the two groups at all time points. 
 
 
Table 3. Total plasma triglyceride levels offspring 
Offspring  TG (mmol/L)  
 4 weeks 8 weeks 16 weeks 
    
Mat WT 0.52 ± 0.08 0.75 ± 0.06 0.55 ± 0.04 
Mat apoE
-/-
 0.62 ± 0.04 0.68 ± 0.08 0.68 ± 0.05 
All data are shown as mean ± SEM. TC indicates total plasma cholesterol; TG, total plasma 
triglycerides; Mat WT, apoE
+/-




 offspring from 
apoE
-/-
 mothers. No significant differences were found between the two groups at all time points. 
 
In contrast to our previous study in which the apoE
+/-
 offspring were fed a high-
cholesterol diet to induce hypercholesterolemia,
7
 all mice received regular chow to 





maternal apoE-deficiency alone on cardiovascular disease risk could be examined. 
With age, a slight increase in total plasma cholesterol was observed in all animals, 
but levels remained within normal range.  
 
Neointima Formation 
The long-term consequences of intrauterine 
exposure to maternal apoE-deficiency were 
determined by studying the response of the vascular 
wall of both apoE
+/-
 offspring from wild-type mothers 
and those from apoE
-/-
 mothers after collar 
placement. Four weeks after collar placement, a 
significantly different response was observed 





 mothers neointimal lesions 
were detected whereas no neointimal lesions were 
found in any apoE
+/-
 offspring from wild-type mothers 
(4 out of 5 versus 0 out of 5; P = 0.024). The 
average lesion volume in the apoE
+/-
 mice from 
apoE
-/-





1A). In addition, a trend towards an increased 
medial volume in the proximal region of the collar 
was observed in apoE
+/-
 offspring from apoE
-/-
 














, Figure 1B).  
 
Carotid Artery Morphology and Lesion Composition 
To characterize the morphology of the adult carotid arteries and the neointimal 
lesions, several histological and immunohistochemical staining techniques were 
used. In apoE
+/-
 offspring from wild-type mothers, the region proximal to the collar 
resembled the normal morphology as observed in noncompromised contralateral 
arteries (Figure 2A-B, D-E and G-H). In response to collar placement, neointimal 
lesions of 1 to 2 subendothelial layers developed in apoE
+/-
 progeny from apoE
-/-
 
mothers (Figure 2C). One lesion per carotid artery was detected. The lesions were 
relatively a-cellular. Extensive deposition of the extracellular matrix proteins elastin 
and collagen was demonstrated (Figure 2F and 2I). Furthermore, thickening of the 
media and disorganization of the smooth muscle cells were detected in comparison 
to apoE
+/-
 offspring from wild-type mothers (Figure 2C,F and I). The internal elastic 
lamina was intact indicating the immaturity of the lesions (Figure 2F).  




Figure 2. Histological staining. Representative cross-sections from (A,D,G) noncompromised carotid 
arteries and the region proximal to the collar in apoE
+/-
 mice from (B,E,H) wild-type mothers and (C,F,I) 
apoE
-/-
 mothers, respectively. Sections were stained with Mayer’s (A-C) hematoxylin and eosine, (D-F) 
Resorcin-Fuchsin and (G-I) Sirius red. The dotted line represents the border between intima and media. 
I indicates intima; M, media; A, adventitia. Scale bars: 20 µm.  
  
 Figure 1. Morphometric analysis of adult carotid arteries 4 weeks after collar placement. (A) 
Estimation of intimal volume and (B) medial volume of noncompromised (control) and collared carotid 
arteries of apoE
+/-
 mice from wild-type mothers (Mat WT) and apoE
-/-
 mothers (Mat apoE
-/-
). Data are 
means ± SEM (n = 5 each). 
 
The CD31 staining revealed an intact endothelial lining in all carotid arteries (Figure 
3A-C). The mesenchymal cells in the neointima were negative for CD31. The 
endothelial cells showed an activated phenotype. In comparison to control arteries 
in which all endothelial cells stained positively for anti-vWF, increased activation 
was observed in apoE
+/-
 from wild-type mothers (Figure 3D-E). In apoE
+/-
 mice from 
apoE
-/-
 mothers increased turnover and upregulation of vWF was seen in 
endothelial cells in the region proximal to the collar resulting in intense staining for 




adventitia in these animals. Besides α-smooth muscle actin staining in the media, 
as also seen in the noncompromised contralateral arteries en those of apoE
+/-
 
offspring from wild-type mothers, additional positivity was observed in the 
neointima of apoE
+/-
 mice from apoE
-/-
 mothers (Figure 3G-I). Macrophages were 
present abundantly in the adventitia and only sporadic presence was seen in the 
neointima and media of apoE
+/-
 mice from apoE
-/-
 mothers, (Figure 3L). The 
noncompromised control arteries and those of apoE
+/-
 offspring from wild-type 




































Figure 3. Immunohistological characterization of the vascular wall. Representative cross-sections from 
(A,D,G,J) noncompromised carotid arteries and the region proximal to the collar in apoE
+/-
 mice from 
(B,E,H,K)  wild-type mothers and (C,F,I,L) apoE
-/-
 mothers, respectively. Sections were stained with (A-
C) anti-CD31, (D-F) anti-vWF, (G-I) α-smooth muscle actin (α-sm actin) and (J-L) anti-Mac-3 to identify 
macrophages. Note the presence of vWF and α-sm actin in the neointima. The dotted line represents 





The present results demonstrate that high-cholesterol feeding is not required in the 
process of initiation of neointimal lesion development in apoE
+/-
 offspring from 
apoE
-/- 
mothers. Obviously, intrauterine exposure to maternal apoE-deficiency has 
a dramatic effect on atherosclerosis development in adult life. A shift from athero-
protective high shear stress levels towards athero-prone low shear stress profiles 
within the carotid arteries as a result of collar placement was already sufficient to 





 mothers. No lesions were observed in apoE
+/-
 mice from wild-
type mothers. These data indicate that the intrauterine environment poses a major 
risk factor for adult cardiovascular disease and can exert its effects independent of 
hypercholesterolemia induced by a cholesterol-containing diet. 
 The neointimal lesions in the carotid arteries of apoE
+/-
 offspring from 
apoE
-/-
 mothers were of substantial size and could be characterized by 1 or 2 
subendothelial layers and relative a-cellularity. Whereas large numbers of 
macrophages were recruited into the adventitia, only sporadic presence of 
macrophages was seen in the neointima of apoE
+/-
 offspring from apoE
-/-
 mothers. 
In our previous study we used an identical approach as in the current study, except 
for the additional use of a cholesterol-containing diet.
7
 In the presence of diet-
induced hypercholesterolemia large lesions developed and massive accumulation 
of macrophages was observed in apoE
+/-
 offspring from apoE
-/-
 mothers. Together, 
these data indicate that high-cholesterol feeding accelerates and aggravates 
neointimal lesion progression. Lesion progression seems to be accelerated through 
increased recruitment of inflammatory cells to the vascular wall. It has been 
reported that rolling of monocytes over the endothelial layer is increased in mice 
fed a cholesterol-containing diet.
14
 Moreover, adhesion molecules like VCAM-1 and 
P-selectin, are enhanced under these conditions.
15,16
 The lack of macrophages in 
the lesions observed in the current study could be the result of limited active 
recruitment of inflammatory cells from the circulation. Future studies have to reveal 
whether the current immature lesions observed in the 5 months old chow-fed 
apoE
+/-
 offspring from apoE
-/-
 mothers will acquire a large numbers of 
macrophages, associated fat deposition, and remodeling upon aging. 
 In addition to hypercholesterolemia induced by high-cholesterol feeding, 
other postnatal environmental risk factors are likely to promote more severe 
vascular disease. Therefore, exposure should be limited to maintain a relatively low 
disease risk throughout life. Awareness and development of risk reducing 
programs in adult life are also beneficial for a second reason; it reduces prenatal 
risk factors as well when applied to pregnant women and women in their 
reproductive period. General monitoring of for example cholesterol levels and 
Atherosclerosis Risk Without Cholesterol Feeding 
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identification of markers of inflammation in relation to apoE polymorphisms may 
identify a high-risk population of pregnant women. To reduce the cardiovascular 
disease risk in progeny, lifestyle management programs and dietary intervention 
should be introduced for these women. 
In apoE
+/-
 mice fetuses and neonates from both normocholesterolemic 
wild-type and hypercholesterolemic apoE
-/-
 mothers no hemodynamically induced 
atherosclerosis was detected throughout the vasculature. In contrast, in humans 
fatty streaks already develop in the fetal aorta.
5
 Development of these lesions is 
greatly enhanced in progeny from hypercholesterolemic mothers. In childhood, 
despite normal cholesterol levels, lesion progression is higher in these children.
6
 
The apparent distinction in the rate of lesion development between mice and 
humans may be explained by hemodynamics. In mice, the average wall shear 
stress in the carotid artery is more than 6 times higher than in humans.
17
 Because 
high shear stress is athero-protective, mice may be more resistant to 
atherosclerosis than humans. We hypothesize that in human fetuses, the combined 
effects of epigenetic programming by maternal hypercholesterolemia, and the 
intrauterine environment almost directly initiate the process of atherosclerosis in 
the fetal vascular wall. Elucidation of the mechanisms of priming by maternal 
atherosclerotic risk factors would give more insight into the fetal tissues that are 
affected and may provide us with early indicators of atherosclerosis susceptibility 
(reviewed by DeRuiter and colleagues
18
).  
 In conclusion, intrauterine exposure to maternal apoE-deficiency, through 
epigenetic programming of the fetus, plays a key role in neointimal lesion initiation 
in adult offspring, even without high-cholesterol feeding. Hypercholesterolemia 
induced by high-cholesterol feeding promotes more severe vascular disease. 
Because there is increasing evidence that prenatal atherosclerotic risk factors are 
of importance for development of adult vascular disease, they should be taken into 











We acknowledge the assistance of Jan Lens in the preparation of the artwork of 
this manuscript. The authors thank Bert Wisse for his assistance with the 
morphometric analyses, and the animal caretakers for animal care and breeding. 
F.E.A. is supported by a grant from the Netherlands Heart Foundation (2003B241). 
L.M.H. and K.W.vD. are supported by the Centre for Medical Systems Biology and 











 1.  Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from 
ischaemic heart disease. Lancet. 1989;2:577-580. 
 2.  Barker DJ. In utero programming of cardiovascular disease. Theriogenology. 2000;53:555-574. 
 3.  Kyle UG, Pichard C. The Dutch Famine of 1944-1945: a pathophysiological model of long-term 
consequences of wasting disease. Curr Opin Clin Nutr Metab Care. 2006;9:388-394. 
 4.  Lumey LH, Stein AD, Kahn HS, van der Pal-de Bruin KM, Blauw GJ, Zybert PA, Susser ES. 
Cohort profile: the Dutch Hunger Winter families study. Int J Epidemiol. 2007;36:1196-1204. 
 5.  Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty 
streak formation occurs in human fetal aortas and is greatly enhanced by maternal 
hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede 
monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690. 
 6.  Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal 
hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in 
childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354:1234-1241. 
 7.  Alkemade FE, Gittenberger-de Groot AC, Schiel AE, VanMunsteren JC, Hogers B, van Vliet LS, 
Poelmann RE, Havekes LM, Willems van Dijk K, DeRuiter MC. Intrauterine exposure to 
maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. 
Arterioscler Thromb Vasc Biol. 2007;27:2228-2235. 
 8.  Bobkova D, Honsova E, Kovar J, Poledne R. Effect of diets on lipoprotein concentrations in 
heterozygous apolipoprotein E-deficient mice. Physiol Res. 2004;53:635-643. 
 9.  Getz GS, Reardon CA. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 
2006;26:242-249. 
 10.  Van Ree JH, van den Broek WJ, Dahlmans VE, Groot PH, Vidgeon-Hart M, Frants RR, Wieringa 
BA. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-
deficient mice. Atherosclerosis. 1994;111:25-37. 
 11.  Von der Thüsen JH, van Berkel TJ, Biessen EA. Induction of rapid atherogenesis by 
perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein 
receptor-deficient mice. Circulation. 2001;103:1164-1170. 
 12.  Bergwerff M, Verberne ME, DeRuiter MC, Poelmann RE, Gittenberger-de Groot AC. Neural 
crest cell contribution to the developing circulatory system. Implications for vascular 
morphology? Circ Res. 1998;82:221-231. 
 13.  Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its 
prediction. J Microscopy. 1987;147:229-263. 
 14.  Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, Ley K. Direct demonstration of 
P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of 
apolipoprotein E-deficient mice. Circ Res. 1999;84:1237-1244. 
 15.  Sakai A, Kume N, Nishi E, Tanoue K, Miyasaka M, Kita T. P-selectin and vascular cell adhesion 
molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal 
accumulation of macrophages and T lymphocytes. Arterioscler Thromb Vasc Biol. 1997;17:310-
316. 
 16.  Li H, Cybulsky MI, Gimbrone MA, Jr., Libby P. An atherogenic diet rapidly induces VCAM-1, a 
cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. 
Arterioscler Thromb. 1993;13:197-204. 
 17.  Cheng C, Helderman F, Tempel D, Segers D, Hierck BP, Poelmann RE, van Tol A, Duncker DJ, 





  Crom R, Krams R. Large variations in absolute wall shear stress levels within one species and 
between species. Atherosclerosis. 2007;195:225-235. 
 18.  DeRuiter MC, Alkemade FE, Gittenberger-de Groot AC, Poelmann RE, Havekes LM, Willems 









The Effect of Maternal Hypercholesterolemia as a 
Consequence of LDL Receptor-Deficiency on Vascular 





, Ko Willems van Dijk
2,3
, J. Conny VanMunsteren
1
, Louis M. 
Havekes
3,4,5
, Adriana C. Gittenberger-de Groot
1






Department of Anatomy and Embryology, 
2





Department of Cardiology, Leiden University Medical Center, 
Leiden, The Netherlands; 
5










The Effect of Maternal Hypercholesterolemia as a 
Consequence of LDL Receptor-Deficiency on Vascular 






In a recent study, we demonstrated that intrauterine exposure to maternal 
hypercholesterolemia, oxidative stress, and a pro-inflammatory immune status as a 
consequence of maternal apoE-deficiency damaged the fetal vasculature and 
accelerated neointima formation in adult offspring. To more specifically determine 
the role of maternal hypercholesterolemia in the process of intrauterine 
programming of adult cardiovascular disease, we aimed to address this issue in the 
low-density lipoprotein receptor-deficient (Ldlr
-/-
) mouse model. 
Hypercholesterolemic Ldlr
-/-
 mothers were crossbred with normocholesterolemic 
heterozygous Ldlr-deficient fathers (Ldlr
+/-
) and vice versa. In this way, we were 
able to study the effects of maternal hypercholesterolemia on both Ldlr
+/-
 and the 
Ldlr
-/-
 offspring. Analysis of the fetal vasculature and cholesterol levels of Ldlr
+/-
 
fetuses revealed no detrimental effects of maternal hypercholesterolemia. The 
long-term consequences of intrauterine exposure to maternal hypercholesterolemia 
were minimal as neointima formation, although a harsh Western-type diet was 
provided, could not be induced in Ldlr
+/-
 offspring. Solely in spontaneous 
atherosclerosis in Ldlr
+/-
 mice from Ldlr
-/-
 mothers, a difference in aortic medial 
hypertrophy was detected in comparison to Ldlr
+/-
 offspring from Ldlr
+/-
 mothers. As 
expected, the Ldlr
-/-
 offspring showed fetal intimal thickening and profound 
spontaneous atherosclerosis in the adult stage. We conclude that maternal 
hypercholesterolemia only minimally affects the heterozygous offspring. The 
increased susceptibility to develop atherosclerosis is not provoked in the Ldlr-
deficient mouse as compared to the apoE-deficient mouse. 





In a previous study, we have reported that intrauterine exposure to maternal 
apolipoprotein E-deficiency (apoE
-/-
) induced a susceptibility for cardiovascular 









 mothers, major endothelial damage was detected in the 
vasculature, whereas no abnormalities were found in genetically identical apoE
+/-
 
fetuses from wild-type mothers. In adult apoE
+/-
 offspring from apoE
-/-
 mothers 
neointima formation was accelerated after challenging of the carotid arteries 
through induction of low shear stress levels by partial constriction of the vessel in 
combination with a high-cholesterol diet. Almost no lesions were found in offspring 
from wild-type mothers. Thus, our data demonstrated that maternal apoE-
deficiency and/or environmental risk factors associated with apoE-deficiency prime 
genetically relatively insensitive apoE
+/-
 fetuses for accelerated cardiovascular 
disease in adult life.  
ApoE plays an important role in lipoprotein metabolism by functioning as a 
ligand for receptor-mediated clearance of VLDL and chylomicron remnant 
lipoproteins.
2
 ApoE-deficiency results in severe hypercholesterolemia,
3,4
 and is 
associated with increased oxidative stress,
5
 and a pro-inflammatory immune 
status.
6





 mouse model therefore presents a number of pro-atherogenic risk 
factors. We would like to further unravel which maternal atherogenic risk factor is 
responsible for the intrauterine programming, and the subsequent increase in 
susceptibility for atherosclerosis.  
 Hypercholesterolemia is considered to be one of the main risk factors for 
atherosclerosis in adult life. Hypercholesterolemia also occurs during the course of 
normal human pregnancy.
8,9
 The serum cholesterol levels of most women increase 
by approximately 25-50% throughout pregnancy. The lipid profile the women show 
in the third trimester would be considered highly atherogenic in a nonpregnant 
state. High circulating concentrations of cholesterol in the mother have been 
associated with a higher number and increased size of fatty streaks in the fetal 
aorta and augmented lesion progression in early childhood of the progeny.
10,11
 
Studies in rabbits demonstrated similar outcomes.
12,13
 These data suggest that 
hypercholesterolemia can adversely influence cardiovascular development and 
promotes early atherogenesis in human and rabbit progeny. To further address the 
role of hypercholesterolemia in intrauterine programming of adult cardiovascular 
disease in a murine model, we used the low-density lipoprotein receptor deficient 
(Ldlr
-/-










  The present experiments were designed to assess the effects of maternal 
hypercholesterolemia per se on intrauterine programming of adult cardiovascular 
disease in mice offspring. We crossbred hypercholesterolemic Ldlr
-/-
 mothers with 
normocholesterolemic heterozygous Ldlr-deficient (Ldlr
+/-
) fathers and vice versa. 
In this way, we were able to study the effect of maternal hypercholesterolemia on 




 fetuses and examine the long-term 
consequences on neointima formation in the carotid arteries, as well as on diet-
induced spontaneous plaque development in the aortas of adult offspring. 
Unexpectedly, results indicated that profound maternal hypercholesterolemia has 
only modest effects on fetal vascular development and induced and spontaneous 
atherosclerosis in Ldlr
+/-















 mice were purchased from Jackson Laboratories (Wilmington, USA). 
The Ldlr
+/-
 mothers were generated within our breeding facility by crossbreeding 
C57Bl/6J females (Charles River Laboratories, Maastricht, The Netherlands, import 
agency for Jackson Laboratories) with Ldlr
-/-





were fed a Western-type diet (0.25% cholesterol, Hope Farms, Woerden, The 
Netherlands) from 3 weeks before pregnancy onwards. The normocholesterolemic 
Ldlr
+/-
 females were mated with Ldlr
-/- 















mothers (Table 1). Wild-type (Ldlr
+/+
) fetuses from wild-type mothers were used as 
control. Each group consisted of 20 fetuses. Mouse genotypes were determined by 
PCR.  
 To induce postnatal hypercholesterolemia in female Ldlr
+/-





 mothers (n=6 each group), a harsh Western-type diet was 
required (1% cholesterol and 0.5% cholate). Female Ldlr
-/-
 mice from both groups 
(n=6 each group) were fed a Western-type diet with 0.25% cholesterol from 
weaning onwards. Diet and water were provided ad libitum. The Committee on 




Total plasma cholesterol and triglyceride levels were quantified by colorimetric 
assays (Roche, Almere, The Netherlands) in blood plasma of 4-hour fasted 
animals. In adult mice blood samples were obtained through tail bleeding while 
fetal blood samples were acquired by decapitation at E17.5. Maternal blood 
samples were acquired prior to dietary intervention, before pregnancy and at 
pregnancy day 17.5. In offspring plasma lipids were monitored at the postnatal 
ages of 4, 8 and 16 weeks. 
 
Perivascular Collar Placement 
Neointima formation was induced by perivascular collar placement around the left 
common carotid artery in Ldlr
+/-
 offspring at the age of 16 weeks, as previously 
described.
1,16








Fetal thorax tissue 
Fetal thorax tissue was obtained at E17.5. Fixation for 48 hours in 4% 
paraformaldehyde in 0.1 mol/L sodium phosphate buffer was followed by 
dehydration in series of ethanol and xylene. Subsequently, the specimens were 
embedded in paraffin. For cryosections, the thorax material was directly embedded 
in TissueTek (Bayer, Mijdrecht, The Netherlands) and stored at -20
o
C until use.  
 
Adult carotid arteries and aorta 




 offspring were anesthetized. Pressure-
perfusion (76 mm Hg) was performed through the cardiac left ventricle with sterile 
PBS for 5 minutes. The aorta and both common carotid arteries were excised and 
the collar around the left common carotid artery of Ldlr
+/-
 mice was removed. The 
carotid arteries and aortas were fixed in 4% paraformaldehyde in 0.1 mol/L sodium 
phosphate buffer for 6 and 48 hours, respectively, or directly embedded in 
TissueTek. Transverse 5-µm sections were cut and serially mounted. 
 
Immunohistochemistry 
Routine staining was performed with hematoxylin and eosin (HE), Resorcin-
Fuchsin for detection of elastin, and Oil Red O on cryosections to detect lipid 
deposition. Immunohistochemistry was performed as described earlier
1,17
 with the 
primary antibodies rabbit polyclonal anti-von Willebrand factor (vWF, 1:2000, 
DAKO, Glostrup, Denmark), rat monoclonal anti-CD31 (1:50, PharMingen, Alphen, 
The Netherlands), and rat anti-ICAM-1 (1:250, GeneTex, Inc., San Antonio, USA) 
to examine endothelial cells. The CD31 signal was enhanced with a tyramide 
signal amplification system (DAKO). 3-3’ Diaminobenzidine tetrahydrochloride was 




In fetuses the volume of the aortic arch was estimated by using the Cavalieri 
principle,
18
 a point counting method using a grid. Ten equally spaced HE stained 
sections covering the complete arch were examined. In adult offspring total 
atherosclerosis, medial wall and lumen volume of the aortic arch were estimated in 
20 equally spaced sections. Carotid artery medial volume was measured in 10 
equally spaced sections covering a total length of 0.7 mm proximal to the collar. 
 
 





Data are represented as mean ± SEM. One-way ANOVA and the two-tailed 
Student’s t-test were used to compare plasma cholesterol and triglycerides levels 




 mothers. The latter test was 
also used to evaluate differences between the two Ldlr
+/-
 groups of fetuses and 
between both Ldlr
-/-
 groups at E17.5 and analysis of the morphometric data. The 









Maternal Lipid Levels 
Western-type diet feeding of Ldlr
+/-
 mothers slightly increased their plasma 
cholesterol levels, but hypercholesterolemia before pregnancy was only detected in 
Ldlr
-/-
 mothers (Table 2). Significant differences were observed between total 




 mothers at all 
experimental conditions: before dietary intervention, after addition of Western-type 
diet and at pregnancy day 17.5. Plasma cholesterol concentrations in Ldlr
+/-
 
mothers remained within normal range throughout pregnancy. As could be 
expected from the data on apoE
-/-
 mice and other species such as rabbits,
1,19
 the 
total reduction in plasma cholesterol concentration from conception until pregnancy 
day 17.5 was striking in Ldlr
-/-
 mothers, namely 62.1%. Nevertheless, 
hypercholesterolemia was still detected at pregnancy day 17.5 in these mothers.  
 
Fetal Lipid Levels 
To address the question whether profound maternal hypercholesterolemia 
influences fetal plasma cholesterol levels in late fetal development, we assessed 




 fetuses at 
E17.5. Intrauterine exposure to maternal hypercholesterolemia did not add to the 
fetal cholesterol concentrations in Ldlr
+/-
 fetuses. Comparable 





 mothers and those from Ldlr
-/-
 mothers (Table 1).  
 In Ldlr
-/-
 fetuses from Ldlr
+/-
 mothers the cholesterol levels were similar to 
those observed in Ldlr
+/- 
fetuses. The effects of maternal hypercholesterolemia on 
fetal lipid metabolism were only found in Ldlr
-/-
 fetuses from Ldlr
-/-
 mothers. 
Maternal hypercholesterolemia significantly enhanced plasma cholesterol 
concentrations in Ldlr
-/-
 fetuses as compared to maternal normocholesteromia (4.77 
± 1.14 versus 3.08 ± 0.26 mmol/L, P < 0.000). In a few cases, 
hypercholesterolemic concentrations were detected with a maximum of 10.6 
mmol/L. Because of the large variation observed in fetal cholesterol concentrations 
in Ldlr
-/-
 fetuses from Ldlr
-/- 
mothers (2.7 mmol/L – 10.6 mmol/L), we examined the 
possible effect of the number of fetuses in one pregnancy and the positioning 
within the uterine horns. No correlation was found. A rise in fetal plasma 
cholesterol levels was accompanied by a small increase in triglyceride 
concentrations in Ldlr
-/-
 fetuses from Ldlr
-/-
 mothers, but the levels remained within 











































  4.77 ± 1.14
*
 0.66 ± 0.13 
All data are shown as mean ± SEM. NC indicates normocholesterolemia; HC, hypercolesterolemia; TC, 
total plasma cholesterol (mmol/L); TG, total plasma triglycerides (mmol/L). 
*













TC    
Before diet 2.37 ± 0.10* *6.34 ± 0.21
†*
 
Western-type diet 4.17 ± 0.14* 35.73 ± 1.22*
†
 
Pregnancy day 17.5 2.67 ± 0.15* 13.53 ± 1.35*
†
 
   
TG   
Before diet 0.49 ± 0.02         *1.21 ± 0.06
†
 
Western-type diet 0.53 ± 0.02 3.13 ± 0.30*
†
 
Pregnancy day 17.5 0.54 ± 0.04 2.00 ± 0.14*
†
 
All data are shown as mean ± SEM. TC indicates total plasma cholesterol (mmol/L); TG, total 
plasma triglycerides (mmol/L).
 
Significant differences (*P = 0.000) were observed between 
TC levels before diet, after dietary intervention and at pregnancy day 17.5 in Ldlr
+/-
, as well 
as in Ldlr
-/-
 mothers. In the latter group, TG levels also showed significant differences 





revealed significant differences at all experimental conditions (
†
P < 0.000). 
 











 mothers to determine the effects of severe 
hypercholesterolemia on fetal vascular development. No damaging effect of 
intrauterine exposure to maternal hypercholesterolemia associated with Ldlr-
deficiency could be detected in the endothelial cell layer in the carotid arteries and 
aortas of Ldlr
+/-
 fetuses. However, in comparison to Ldlr
+/+
 control fetuses, all Ldlr
+/-
 
fetuses showed endothelial cell activation, characterized by reduced vWF as a 
result of exocytosis, and enhanced ICAM-1 staining (Figure 1A-B, D-E). Minimal 
traces of vWF were found in the subendothelial space. The endothelial cell lining 






Resorcin-Fuchsin staining (Figure 1G-H, J-K). No signs of vascular pathology were 











 fetuses from normocholesterolemic Ldlr
+/-
 mothers, a phenotype similar to 
that seen in the Ldlr
+/-
 fetuses (group 1 and 2) was observed. We expected that 
combined genetic susceptibility to cardiovascular disease and maternal 





 mothers. Besides a few small areas of intimal thickening, 
consisting of several cells and an additional elastic lamina, no abnormalities were 
detected in the intima of the carotid arteries in all mice (Figure 1C,F,I,L). In the 
vascular media, a more spacious distribution of the elastic lamina and medial 
presence of vWF was shown (Figure 1F,L). 
 In the ascending aorta of all Ldlr
-/-
 fetuses from hypercholesterolemic Ldlr
-/-
 
mothers, however, endothelial detachment and intimal thickening were observed 




 fetuses (Figure 2A-C). In the 
aortic arch fewer abnormalities were observed than in the ascending aorta and in 
the descending aorta normal morphology was shown. Irregular distribution of the 
elastic lamina in the media was found (Figure 2D-F). In addition, the orientation of 
the spindle-shaped smooth muscle cells in the media as present in normal aortas 
was disturbed in aortas of intrauterine exposed Ldlr
-/-
 fetuses (Figure 2G-I). VWF 
was present in endothelial cells, as well as in the subendothelial intimal and medial 
layers. No free lipid deposition and fatty streaks were observed. No clear link could 
be established between the plasma cholesterol levels and the severity of intimal 
thickening in the ascending aortas of the Ldlr
-/-
 fetuses. 
 As there seemed to be a more spacious distribution of elastic lamina and 
intimal thickening in the carotid arteries and ascending aorta of Ldlr
-/-
 fetuses from 
Ldlr
-/-
 mothers, we estimated the medial wall volume of the ascending aorta and 
aortic arch by morphometric analysis. The aortic medial wall volumes of 
intrauterine exposed Ldlr
-/-





 mothers (0.053 ± 0.003 versus 0.053 ± 0.010 mm
3
) thereby excluding 
fetal vascular hypertrophy. Furthermore, no differences were observed between 




 fetuses. (Group 1 0.054 ± 0.008 versus 
group 2 0.071 ± 0.002 mm
3
). All estimated volumes were comparable to Ldlr
+/+
 



















 mothers and (C,F,I,L) Ldlr
-/-
 fetuses from Ldlr
-/-
 mothers at E17.5. Because identical staining 








 mothers, sections B,E,H,K also 
represent these two groups. Immunostaining for (A-C) ICAM-1, (D-F) vWF, (G-I) CD31 and (J-L) elastin. 
Picture 1D,E,F,L show enlargement of box in right upper corner. Arrows indicate intimal thickening, 
which was observed in the carotid arteries of all Ldlr
-/-
 fetuses from Ldlr
-/-























 mothers with (A-C) general HE staining, (D-F) elastin 








 mothers. Note 





 mothers. I indicates intima; M, media and dotted line represents border between 
intima and media. Scale bars: 20 µm. 
 
Induction of Neointima Formation in Ldlr+/- Offspring 
To assess the effect of in utero exposure to Ldlr-deficiency on lesion initiation in 
adult life, a perivascular constrictive collar was placed around the carotid artery of 
Ldlr
+/-




mothers. From weaning onwards all Ldlr
+/-
 
animals received a Western-type diet containing 1% cholesterol and 0.5% cholate. 
Such a harsh diet was necessary to induce postnatal hypercholesterolemia. No 
differences were observed between the total plasma cholesterol levels of the two 
groups throughout the experiment. Prior to collar placement, plasma cholesterol 
levels were 19.00 ± 1.54 and 19.58 ± 1.94 mmol/l, respectively. In spite of the high 
circulating cholesterol concentrations, 4 weeks after collar placement no neointimal  
 




lesions were found. Moreover, no differences were found in the carotid medial 
volume of both groups of Ldlr
+/-




Spontaneous Atherosclerosis Development in Ldlr+/- and Ldlr-/- 
Offspring 
The two types of Western-type diet initiated spontaneous atherosclerosis 
development in the aortic arch of all animals. Lesions were detected in the aortic 
root, the inner curvature of the aortic arch and in the areas upstream of the branch 




 offspring to maternal 
hypercholesterolemia did not affect the degree of advanced atherosclerosis in adult 
life as no differences were found in the total volumes of spontaneous 
atherosclerosis in the aortic arch between both groups of Ldlr
+/-
 mice and between 
the two Ldlr
-/-
 groups (Figure 3B). The only observed difference was found in the 
total volume of the vascular media of the aortic arch of Ldlr
+/-
 mice from Ldlr
-/-
 





 mothers (1.00 ± 0.05 versus 0.71 ± 0.07 mm
3
, P = 0.016, Figure 3C). 










 mice on spontaneous atherosclerosis in adult 
life. (A) Representive cross-section of the adult aorta showing the sites of atherogenesis; the aortic root, 
the inner curvature of the aortic arch and the areas upstream of the branch points. Scale bar: 300 µm. 





 mice. MNC indicates maternal normocholesterolemia; MHC, maternal hypercholesterolemia. 








Studies in humans and rabbits have demonstrated that intrauterine exposure to 
maternal hypercholesterolemia enhances atherosclerotic lesion formation in the 
offspring prenatally and postnatally.
10-13
 In the present study, we investigated the 
role of maternal hypercholesterolemia associated with Ldlr-deficiency in the 
process of intrauterine programming of cardiovascular disease in mice. Whereas 
we expected that severe maternal hypercholesterolemia would affect vascular 
development in Ldlr
+/-





opposite was true. No harmful effects of maternal hypercholesterolemia were found 
on plasma cholesterol levels and the vasculature in Ldlr
+/-
 fetuses. In adult life, 
profound hypercholesterolemia in combination with the application of athero-prone 
low shear stress in the carotid arteries did not reveal any effect of intrauterine 
exposure on neointima formation. Solely in the process of spontaneous 
atherosclerosis, a significant increase in aortic medial hypertrophy was detected 
compared with Ldlr
+/-
 offspring from Ldlr
+/-
 mothers. The data indicate that the sum 
of pathogenic factors in Ldlr
+/-
 offspring is not sufficient, at least in this mouse 
strain, to cause atherosclerosis. The most apparent effects of maternal 
hypercholesterolemia were observed in Ldlr
-/-
 fetuses that are genetically 
susceptible to atherosclerosis. In these fetuses plasma cholesterol levels were 
significantly increased and already at this early point in life intimal thickening was 
detected in the aorta. However, the long-term consequences of prenatal exposure 
to hypercholesterolemia on the development of atherosclerosis were minimal in 
Ldlr
-/-
 offspring. Overall, the results suggest that the effect of severe maternal 
hypercholesterolemia on intrauterine programming of adult cardiovascular disease 
in mice is limited. 
 Despite much lower cholesterol levels in apoE
-/-
 mothers, major endothelial 
damage was detected in the vasculature of apoE
+/-
 fetuses in our previous study.
1
 
In moderately hypercholesterolemic adult apoE
+/-
 offspring from apoE
-/-
 mothers, 
severe neointima formation was detected after induction with a perivascular collar. 
Our data show that the atherosclerotic risk factors associated with maternal Ldlr-
deficiency were insufficient to directly damage the vessels in Ldlr
+/- 
fetuses. This 





 mothers. The dual deficiency of both maternal and fetal Ldlr 
was necessary to observe a detrimental effect on the fetal vascular wall. This 
suggests that the combination of risk factors is crucial in determining whether or 
not the fetal vasculature is primed for accelerated atherosclerosis in adult life.   
 Besides the intrauterine environment, postnatal environmental triggers, as 
well as the chosen end points have to be evaluated. In spite of harsh Western-type 
diets inducing severe postnatal hypercholesterolemia, no effects of maternal  









 offspring. These data are partially in line with a study of Madsen and 
colleagues
20
 who demonstrated that maternal apoE-deficiency during pregnancy 
did not aggravate the development of diet-induced advanced atherosclerosis in 
offspring aged 24 weeks compared with nonexposed counterparts. Napoli and 
colleagues reported that in chow fed Ldlr
-/-
 offspring from hypercholesterolemic 
mothers postnatal atherogenesis was enhanced at the age of 12 weeks relative to 
progeny of normocholesterolemic mothers.
21
 We propose that the postnatal use of 
harsh Western-type diets instead of chow concealed the effects of in utero priming 





Moreover, lesion examination during the initial phases of atherogenesis may 
potentially reveal more differences in lesion acceleration between the groups than 
in the stage of advanced lesion formation as the latter can be considered a feature 
of the plateau phase of the process. 
 Recent studies demonstrated that besides hypercholesterolemia, oxidative 
stress and inflammatory pathways play an important role in intrauterine 
programming of adult disease. Maternal immunization of athero-prone New 
Zealand White rabbits and Ldlr
-/-
 mice with oxidized LDL reduced development of 
atherosclerosis in offspring independent of maternal cholesterol status during 
pregnancy.
22
 In addition, maternal treatment with vitamin E, an antioxidant, or 
cholestyramine, a lipid-lowering drug, significantly diminished atherosclerosis in the 
rabbit offspring suggesting a role for oxidative stress and inflammatory 
pathways.
12,13
 A striking observation in our study was the lack of induction of 
neointima in the presence of high circulating cholesterol concentrations. Obviously, 
intrauterine exposure, postnatal hypercholesterolemia and athero-prone low shear 
stress together are not sufficient to trigger neointima formation in the carotid 
arteries of Ldlr
+/-




 mouse models 
hypercholesterolemia appears not to be the most important trigger for prenatal 
programming, we hypothesize that other risk factors associated with apoE-
deficiency play an important role in the process of programming of adult 
atherosclerosis. These could be murine apoE itself, maternal inflammation, and/or 
adaptive immunity. 
 Intrauterine exposed Ldlr
+/-
 mice showed a more proliferative response of 
smooth muscle cells in the development of spontaneous atherosclerosis compared 
with Ldlr
+/-
 mice from Ldlr
+/-
 mothers. These data suggest that maternal 
hypercholesterolemia influences adult susceptibility to atherosclerosis of Ldlr
+/-
 
offspring by affecting smooth muscle cells. Increasing evidence from studies using 
animal models indicates that permanent epigenetic changes, through e.g. DNA 





programming of increased atherosclerosis risk in adult life (reviewed by DeRuiter 
and colleagues
23
). Further studies are necessary to elucidate the exact signals and 
mechanisms through which hypercholesterolemia influences the endothelial cells 
and smooth muscle cells in the process of priming. 
 In conclusion, the present study demonstrates that severe maternal 
hypercholesterolemia caused by Ldlr-deficiency has only modest effects on fetal 




 offspring. The data 
indicate that maternal hypercholesterolemia is sufficient for intrauterine 
programming of adult cardiovascular disease in mouse models. However, this does 
not preclude that hypercholesterolemia has a modulating role in this process. 
Whether maternal apoE status, inflammation and/or innate immunity play a 
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In a previous study we demonstrated that embryonic endothelial cells in vivo have 
the capacity to undergo endothelial-to-mesenchymal-transformation (EMT). We 
hypothesized that adult endothelial cells also have that capacity in vivo during the 
initial phase of neointimal lesion development. To investigate this, we induced 
neointimal lesions, a reflection of cardiovascular disease, in Tie2LacZ mice by 
placement of a nonconstrictive collar around the femoral artery. Three days after 
collar placement we detected endothelial detachment and proliferation. In addition, 
a decrease in phosphoSmad2 staining, a Tgf-β-related protein associated with 
differentiation and quiescence, was observed. From 7 days onwards β-
galactosidase positive mesenchymal cells were found in the developing neointimal 
lesions. A number of these β-galactosidase-positive mesenchymal cells also 
showed positivity for α-smooth muscle actin. Since Tie2 is also expressed in part of 
the bone marrow cells, we assessed their contribution to neointimal lesion 
formation. Beta-galactosidase-positive bone marrow-derived cells were recruited to 
the adventitia, but could not be detected in the neointima and media.  We conclude 
that adult vascular endothelial cells in vivo have the capacity to undergo EMT. 
Furthermore, through EMT, endothelial cells contributed to the total pool of 
mesenchymal cells that compose the neointima. These data indicate that EMT 
could be important in development and progression of cardiovascular disease.   




In a previous study using a quail model, we demonstrated that embryonic 
endothelial cells in vivo have the capacity to undergo endothelial-to-mesenchymal-
transformation (EMT).
1
 During the initial phases of arterial differentiation, 
embryonic endothelial cells of the descending aorta detached from the epithelial 
layer and differentiated into subendothelial mesenchymal cells. The transformation 
from endothelial to mesenchymal phenotype was accompanied by a reduction in 
the expression of the endothelial marker QH1 and gain of α-smooth muscle actin 
positivity. A number of reports substantiated our data and appointed a role for Tgf-
β signaling in this process.
2-4
 However, it remained unclear whether also adult 
endothelial cells have the potential to transdifferentiate into mesenchymal cells in 
vivo.  
 Therefore, in this study we investigated the capacity of adult vascular 
endothelial cells to undergo EMT in vivo. For this purpose we used Tie2LacZ 
reporter mice.
5
 The Tie2 gene encodes a vascular endothelial-specific receptor.
6,7
 
Subsequently, in Tie2LacZ reporter mice positivity for β-galactosidase in the 
normal vascular wall is exclusively found in the endothelial cell population. Adult 
vascular endothelial cells are fully differentiated and are in a state of quiescence. 
To study the capacity of these cells to undergo EMT, we challenged the mouse 
vascular system by placement of a nonconstrictive collar around the femoral artery. 
This technique is frequently used to induce neointimal lesions, a reflection of 
cardiovascular disease.
8-12
 Besides determination of the EMT capacity of adult 
endothelial cells in vivo, this experimental set-up enabled us to assess whether 
endothelial cells are active contributors to the mesenchymal cell population in 
neointimal lesions. 
 To investigate the role of Tgf-β signaling in our model, the expression 
patterns of several proteins of the Tgf-β/Smad signal transduction pathway
13
 were 
studied. Tgf-β can signal via two different pathways on endothelial cells. Tgf-β 
signaling through the type I receptor Alk5 and Smad2/3 has been reported to 
maintain a quiescent differentiated phenotype of the endothelium.
14
 Signaling 
through the Tgf-β type I receptor Alk1 and Endoglin via Smad1/5/8 on the other 
hand, stimulates proliferation and migration of endothelial cells.
15
  
 Our results demonstrate that adult endothelial cells have the capacity to 
undergo EMT in vivo. Furthermore, we show that a first population of mesenchymal 









For these experiments we used Tie2LacZ, Rosa26LacZ and wild-type FVB mice. 
The Tie2LacZ reporter line (a generous gift of Dr. U. Deutsch) was derived from 
founder 182.30 as described.
5
 The construct contained the 2.1 kb HindIII Tie2 
promoter fragment followed by the LacZ reporter gene and simian virus 40 poly(A) 
signal sequence. In addition, a mouse Tie2 genomic fragment extended from an 
NgoMI site at the 3’ end of exon 1 approximately 10 kb into the first intron 
downstream of the LacZ cassette (HHNS construct). The founders were 
backcrossed to FVB for more than 10 generations. The Rosa26LacZ reporter 
mouse, a knock-in mouse expressing the LacZ gene in essentially all tissues, was 
kindly provided by Dr. P. Soriano.
16
 Wild-type FVB mice were generated by our 
internal breeding facility. Diet and water were provided ad libitum. The Committees 
on Animal Welfare, Leiden University Medical Center and TNO Quality of Life, 
approved all animal experiments. 
 
Femoral Artery Collar Placement  
In Tie2LacZ mice average age 6 months, a nonconstrictive collar was placed 
around the femoral artery to induce neointima formation.
8,9
 With this technique 
neointimal lesions induced within the area of the collar. The mice were 
anesthetized by an intraperitoneal injection of 2.5 µl/g Hypnorm® (containing 
fentanyl citrate 0.315 mg/mL and fluanisone 10 mg/mL, Bayer, Mijdrecht, The 
Netherlands) and 2.5 µl/g Dormicum® (midazolam 5 mg/mL, Roche, Woerden, The 
Netherlands). The nonconstrictive polyethylene collar (0.40 mm inner diameter, 
0.80 mm outer diameter, 1.5 mm length, Portex, Hythe, UK) was placed around 
one of the femoral arteries avoiding damage to the vascular wall. The other hind 
leg was sham-operated.  
 
Beta-Galactosidase Staining  
Tie2LacZ mice were sacrificed at 3, 7, 14 and 21 days (n=7, 16, 27 and 4) and the 
bone marrow recipients 14 days after collar placement, respectively. After cervical 
dislocation both collared and sham-operated femoral arteries were harvested. For 
detection of the β-galactosidase by light microscopy, tissues were first fixed in 2% 
paraformaldehyde (PFA) in phosphate buffered saline (PBS) for 2 hours at 4
o
C 
followed by incubation for 2 hours at 37 
o
C in a solution containing 10 mM 
potassium ferricyanide, 10 mM potassium ferrocyanide, 2 mM MgCl2 and 0.1%  
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X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside, Roche). Postfixation 
was performed overnight in 4% PFA after which the tissue was dehydrated in 
series of ethanol and xylene, and paraffin embedded. 
 For visualization of the β-galactosidase staining reaction by transmission 
electron microscopy the arteries were fixed in 2% PFA/0.1% glutaraldehyde in 
0.1M cacodylate buffer (pH 7.4) for 1 hour at 4 
o
C followed by incubation in a 
solution containing 10 mM potassium ferricyanide, 10 mM potassium ferrocyanide, 
2 mM MgCl2 and 0.1% Bluo-gal (5-bromo-3-indolyl-beta-D-galactosidase, 
Invitrogen, Breda, The Netherlands) for 2 hours at 37 
o
C. Postfixation was carried 
out for 12 hours in 2% PFA/2% glutaraldehyde in 0.1M cacodylate buffer (pH 7.4) 
and in 1% OsO4/PBS for 1 hour. The tissue was embedded in epoxy resin mixture 
and sections of 1 µm were cut. Sections of interest were re-embedded, ultra thin-
sectioned and subsequently stained with lead citrate and uranyl acetate. The 
EM410 transmission electron microscope (Philips, Eindhoven, The Netherlands) 
was used for assessment of the β-galactosidase staining.  
 
Immunohistochemistry 
Overnight fixation of the tissues in 2% acetic acid in 98% ethanol or in 3% PFA in 
66% ethanol was followed by dehydration in series of ethanol and xylene and the 
tissues were paraffin embedded. Transverse 5-µm sections were cut and serially 
mounted. Unless indicated otherwise the immunohistochemistry was performed as 
previously described.
17
 Sections were incubated overnight at room temperature 
with rat monoclonal antibodies against ICAM-1 (1:100, R&D systems, Abingdon, 
UK), CD31 (1:500, Serotec, Düsseldorf, Germany), CD34 (1:50, PharMingen, 
Breda, The Netherlands), and Mac-3 (1:400, PharMingen). The rabbit polyclonal 
antibodies against phosphoSmad1/5/8 (PSmad1/5/8; 1:50) and phosphoSmad2 
(PSmad2; 1:1500) were generated as previously described.
18
 Furthermore, rabbit 
polyclonal antibody against Von Willebrand factor (vWF; 1:500, DAKO, Glostrup, 
Denmark) and goat polyclonal antibodies against VCAM-1 (1:200, Santa Cruz, 
Heerhugowaard, The Netherlands) and Ki67 (1:1000, Sanver Tech, 
Heerhugowaard, The Netherlands) were used. Rabbit anti-rat biotin conjugate 
(1:200, Vector, Amsterdam, The Netherlands), goat anti-rabbit biotin conjugate 
(1:200, Vector) or rabbit anti-goat biotin conjugate (1:200, Vector) with normal 
rabbit and goat serum diluted in PBS were used as secondary antibodies and 
incubated for 1 hour at room temperature. Biotin labeling was followed by 
incubation with Vectastain ABC (Vector) for 1 hour. 3-3’ diaminobenzidine 
tetrahydrochloride was used for visualization and counterstaining was performed 





 For staining of the sections with mouse monoclonal anti-α smooth muscle 
actin (1:2000, Sigma-Aldrich), the primary antibody was coupled overnight to 
polyclonal rabbit anti-mouse peroxidase conjugate (1:200, DAKO) secondary 
antibody.
19
 Sections were incubated for 2 hours at room temperature. Several X-
gal sections were stained with nuclear red using the standard protocol.  
 
Bone marrow transplantations 
To demonstrate that the neointimal cells expressing X-gal, Bluo-gal and α-smooth 
muscle actin were not derived from circulating cells expressing Tie2, the bone 
marrow of wild-type mice was replaced by bone marrow of Tie2LacZ and 
Rosa26LacZ mice and followed by collar placement 4 weeks after transplantation.  
 The drinking water of wild-type bone marrow recipients (n=8) was 
supplemented with the antibiotics polymixin B (Bupha, Uitgeest, The Netherlands), 
ciprofloxacin (Bayer), amfotericine B (Bristol-Myers Squibb, Woerden, The 
Netherlands) and saccharose from week -1 until +4 after bone marrow 
transplantation. Donor bone marrow was harvested from femurs and tibias of 
Tie2LacZ (n=4) and Rosa26LacZ (n=4) mice. Bone marrow recipients were 
irradiated with a single dose of 13 Gy X-ray total body irradiation as previously 
described.
20
 One day after irradiation approximately 1x10
7
 donor cells were 
injected via caudal vein injection.  
 
Statistical analysis 
The endothelial cell proliferation response was studied in femoral arteries 3 days 
after collar placement or sham-operation (n=6 each group). The total number of 
nuclei and the total number of Ki67-positive nuclei were determined by counting 
the nuclei in each fifth section of 5 µm over a length of 0.7 mm. The lumen volume 
was estimated by applying Cavalieri’s principle
21
 and used to calculate and correct 
for endothelial surface area. Data are represented as mean ± SEM. Statistical 
significance of the differences between the groups were determined using the 
Student’s t-test and considered significant if P < 0.05. 





Time Course of Neointima Formation 
We studied the neointimal response at 3, 7, 14 and 21 days after collar placement 
and sham-operation. Normal vascular morphology was observed in the femoral 
arteries of sham-operated mice at all time points after intervention (Figure 1A). 
Similar morphology was detected in areas outside the region of the collar. Within 
the collar region on the other hand, 3 days after collar placement an endothelial 
cell response was observed characterized by detachment and proliferation (Figure 
1B). Morphometric analysis based on the Ki67 staining revealed a significantly 
increased proliferation rate of the endothelial cells in collared femoral arteries 
compared with sham-operated femoral arteries (35.05 ± 6.09 versus 1.44 ± 0.61% 
Ki67-positive cells, P < 0.001, Figure 1C).  
 One layer of subendothelial cells was present after 7 days and 2 to 3 
layers could be detected 14 days after collar placement. Endothelial cells of both 
collared and sham-operated femoral arteries showed positivity for vWF (Figure 2A-
B). In addition to positivity in the endothelial cell lining, vWF deposition was found 
in the neointima of collared femoral arteries (Figure 2B). ICAM-1 expression in 
endothelial cells of collared femoral arteries was decreased compared with sham-
operated arteries (Figure 2C-D). The CD31 staining remained unaffected and was 
restricted to the endothelial cells throughout the process of neointima development 
(Figure 2E-F). From 14 days onwards the first signs of fragmentation of the internal 
elastic lamina were observed and medial smooth muscle cells started to migrate 
into the neointima. After 21 days large parts of the internal elastic lamina had 
disappeared and many smooth muscle cells were present in the neointima (data 
not shown).  
 
 
Figure 1. Endothelial cell proliferation 3 days after collar placement. Representative immunostaining for 
Ki67 in (A) sham-operated and (B) collared femoral arteries. LEI indicates lamina elastica interna; M, 
media; A, adventitia. Scale bar: 30 µm. (C) Morphometric analysis of endothelial cell proliferation in the 
region of the collar compared with sham-operated femoral arteries. Data are means ± SEM, *P < 0.001. 
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Figure 2. Endothelial cell markers in representative cross-sections from (A,C,E) sham-operated and 
(B,D,F) femoral arteries 7 days after collar placement that were stained with antibodies against (A-B) 
vWF, (C-D) ICAM-1 and (E-F) CD31. LEI indicates lamina elastica interna. Arrowheads show regions of 
endothelial cell detachment. Scale bars: A,E,F 20 µm, B,C,D 30 µm. 




Figure 3. Beta-galactosidase expression in femoral arteries. Representative cross-sections from (A,C) 
sham-operated and (B,D,E) collared femoral arteries 2 weeks after collar placement. Beta-
galactosidase expression in (A) endothelial cells and (B, small speckles, arrowheads) β-galactosidase 
expression in endothelial cells and mesenchymal cells. Transmission electron microscopic pictures of β-
galactosidase in nuclear and cellular membranes of (C) endothelial cells and (D) cellular membranes of 
mesenchymal cells, magnification 5900x and 4400x respectively. (E) Beta-galactosidase and α-smooth 
muscle actin-positivity in mesenchymal cells. (F,G, α-sm actin) Detail of mesenchymal cells with α-sm 
actin and β-galactosidase within the same cell (arrow). L indicates lumen; LEI, lamina elastica interna; 





In Tie2LacZ reporter mice, β-galactosidase can be detected in tissues expressing 
Tie2, such as vascular endothelial cells (Figure 3A). Medial smooth muscle cells 
and adventitial fibroblasts of the vascular wall on the other hand, were completely 
devoid of staining. To precisely determine the localization of X-gal precipitate in the 
endothelial cells, expression was studied with transmission electron microscopy. In 
endothelial cells, the X-gal precipitate was found in the nuclear and cellular 
membranes (Figure 3C). Furthermore, staining was observed in the Golgi of these 
cells. There was no indication of phagocytosis as neither vacuoles nor a-specific 
depositions of β-galactosidase were found.  
 From 7 days after collar placement onwards, β-galactosidase was not only 
detected in the endothelial cells, but also in the neointima (Figure 3B). In these 
mesenchymal cells β-galactosidase expression was solely observed in the cellular 
membrane (Figure 3D). Staining of X-gal in the mesenchymal cells gradually 
diminished but could still be detected at 14 days after collar placement. A number 
of β-galactosidase-positive mesenchymal cells showed positivity for α-smooth 
muscle actin from 7 days onwards (Figure 3E-G).  
 The results indicate that endothelial cells have the capacity to undergo 
EMT. However, Tie2 is not exclusively expressed in vascular endothelial cells, but 
can also be detected in part of the bone marrow-derived cells. To exclude the 
contribution of bone marrow-derived cells to the neointimal lesions, we performed 
bone marrow transplantations from Tie2LacZ and ROSA26LacZ mice to wild-type 
recipients prior to collar placement. No β-galactosidase-positive cells were 
detected in the endothelial cell lining of the femoral arteries 14 days after collar 
placement in bone marrow recipients (Figure 4A). In addition, no β-galactosidase-
positive cells were found within the neointima and media of the arteries. We only 
demonstrated X-gal positivity in the adventitia and perivascular space, the area 
between the adventitia and the position of the collar, of wild-type mice transplanted 
with bone marrow of Rosa26LacZ donors (Figure 4B).  
 Both macrophages and CD34-positive endothelial progenitor cells are 
derived from the bone marrow. The lack of X-gal positivity in the neointima and 
media suggested the absence of both cell-types in this region. 
Immunohistochemistry confirmed that macrophages (Figure 4C-D) and endothelial 
progenitor cells (Figure 4E-F) homed into the adventitia, but not towards the 








Figure 4. Bone marrow-derived cells in the adventitia. Representative cross-sections of the (A,C,E)  
intima and media and (B,D,F) adventitia 2 weeks after collar placement. (A-B) Beta-galactosidase 








The Effects of Collar Placement on Tgf-β Signal Transduction  
Since Tgf-β signaling is important in EMT, we examined the consequences of 
collar placement on Tgf-β signaling in the initiation phase of EMT, 3 days after 
collar placement. Intense nuclear PSmad2 staining was detected in endothelial and 
smooth muscle cells of sham-operated femoral arteries (Figure 5A). In contrast, 
PSmad2 staining was markedly decreased and even absent in numerous areas 
within collared femoral arteries (Figure 5B). Nuclear expression of PSmad1/5/8 
was present in the endothelial and smooth muscle cells of sham-operated, as well 
as collared femoral arteries (Figure 5C-D).  
 
 
Figure 5. Tgf-β signaling pathway 3 days after collar placement. Representative cross-sections from 
(A,C) sham-operated and (B,D) collared femoral arteries were stained with antibodies against (A-B) 
PSmad2 and (C-D) PSmad1/5/8. EC indicates endothelial cell; M, media; A, adventitia. Scale bars: 20 
µm. 




In the present study we show that endothelial cells in the vasculature of adult mice 
still have the capacity to undergo EMT. By doing so, endothelial cells contributed to 
the total pool of mesenchymal cells that composed the neointima. Recently, it has 
been reported that adaptive intimal thickening may be important in the 
development of early stage atherosclerosis as it was found that it preceded 
pathological plaque formation.
22
 Furthermore, an important role has been ascribed 
to EMT in the process of cardiac fibrosis.
23
 Constriction of the murine ascending 
aorta induced cardiac fibrosis and, in addition, evoked transdifferentiation of 
endothelial cells towards a fibroblast phenotype. Together, these data indicate that 
EMT could be important in development and progression of cardiovascular 
disease.   
 The early response to collar placement, at 3 days, was characterized by 
endothelial cell detachment and proliferation. Endothelial cell detachment is part of 
the process of cell scattering.
24
 During cell scattering cell-cell adhesion complexes 
dissociate and the cells acquire cell motility. This process is a prerequisite for the 
occurrence of EMT. In addition to endothelial cell detachment, endothelial cell 
proliferation was observed. Smooth muscle cell proliferation was not detected. Our 
data are in accordance with a study that demonstrated that nonconstrictive collar 
placement solely induces intimal proliferation and has not adverse effects on the 
smooth muscle cell population of the media up to 2 weeks after collar placement.
9
 
We conclude that perivascular collar placement around the femoral artery is a 
suitable technique to study EMT. 
 Our data indicate that the initial population of mesenchymal cells is of 
endothelial origin. Besides positivity of the endothelial cells for β-galactosidase in 
the Tie2LacZ reporter mouse model, part of the bone marrow-derived cells can 
express Tie2. Bone marrow transplantations were performed to elucidate the role 
of circulating cells in our model and to exclude bone marrow origin of the 
mesenchymal cells. Bone marrow-derived cells were only detected in the 
adventitia. Our results are supported by the data of Xu and colleagues who in the 
same animal model showed that all bone marrow-derived cells were directed to the 
adventitia and none were found in the intima.
10
 Thus, the β-galactosidase-positive 
mesenchymal cells are most likely of endothelial origin. 
 The β-galactosidase positivity seen in the mesenchymal cells was much 
less intense than that found in the endothelial cells. We showed that β-
galactosidase staining was only present in the cellular membrane whereas in 
endothelial cells additional positivity was found in the nuclear membrane and Golgi. 





membranes diminished. These data indicate that Tie2 transcription in the 
mesenchymal cells is downregulated. Consequently, these cells lose endothelial 
cell-specific characteristics.  
 Mesenchymal cell characteristics on the other hand, were acquired. From 
7 days after collar placement onwards a number of mesenchymal cells showed 
double positivity for β-galactosidase and α-smooth muscle actin. Our data are 
supported by a number of reports describing that during the initial phase of 
neointima formation the lesions contained α-smooth muscle actin positive cells.
8,9
 
Since transmission electron microscopy revealed that the internal elastic lamina 
remained intact up to 14 days, active contribution of medial smooth muscle cells to 
the neointima between 7 and 14 days after collar placement can be excluded.  
 LeClair and colleagues recently reported that normal mouse carotid 
arteries highly express the Tgf-β-related proteins PSmad1/5/8 and PSmad2/3 in 
the nuclei of the endothelial cells.
25
 Our data in the femoral artery are in 
concordance with this observation. We found high levels of PSmad1/5/8, as well as 
PSmad2 in endothelial and smooth muscle cells.  High expression of these Smad 
proteins appears to be related to a differentiated and quiescent state.
14
 Tgf-β 
signaling pathways are not only associated with cell differentiation and quiescence, 
but also with the induction of EMT (reviewed by Zavadil
26
). Therefore, for in vitro 
experiments this cytokine has been generally used to initiate EMT.
2-4
 Our data 
show that collar placement results in downregulation of Tgf-β/Alk5/PSmad2 
signaling in endothelial cells. As a consequence, the balance between PSmad2/3 
and PSmad1/5/8 shifted towards the Tgf-β/Alk1/Eng/Smad1/5/8 signaling pathway. 
Since the latter is associated with increased proliferation and migration of cells,
27
 
we postulate that Tgf-β signaling plays an important role in EMT in vivo. Additional 
studies on Smad proteins, Endoglin and the receptors Alk1 and Alk5 are foreseen 
to determine their role and the overall influence of Tgf-β. 
 In conclusion, the present study has provided evidence that adult 
endothelial cells in vivo have the capacity to undergo EMT. Furthermore, through 
EMT endothelial cell provide a first population of mesenchymal cells. We postulate 
that EMT may play an important role in the development and progression of 
cardiovascular disease. 
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Purpose of review  
In the last 20 years, an increasing amount of epidemiological and pathological 
evidence has become available illustrating the relationship between an adverse in 
utero environment and increased risk of vascular disease in the offspring. It is now 
generally accepted that epigenetic phenomena, such as either DNA methylation or 
chromatin modifications or both mediate the long-term memory and thus 
developmental programming of cells and tissues. 
Recent findings 
In utero, the placenta and fetus are exposed to the metabolic, antioxidant and pro- 
inflammatory and anti-inflammatory signals from the mother and will likely respond 
specifically. In the fetus, these responses may lead to permanent changes either in 
DNA methylation or chromatin modification or both and these changes may lead to 
increased atherosclerosis susceptibility in adulthood. However, the molecular 
mechanisms responsible for the translation of an adverse maternal environment 
into permanent epigenetic changes are poorly understood.  
Summary 
In this review, we briefly summarize the possible signals crossing the placental 
barrier and discuss the molecular mechanisms of epigenetic programming in the 









Embryonic and fetal development is a delicately regulated process. Multiple 
signaling pathways, including transcriptional and (post)translational interactions, 
have to be framed in exact spatiotemporal windows during development. A small 
deviation in one of these processes can easily affect cellular differentiation or 
cellular contribution to developing organs. Many genetic defects and teratogenic 
agents such as ionizing radiation, drugs and environmental chemicals, can harm 
normal development and result in dramatic congenital malformations and even 
embryonic lethality. This knowledge had led in the 1970s to a world wide restriction 
on irradiation and medicine application during pregnancy. 
 The placenta plays a crucial, intermediary role in providing the proper 
microenvironment that allows normal development of the embryo and fetus and 
that adjusts the metabolism of both mother and child. Disturbances in the critical 
maternal-fetal metabolic balance, however, affect fetal growth ranging from a low 
birth weight to macrosomia (too large for the gestational age). In 1989, the 
epidemiologists Barker and colleagues
1
 elegantly demonstrated the association of 
low birth weight with an increased risk of cardiovascular disease in adult life. This 
led to the “fetal origins hypothesis” proposing that cardiovascular risk is at least 
partially determined by the maternal environment in utero. The fetal origins 
hypothesis states that adaptation to unfavorable aspects of the maternal 
environment is beneficial to the developing embryo in utero. However, when the 
adult environment differs from the fetal environment, these adaptations may lead to 
an increased risk for cardiovascular disease. A subsequent burst of 
epidemiological studies both in humans and animals have proven the relation of 







 on the one hand with size at birth, atherogenic lipid profiles 
and on the other hand with increased susceptibility to atherosclerosis in later life. 
 The challenging question is how an adverse maternal environment can be 
translated into an increased atherosclerosis susceptibility of the offspring. Which 
maternal signals can cross the placenta and what mechanisms are involved to 
predispose the developing embryo or fetus? In this review, we focus on the recent 
evidence that indicates that either the establishment of normal cell and tissue-
specific DNA methylation patterns or chromatin modification status from early 
embryonic to late fetal life or both can be influenced by maternal signals. 
 
Fetal Undernutrition 
Protein restriction during pregnancy is associated with a low birth weight and an 




plays a crucial role in modulating the effects of protein restriction on the fetus and 
the mother by balancing their nutritional interests. Recent publications of the Dutch 
Hunger Winter (1944-45) family study
6
 demonstrate that exposure to famine during 
gestation results in an increased incidence of glucose intolerance, obesity, CHD, 
atherogenic lipid profile, hypertension and a series of noncardiovascular diseases.
2
 
Interestingly, the effect on cardiovascular risk factors depends on the trimester 
during pregnancy in which the embryo is exposed to famine. Because the effects of 
protein restriction are most likely exerted through different mechanisms depending 
on the developmental stage, the time frame of exposure is essential. Exposure to 
famine in the first trimester results in an increased CHD risk, though birth weight is 
normal. This is presumably due to adequate nutrition and catch-up growth later on 
during pregnancy. Remarkably, the intima-media thickness of the vessel wall, a 
marker of CHD, is reduced in these offspring. However, this reduction in intima-
media thickness does not decrease the risk of CHD at adult age. Experiments in 
rats
7
 also demonstrate a reduced aortic wall thickness and elastin content after 
maternal undernutrition. Thus, as protein restriction in early fetal development can 
result in normal birth weight and a reduced intima-media thickness, these factors 
have a limited predictive value. Other factors associated with increased risk of 
atherosclerosis have to be considered while operating during development and 
maintained into adulthood. 
 Feeding pregnant rats a protein-restricted diet results in measurable 
epigenetic changes such as hypomethylation of the peroxisome proliferator-
activated receptor alpha and hepatic glucocorticoid receptor promoters in the 
offspring.
8,9
 Interestingly, the altered phenotype of the offspring and 
hypomethylation of the glucocorticoid receptor is prevented by addition of folic acid 
to the diet,
10
 a key intermediate in methylation reactions. Expression of the DNA 
methyltransferase (Dnmt)1 is reduced by protein restriction.
11,12
 These experiments 
link protein restriction to hypomethylation of specific promoters through reduction of 
Dnmt1. These experiments also suggest that the actual signal conferred by the 
protein-restricted diet is a relative deficiency in one-carbon metabolism. 
Pharmacological blockade of maternal glucocorticoid synthesis also prevents part 
of the phenotype that is hypertension. This suggests that increased corticosteroid 
levels, as a consequence of food restriction, may be the actual signal.
13
 It has been 
shown that binding of the glucocorticoid receptor complex to DNA is associated 
with local DNA demethylation and chromatin remodeling, subsequently resulting in 
a stronger glucocorticoid response.
14
 The binding of glucocorticoid receptor 
complexes to fetal DNA during developmental programming of DNA methylation 
status may thus account for persistent epigenetic changes. Deficiency in one-
carbon metabolism, subsequent changes in Dnmt1 activity, increased  
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corticosteroid levels and successive transcription factor mediated changes in DNA 
methylation, converge on the same mechanism that increases the risk of 
atherosclerosis. They all may well contribute to epigenetic programming in 
response to a protein-restricted diet. 
 Alternatively, a mechanistic link between gestational growth restriction and 
increased cardiovascular diseases may be found in shortening of telomere length. 
Telomere shortening is found in atherosclerotic plaques and the media of  the 
aorta.
15
 A rapid (post)natal weight gain after growth restriction in rats impairs the 
normal upregulation of the antioxidant defense capacity seen during normal slow 
increase of weight.
16
 An increased number of DNA single-strand breaks are 
detected resulting in enhanced telomere shortening during aging of the rats. These 
data indicate that adaptive pathways coping with oxidative stress are adjusted 
during early embryonic stages to the prevailing environmental circumstances. 
During rapid changes in food supply, these defense mechanisms are no longer 
adequate and result in a pro-atherogenic condition.  
 
Maternal Hypercholesterolemia 
Cholesterol is an essential component for adequate development of the fetus as it 
is an integral part of cell membranes, for example lipid rafts. In the third trimester of 
human pregnancy, when fetal growth rate is fast and fetal requirements are 
enhanced, the majority of mothers develop gestational hypercholesterolemia. 
Through changes in maternal cholesterol metabolism, nutrients are provided for 
pregnancy maintenance and fetal growth. Therefore, gestational 
hypercholesterolemia is generally considered to be a natural phenomenon not 
directly posing a risk for cardiovascular disease in both mother and progeny. In 
contrast, examination of human aortas from fetuses from overt 
hypercholesterolemic mothers reveals an increased number and size of 
atherosclerotic lesions compared with the aorta from fetuses from 
normocholesterolemic mothers.
4
 An extended study
17
 in neonates and young 
children demonstrates a persisting effect of maternal hypercholesterolemia in the 
offspring as a more rapid progression of atherosclerosis was detected, even when 
the offspring was normocholesterolemic. These results were substantiated and 
expanded in an apolipoprotein E (apoE) heterozygous knockout mouse model 
showing that maternal hypercholesterolemia is associated with endothelial damage 
in the fetal vasculature. The harmful effects persist until adult life and accelerate 
atherosclerotic lesion formation even in absence of a genetic susceptibility to 
cardiovascular disease.
5,18
 A remarkable finding in the heterozygous apoE-deficient 
mouse model
5
 was that, after birth, neither difference in morphology, in intima-




exposed and nonexposed groups. The exposed group, however, develops 
substantial intimal hyperplasia in response to reduced shear stress levels. The 
reduced or disturbed flow over the endothelium represents an additional pro-
atherogenic condition for the vessel wall.
19
 This indicates that atherosclerosis 
susceptibility can be imprinted in fetuses with arteries that do not as yet manifest 
atherosclerotic disease. The question is which cell types involved in intimal 
hyperplasia, for example endothelial cells, smooth muscle cells, fibroblasts or 
circulating bone marrow derived cells, are affected during development.  
 The signals conferred from the hypercholesterolemic mother to the fetus 
include fatty acid composition, oxidative stress, inflammatory stress and adaptive 
immunity (reviewed by Palinski and colleagues
20
). Recently, strong evidence for 
the transmission of oxidative stress to the fetus and a potential role for the placenta 
in modulating this signal has been obtained.
21
 Oxidative stress in the fetus most 
likely results not only in damage of the vessel wall, but also in an antioxidative 
stress response to counter this damage. The transcription factors modulating this 
response during a critical period of development may permanently alter the 
structure of the chromatin by preventing or enhancing DNA methylation status and 
chromatin modifications. Alternatively, oxidative stress has been proposed to alter 
the availability of cofactors such as S-[methyl-3H]-adenosyl-L-methionine to Dnmts 
and chromatin modifying enzymes.
22
 Either or both mechanisms could operate to 
translate oxidative stress to epigenetic changes. 
 The placenta functions as an efficient barrier to inflammatory cytokine 
transfer from the mother to the fetus.
23,24
 However, high levels of circulating 
cytokines in the mother will affect the placenta, which may subsequently affect 
inflammatory cytokine expression in the fetus. The challenge is to dissect the 
effects of the affected placenta on the fetus from the effects of the maternally 
increased oxidative stress directly on inflammatory markers in the fetus. Similar to 
oxidative stress, maternal inflammatory stress will affect pro-inflammatory and anti-
inflammatory gene transcription in the fetus. If this occurs during a critical period of 
development, the epigenetic setting of the DNA may be permanently altered. 
 The strongest evidence for a role of the immune system in transmitting 
atherosclerosis susceptibility comes from maternal immunization studies. 







 decreases the extent of atherosclerosis in 
the offspring. Developmental programming of the immune system is poorly 
understood. It is clear that the mother’s immune system is tolerant for the semi-
allogeneic fetus, in which regulatory T cells play an important role.
28
 Antibodies are 
actively transferred from the mother to the fetus and the suckling neonate. This 
maternal-derived antibody repertoire will affect immune responses of the neonate  
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and will play a role in the development and setting of the adaptive immune system 
extending into the adult offspring. 
 It is clear that epigenetic programming in the fetus in response to maternal 
hypercholesterolemia may occur through several signals and molecular 
mechanisms. Which of these signals and mechanisms are dominant will differ 
depending on the type of response that is being considered in the adult. Global 
gene expression analysis using microarrays of adult noncompromised arteries in 
the above discussed apoE heterozygous knockout mouse model,
5
 demonstrates 
upregulation of genes involved in immune pathways and fatty acid metabolism in 
the offspring from hypercholesterolemic mothers. This indicates that the signals 
from the adverse maternal environment are programmed in basic cellular 
processes of the fetal vascular cells. Furthermore, these are maintained throughout 
adulthood. Future studies have to prove which changes in DNA methylation are 
responsible for the increased atherosclerosis susceptibility. 
 
Other Maternal Drivers of Increased Atherosclerosis in 
Offspring 
Both maternal diabetes mellitus type 1 or 2 and gestational diabetes are 
characterized by macrosomia and obesity. Maternal diabetes results in an 
increased aortic intima and media thickness and left ventricular mass in the 
macrosomic newborns.
3
 Furthermore, the newborns have an increased risk of 





 or even reduced
30
 by maternal diabetes. Although lipid 
profiles may remain unaffected in cord blood in offspring of diabetic mothers, a 
striking effect is exerted on inflammatory pathways involving ICAM-1 and IL-6 
levels.
29,31
 Subclinical inflammation and altered vascular remodeling, detected in 
newborns of diabetic mothers, are likely involved in the increased risk of 
pathogenesis of atherosclerosis in adult life. Whether the inflammatory pathways 
are permanently altered by changes either in DNA methylation or chromatin 
modification patterns or both are still unknown and a challenge for future research. 
 Comparable effects are observed in offspring from mothers smoking during 
pregnancy. The detrimental effects of tobacco do not only affect the smokers 
themselves, but both direct and passive smoking during pregnancy is a major risk 
factor of reduced birth weight and increased atherosclerosis of the offspring. In 
children of mothers who smoked during pregnancy,
32
 significant lower plasma 
cholesterol levels were detected compared with nonexposed offspring even after 





atherosclerotic risk of the exposed offspring, a significant increase in plasma 
cholesterol levels of 0.12 mmol/L per 10 years was seen when compared with 
nonexposed children. This resulted in cholesterol levels exceeding those of 
nonexposed counterparts in adolescence. At adult age, the exposed group has an 
increased atherosclerotic risk compared with the nonexposed offspring. The 
combination of an increased aortic intima media thickness in the neonate
33
 and the 
long-term adverse effects on offspring lipid metabolism in the exposed group may 
manifest accelerated atherosclerosis in adult life. 
 
Conclusion 
The correlation between exposure to an adverse maternal environment during 
development and increased risk for adult vascular lesion formation is well 
described in human epidemiological and human and mouse pathological studies. 
Increasing evidence from animal studies indicates that permanent changes either 
in DNA methylation or chromatin modification status or both are responsible for the 
epigenetic programming of increased atherosclerosis susceptibility. Changes in the 
normal programming of either DNA methylation or chromatin modification patterns 
or both during either sensitive embryonic or fetal developmental periods or both 
may be caused by presence or absence of DNA-transcription factor complexes on 
the substrate DNA, and/or changes in the activity of enzymes involved in DNA 
methylation and/or chromatin modification. Which mechanism is dominant will likely 
depend on the maternal trigger and signal. Developmentally programmed cell and 
tissue-specific patterns of DNA methylation are largely maintained throughout life 
and are scarcely altered during aging.
34
 Thus, genome-wide methylation arrays 
compared with RNA expression profiles of exposed and nonexposed human 
specimens may provide an insight in the link between developmental programming 
and pathology. These changes in specific DNA methylation profiles may be better 
indicators of atherosclerosis susceptibility in the offspring as compared with for 
example birth weight and intima media thickness. 
 
Acknowledgements 
F.E.A. is supported by a grant of the Netherlands Heart Foundation 
(NHS2003B241). L.M.H. and K.W.vD. are supported by the Centre for Medical 
Systems Biology and Nutrigenomics Consortium in the framework of the 
Netherlands Genomics Initiative. 





 1.  Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from 
ischaemic heart disease. Lancet. 1989;2:577-580. 
 2.  Kyle UG, Pichard C. The Dutch Famine of 1944-1945: a pathophysiological model of long-term 
consequences of wasting disease. Curr Opin Clin Nutr Metab Care. 2006;9:388-394. 
 3.  Akcakus M, Koklu E, Baykan A, Yikilmaz A, Coskun A, Gunes T, Kurtoglu S, Narin N. 
Macrosomic newborns of diabetic mothers are associated with increased aortic intima-media 
thickness and lipid concentrations. Horm Res. 2007;67:277-283. 
 4.  Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty 
streak formation occurs in human fetal aortas and is greatly enhanced by maternal 
hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede 
monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690. 
 5.  Alkemade FE, Gittenberger-de Groot AC, Schiel AE, VanMunsteren JC, Hogers B, van Vliet LS, 
Poelmann RE, Havekes LM, Willems van Dijk K, DeRuiter MC. Intrauterine exposure to 
maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. 
Arterioscler Thromb Vasc Biol. 2007;27:2228-2235. 
 6.  Lumey LH, Stein AD, Kahn HS, van der Pal-de Bruin KM, Blauw GJ, Zybert PA, Susser ES. 
Cohort profile: the Dutch Hunger Winter families study. Int J Epidemiol. 2007;36:1196-1204. 
 7.  Skilton MR, Gosby AK, Wu BJ, Ho LM, Stocker R, Caterson ID, Celermajer DS. Maternal 
undernutrition reduces aortic wall thickness and elastin content in offspring rats without altering 
endothelial function. Clin Sci (Lond). 2006;111:281-287. 
 8.  Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC. Feeding pregnant 
rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic 
PPARalpha promoter of the offspring. Br J Nutr. 2008;1-5. 
 9.  Liautard JP, Egly JM. In vitro translation studies of the cytoplasmic nonpolysomal particles 
containing messenger RNA. Nucleic Acids Res. 1980;8:1793-1804. 
 10.  Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC. Dietary protein restriction of 
pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic 
gene expression in the offspring. J Nutr. 2005;135:1382-1386. 
 11.  Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA, Burdge GC. Induction of 
altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a 
protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 
expression is involved in impaired DNA methylation and changes in histone modifications. Br J 
Nutr. 2007;97:1064-1073. 
 12.  Langley-Evans SC, Lilley C, McMullen S. Maternal protein restriction and fetal growth: lack of 
evidence of a role for homocysteine in fetal programming. Br J Nutr. 2006;96:578-586. 
 13.  Langley-Evans SC. Hypertension induced by foetal exposure to a maternal low-protein diet, in 
the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J 
Hypertens. 1997;15:537-544. 
 14.  Thomassin H, Flavin M, Espinas ML, Grange T. Glucocorticoid-induced DNA demethylation and 
gene memory during development. EMBO J. 2001;20:1974-1983. 
 15.  Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, Bennett M. 
Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: 
effects of telomerase and oxidative stress. Circ Res. 2006;99:156-164. 
 16.  Tarry-Adkins JL, Martin-Gronert MS, Chen JH, Cripps RL, Ozanne SE. Maternal diet influences 
DNA damage, aortic telomere length, oxidative stress, and antioxidant defense capacity in rats. 




 17.  Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal 
hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in 
childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354:1234-1241. 
 18.  Goharkhay N, Sbrana E, Gamble PK, Tamayo EH, Betancourt A, Villarreal K, Hankins GD, 
Saade GR, Longo M. Characterization of a murine model of fetal programming of 
atherosclerosis. Am J Obstet Gynecol. 2007;197:416e1-416e5. 
 19.  Van der Heiden K, Hierck BP, Krams R, de Crom R, Cheng C, Baiker M, Pourquie MJ, 
Alkemade FE, DeRuiter MC, Gittenberger-de Groot AC, Poelmann RE. Endothelial primary cilia 
in areas of disturbed flow are at the base of atherosclerosis. Atherosclerosis. 2008;196:542-550. 
 20.  Palinski W, Yamashita T, Freigang S, Napoli C. Developmental programming: maternal 
hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Rev. 
2007;65:S182-S187. 
 21.  Liguori A, D'Armiento FP, Palagiano A, Balestrieri ML, Williams-Ignarro S, de NF, Lerman LO, 
D'Amora M, Rienzo M, Fiorito C, Ignarro LJ, Palinski W, Napoli C. Effect of gestational 
hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental 
passage of normal and oxidised fatty acids. BJOG. 2007;114:1547-1556. 
 22.  Hitchler MJ, Domann FE. An epigenetic perspective on the free radical theory of development. 
Free Radic Biol Med. 2007;43:1023-1036. 
 23.  Zaretsky MV, Alexander JM, Byrd W, Bawdon RE. Transfer of inflammatory cytokines across the 
placenta. Obstet Gynecol. 2004;103:546-550. 
 24.  Aaltonen R, Heikkinen T, Hakala K, Laine K, Alanen A. Transfer of proinflammatory cytokines 
across term placenta. Obstet Gynecol. 2005;106:802-807. 
 25.  Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, Palinski W. Maternal 
immunization programs postnatal immune responses and reduces atherosclerosis in offspring. 
Circ Res. 2006;99:e51-e64. 
 26.  Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, 
Witztum JL, Silverman GJ. Pneumococcal vaccination decreases atherosclerotic lesion 
formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 
2003;9:736-743. 
 27.  Caligiuri G, Khallou-Laschet J, Vandaele M, Gaston AT, Delignat S, Mandet C, Kohler HV, 
Kaveri SV, Nicoletti A. Phosphorylcholine-targeting immunization reduces atherosclerosis. J Am 
Coll Cardiol. 2007;50:540-546. 
 28.  Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat 
Immunol. 2006;7:241-246. 
 29.  Marseille-Tremblay C, Ethier-Chiasson M, Forest JC, Giguere Y, Masse A, Mounier C, Lafond J. 
Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism 
in human term placenta. Mol Reprod Dev. 2007. 
 30.  Nelson SM, Freeman DJ, Sattar N, Johnstone FD, Lindsay RS. IGF-1 and leptin associate with 
fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes. 
2007;56:2705-2709. 
 31.  Nelson SM, Sattar N, Freeman DJ, Walker JD, Lindsay RS. Inflammation and endothelial 
activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes. 
2007;56:2697-2704. 
 32.  Jaddoe VW, de Ridder MA, van den Elzen AP, Hofman A, Uiterwaal CS, Witteman JC. Maternal 
smoking in pregnancy is associated with cholesterol development in the offspring: A 27-years 
follow-up study. Atherosclerosis. 2008;196:42-48. 
 33.  Gunes T, Koklu E, Yikilmaz A, Ozturk MA, Akcakus M, Kurtoglu S, Coskun A, Koklu S. Influence 
of maternal smoking on neonatal aortic intima-media thickness, serum IGF-I and IGFBP-3 
levels. Eur J Pediatr. 2007;166:1039-1044. 
Maternal Transmission of Risk for Atherosclerosis 
 103 
 
 34.  Heijmans BT, Kremer D, Tobi EW, Boomsma DI, Slagboom PE. Heritable rather than age-
related environmental and stochastic factors dominate variation in DNA methylation of the 

















Altered Global Histone Methylation Profiles in Vascular 
Endothelial and Smooth Muscle Cells in Offspring 







, Ko Willems van Dijk
2,3
, Beerend P. 
Hierck
1
, J. Conny van Munsteren
1
, Louis M. Havekes
3,4,6
, Adriana C. Gittenberger-
de Groot
1
, Peter J. van den Elsen
5,7#






Department of Anatomy and Embryology, 
2





Department of Cardiology, 
5
Department of Immunohematology 
and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands; 
5
TNO-
Quality of Life, Gaubius Laboratory, Leiden, The Netherlands; 
7
Department of Pathology, VU 
University Medical Center, Amsterdam, The Netherlands 
# 
= Equal contribution 
 
 





Altered Global Histone Methylation Profiles in Vascular 
Endothelial and Smooth Muscle Cells in Offspring 






We recently demonstrated that atherosclerosis susceptibility of adult heterozygous 
apolipoprotein E-deficient (apoE
+/-
) offspring from apoE
-/-
 mothers is significantly 
increased as compared to adult apoE
+/-
 offspring from wild-type mothers. Here, we 
investigated the hypothesis that the adverse maternal environment in apoE
-/-
 
mothers alters the epigenetic modifications of DNA and histones in the vasculature 
of the offspring and thereby programs atherosclerosis susceptibility. Differential 
methylation hybridization microarray analysis was performed to study methylation 
patterns of CpG islands in DNA from the aortic arch and carotid arteries. An 
immunohistochemical approach was used to detect global histone methylation 
modifications. The microarray revealed a trend in hypermethylation of several CpG 
islands in the apoE
+/-
 mice from apoE
-/-
 mothers compared with those from wild-
type
 
mothers. Profiles of histone triple-methylation modifications of lysines and the 
accompanying lysine methyltransferases on the other hand, were clearly 
differentially affected by the maternal apoE status in the vascular endothelial and 
smooth muscle cells. We conclude that chromatin modification marks in the 
vasculature were affected by maternal apoE-deficiency. The observed changes in 
global histone methylation modifications within the vascular cells are associated 









An increasing amount of epidemiologic and pathological evidence is provided that 
an adverse maternal environment during embryonic development is correlated with 
an increased risk of cardiovascular disease in the offspring in adulthood.
1,2
 The 
“fetal origins hypothesis” postulated by Barker
2
 proposes that adaptation to an 
adverse maternal environment is favorable to the developing embryo. However, 
when the adult surroundings differ from the fetal setting, these fetal adaptations 
may lead to an increased disease risk. 
 In a recent animal study, we were able to demonstrate that maternal 
hypercholesterolemia and associated risk factors caused by apolipoprotein E-
deficiency (apoE
-/-
) induced a susceptibility for neointima formation in the offspring. 





 mothers, resulted in extensive intima formation, both in the 
presence
3
 and absence (unpublished data) of high-cholesterol feeding. ApoE
+/-
 
offspring from wild-type mothers were mainly nonresponders. These data indicate 
that atherosclerosis susceptibility may be programmed within the differentiating 
arteries during embryonic and fetal development and can persist into adulthood. 
The mechanisms underlying the observed atherosclerosis susceptibility are at 
present unknown. Global gene expression analysis on noncompromised (no collar) 
carotid arteries of adult apoE
+/-
 mice from apoE
-/-
 mothers, revealed upregulation of 
pathways involved in the immune response, fatty acid metabolism, and 
carbohydrate metabolism compared to offspring from wild-type mothers.
3
 Because 
the offspring are 100% genetically homogeneous, the observed differential 
expression patterns are likely to be governed by epigenetic mechanisms.  
 Epigenetic mechanisms affect gene expression by modification of the 
chromatin organization without changing the nucleotide sequence within a cell and 
ensures the maintenance of such an organization through mitotic cell divisions into 
the daughter cells. DNA methylation and covalent post-translational histone 
modifications are key players in the epigenetic regulation of the transcription 
machinery. Methylation of CpG sites within the DNA regulates gene expression, 
but is also thought to play an important role in silencing (retro)viral DNA 
sequences.
4,5
 As early as at the time of and directly after fertilization DNA 
demethylation of the paternal genome occurs, followed by de novo methylation. 
Both are important in the incorporation process of the maternal and paternal 
genomes.
6,7
 The mechanisms that apply or maintain DNA methylation are still not 
fully understood but involve many different proteins, and modified histones, and 
non-histone proteins such as DNA methyltransferases (Dnmts) like Dnmt1, and 
Dnmt3a/3b.
8,9
 In mammals, DNA methylation predominantly occurs symmetrically 








for histone modifications are conserved residues located 
mainly
 
in the amino-terminal tails of histones H3 and H4. These post-translational 
modifications include methylation, acetylation, phosphorylation, ubiquitination and 
sumoylation and together they establish the “histone code”. Histone methylation is 
thought to be the most stable of the modifications (reviewed by Shilatifard
11
). 
Histones are methylated either on the lysine and/or arginine residues. These 
modifications affect gene transcription. Triple-methylation of lysine 27 in histone H3 
(3Me-K27-H3) by the accompanying lysine methyltransferase EZH2 complex is an 
epigenetic mark generally associated with gene silencing. Until recently, triple-
methylation of lysine 9 within histone H3 (3Me-K9-H3) by the lysine 
methyltransferase SUV39H1 was also thought to be a unique hallmark of gene 
silencing. However, Vakoc and colleagues showed that 3Me-K9-H3 is also present 
in transcribed regions of active genes indicating that 3Me-K9-H3 has a dual role.
12
 
In contrast to 3Me-K9-H3 and 3Me-K27-H3, 3Me-K4-H3 is linked to active 
transcription. Acetylation of histones reduces the affinity between histones and 
DNA thereby mediating and enhancing transcription.
13,14
 
 We hypothesized that adverse factors associated with maternal apoE-
deficiency alter either the DNA methylation and/or histone methylation modification 
patterns or both in embryonic vascular endothelial cells (EC) and smooth muscle 
cells (SMC) and that these differences persist into adulthood. To study the effect of 
maternal apoE-deficiency on DNA methylation patterns in the vasculature of 
apoE
+/-
 offspring, a differential methylation hybridization microarray analysis was 
performed. An immunohistochemical approach was used to detect post-
translational modifications in the histone amino-terminal tails within the vessel wall. 
Detection of changes in DNA methylation and histone modifications within the 
vascular cells may provide us with a first indication of an underlying epigenetic 












 and wild-type C57Bl/6J mice were purchased from Charles River 
Laboratories (import agency for Jackson Laboratories). The apoE
-/-
 and wild-type 
mice were crossbred to generate genetically identical apoE
+/-
 offspring (n=13 each 
group) from apoE
-/-
 as well as from wild-type mothers. From weaning onwards (age 
4 weeks) the animals received a Western-type diet (1% cholesterol, Hope Farms). 
Diet and water were provided ad libitum. The Committee on Animal Welfare, 
Leiden University Medical Center, approved all animal experiments. 
 
Tissue Harvesting and Preparation 
For the Differential Methylation Hybridization (DMH) Microarray Analysis the aortic 
arch and carotid arteries were harvested at age 8 weeks (n=8 each group). The 
mice were anesthetized and the thorax opened.
3
 Pressure-perfusion (76 mm Hg) 
was performed through the cardiac left ventricle with phosphate buffered saline 
(PBS) for 5 minutes. The arteries were dissected and immediately snap frozen. For 
immunohistochemistry, the carotid arteries were obtained at 20 weeks and fixed for 
6 hours in 4% paraformaldehyde in 0.1 mol/L sodium phosphate buffer (n=5 each 
group). After fixation, the tissues were dehydrated in graded ethanol and xylene, 
and paraffin embedded. Transverse 5-µm sections were cut and serially mounted.  
 
DMH Microarray Analysis and Bisulfite Sequencing 
Analysis of differential methylation using CpG island containing microarrays was 
done essentially as described by others.
15,16
 Detailed protocols for the generation 
of methylated amplicons and the hybridization procedure for the DMH assay are 
available on request at http://www.lgtc.nl. In short, high molecular DNA was 
isolated from the aortic arch and carotid arteries as previously described.
17
 An 
amount of 600 ng DNA was digested with the restriction enzyme MseI.  5' 
Overhangs were ligated with the linkers 5'- AGG CAA CTG TGC TAT CCG AGG 
GAT-3’ and 5’- TAA TCC CTC GGA -3’. Fragments were then digested with the 
DNA methylation-sensitive restriction enzymes BstUI and HpaII (Fermentas), 
followed by amplification. Fragments were labeled with CY3 or CY5 (GE 
Healthcare) fluorescent labels. Samples were hybridized on a single-spotted array 
containing 4.6 k mouse CpG-island clones (University of Toronto, Ontario, Canada: 
(http://www.microarrays.ca/products) from a library obtained from the Sanger 
Institute. Microarrays were hybridized conform a dye-swap procedure;
15
 a set of 




were scanned with the G2565BA microarray scanner of Agilent. To analyze the 
microarray data (two separate images), the circular features mode of GenePix 4.0 
was used. Normalization of the data and analysis of differential methylation 
between the vasculature of apoE
+/-
 mice from apoE
+/+
 mothers and those from 
apoE
-/-
 mothers was performed in Rosetta Resolver software 
(http://www.rosettabio.com) by means of t-tests. Multiple test correction implied 
Bonferroni and Benjamini-Hochberg. Because none of the analyzed clones showed 
significant differences (corrected for multiple testing (MT)) in methylation between 
groups, the top 88 of the uncorrected MT potential differentially methylated clones 
with a P-value < 0.0001, sufficient intensities on the array, and a fold change of at 
least 1.2  were searched for nearby genes at: http://data.microarrays.ca/cpgmouse. 




Validation of potentially biologically relevant differentially methylated regions or 
CpG islands of nearby genes was performed by bisulfite sequencing as previously 
described.
18,19
 Approximately 500 ng of genomic DNA was used in the modifying 
bisulfite reaction. The following CpG island loci, in or near the respective gene, 
were selected for validation of the CpG microarray analysis: Prostaglandin-
endoperoxide synthase 1 (Ptgs 1), Tubulin beta 2 (Tubb2b), Tumor necrosis factor 
receptor superfamily 4 (Tnfrsf4), Interleukin 12b (IL12b), GATA binding protein 2 
(Gata2) and Cystin 1 (Cys1). Sequencing analysis was performed with Big Dye 
terminator kit (v3.1) of Applied Biosystems and analyzed on an ABI3100. Details on 
bisulfite PCR and sequencing primers are available on request.  
 The analyses revealed all loci to be completely unmethylated. To exclude a 
bias due to preferential amplification and to verify that the bisulfite PCR could 
detect unmethylated as wel as methylated DNA, PCR-amplified (unmethylated) 
DNA was enzymatically methylated. In vitro methylation of extended PCR 
fragments of IL12b was performed by SssI CpG methylase (NEB, approximately 
450 bp, primers available on request). The fragments were modified with the 
bisulfite reaction and checked for 100% methylation by HpaII digestion and after 
that diluted 1:1 with unmethylated PCR fragments. In this way, we generated a 
positive control of 50% methylated PCR IL12b fragments, which we amplified with 
our IL12b methylation detecting PCR assay. We found no evidence for preferential 








Unless indicated otherwise the immunohistochemistry was performed as described 
earlier.
3,20
 Overnight incubation at room temperature was performed with rabbit 
anti-trimethyl-histone H3 (Lys 27) (1:1000, Upstate, Lake Placid, USA, Cat no. 07-
449) and the accompanying lysine methyltransferase mouse anti-EZH2 (1:250, BD 
Biosciences, Breda, The Netherlands, Cat no. 612267), rabbit anti-trimethyl-histone 
H3 (Lys 9) (1:1000, Upstate, Cat no. 07-442) and its accompanying lysine 
methyltransferase rabbit anti-SUV39H1 (1:1000, Abcam, Cambridge, UK, 
ab38637), rabbit anti-trimethyl-histone H3 (Lys4) (1:1000, Upstate, Cat no. 07-473) 
and its accompanying lysine methyltransferase rabbit anti-hSet1 (1:500, Bethyl 
laboratories, Montgomery, USA, Cat no. IHC-00171), rabbit anti-acetyl-histone H3 
(1:1500, Upstate, Cat no. 06-599), and rabbit anti-acetyl-histone H4 (1:2000, 
Upstate, Cat no. 06-866). Goat anti-rabbit biotin conjugate (1:200, Vector, 
Amsterdam, The Netherlands) with normal goat serum diluted in PBS was used as 
secondary antibody. For EZH2, the primary antibody was coupled overnight to 
polyclonal rabbit anti-mouse peroxidase conjugate (1:200, DAKO, Glostrup, 
Denmark) secondary antibody.
21
 Sections were incubated for 2 hours at room 
temperature. Biotin labeling was followed by incubation with Vectastain ABC 
(Vector). The SUV39H1 signal was enhanced with a CSA kit (DAKO, Glostrup, 
Denmark). 3-3’ diaminobenzidine tetrahydrochloride (DAB) was used for 
visualization and counterstaining was performed with Mayer’s hematoxylin.  
 
Data Analysis 
In randomly selected sections (5-10 each carotid artery) the number of positive and 
negatively stained EC and SMC were counted for each antibody. The data were 
analyzed with linear mixed model statistics. With this technique we were able to 
take into account the possible variation between individual mice. The differences 







The vascular material of a total of 16 mice, 8 apoE
+/-
 offspring from wild-type 
mothers and 8 apoE
+/-
 offspring from apoE
-/-
 mothers, were hybridized (dye-swap) 
on 16 CpG island microarrays. Analysis of differential methylation showed 88 
regions with a significant difference (hypermethylation) in methylation pattern (for 
P-value ≤ 0.01, P-value plot and table see Appendix). After Bonferoni and 
Benjamini-Hochberg correction for multiple testing no significant differences in 
methylation patterns between both groups of apoE
+/-
 mice were detected. We 
evaluated the 88 clones on intensity (on both dye-swap microarrays) and fold 
change. Furthermore, this statistical selection was submitted to the UHN mouse 
CpG island database (see methods) and evaluated for biological relevance with 
respect to the vascular phenotype difference between the two groups. The 
submitted clones were screened for being in the vicinity or within potentially 
relevant genes. This selection procedure yielded six promising loci: The genes 
Ptgs1, Tubb2b, Tnfrsf4, IL12b, Gata2 and Cys1. However, bisulfite sequencing did 
not indicate that the CpG islands near/within Ptgs1, Tubb2b, Tnfrsf4, IL12b, Gata2 
and Cys1 were differentially methylated.  
 
Histone Modifications 
3Me-K27-H3 and EZH2  
The majority of EC nuclei were stained with anti-3Me-K27-H3 (Figure 1A-B). A 
trend towards an increase in the number of cells staining with the anti-3Me-K27-H3 
antibody was observed in the carotid arteries of apoE
+/-
 offspring from apoE
-/-
 
mothers compared with those of wild-type mothers (Figure 1C). The accompanying 
histone methyltransferase EZH2 (Figure 1E-F) colocalized and showed a 
significant enhancement of staining in the EC (97.4 ± 0.7% versus 92.5 ± 1.1%, P 
= 0.026, 1G). In SMC on the other hand, a significant decrease in the number of 





 mothers relative to apoE
+/-
 offspring from wild-type mothers (69.1 ± 
1.3% versus 51.5 ± 1.4%, P = 0.005, Figure 1D). EZH2 showed a similar tendency, 
although not resulting in statistical significance (Figure 1H). A striking finding was 
that not all SMC nuclei were stained completely. Partial nuclear staining was a 
common feature (clearly visualized in Figure 1A,F). This phenomenon of 
asymmetric nuclear staining was also seen in sections stained with the other 
antibodies. 
 




Figure 1. 3Me-K27-H3 and EZH2 staining in carotid arteries. Representative immunostaining for (A-B) 
3Me-K27-H3 and (E-F) EZH2 in cross-sections from apoE
+/-
 offspring from wild-type mothers (Mat WT) 
and apoE
-/-
 mothers (Mat apoE
-/-
). Scale bars: 20 µm. Percentage of (C-D) 3Me-K27-H3-positive and (G-
H) EZH2-positive EC and SMC in Mat WT and Mat apoE
-/-
 offspring. Note the clear and significant 
reduction in 3Me-K27-H3 staining in the SMC of Mat apoE
-/-
 offspring. In addition, Figure 1A and 1F 
clearly show partial nuclear staining in the SMC. Data are means ± SEM. Significant difference 





Figure 2. 3Me-K9-H3 and SUV39H1 staining in carotid arteries. Representative immunostaining for (A-
B) 3Me-K9-H3 and (E-F) SUV39H1 in cross-sections from apoE
+/-
 offspring from wild-type mothers (Mat 
WT) and apoE
-/-
 mothers (Mat apoE
-/-
). Scale bars: 20 µm. Percentage of (C-D) 3Me-K9-H3-positive and 
(G-H) SUV39H1-positive EC and SMC in Mat WT and Mat apoE
-/-
 offspring. Note the evident and 
significant increase in 3Me-K9-H3 staining in the EC from Mat apoE
-/-
 mice. Data are means ± SEM. *P 




3Me-K9-H3 and SUV39H1 
A striking significant increase in staining of 3Me-K9-H3 was detected in the EC of 
carotid arteries of apoE
+/-
 offspring from apoE
-/-
 mothers compared with those of 
wild-type mothers (74.4 ± 2.1% versus 95.0 ± 0.9%, P = 0.021, Figure 2A-C). The 
histone methyltransferase SUV39H1, which catalyzes the triple-methylation of K9-
H3, colocalized with 3Me-K9-H3 in the EC (Figure 2E-G). No statistical differences 
were observed between SUV39H1-positivity in EC of apoE
+/-





 offspring from wild-type mothers. In contrast to the observed 




 mothers, a reduction in 3Me-K9-H3 and also 
SUV39H1 was observed in the SMC (Figure 2D,H). Remarkable was the low 
number of SUV39H1 positive SMC in all sections (29-33%). 
 
3Me-K4-H3 and hSet1 
In contrast to the gene repressive role attributed to 3Me-K27-H3 and 3Me-K9-H3, 
the marker 3Me-K4-H3 is linked to active transcription. No effects of maternal 
apoE-deficiency were detected in the vascular EC of all mice (Figure 3A-C, E-G). 
However, a significant reduction in the percentage of 3Me-K4-H3 positive SMC 




 mothers compared with 
apoE
+/-
 offspring from wild-type mothers (59.4 ± 1.6% versus 42.8 ± 1.7%, P < 
0.000, Figure 3D). In addition, the accompanying lysine methyltransferase hSet1 
revealed a significant decrease in staining (36.1 ± 1.0% versus 25.0 ± 1.0%, P = 
0.005, Figure 3H). 
 
Acetylation markers Ac-H3 and Ac-H4 
Acetylated histones are normally associated with active transcription. Although 
histone H3 in EC and SMC nuclei appeared to be sensitive to alterations in 
methylation as a result of maternal apoE-deficiency, no significant differences were 
detected in the acetylation pattern of histone H3 (Figure 4A-C). The acetylation of 





 mothers compared with apoE
+/-
 offspring from wild-type 
mothers (78.7 ± 4.4% versus 86.9 ± 1.2%, P = 0.015, Figure 4E-G). Similar to the 
staining profiles observed with the methylation markers, also acetylation of both 
histone H3 and H4 appeared to be decreased in the SMC (Figure 4D,H). 




Figure 3. 3Me-K4-H3 and hSet1 staining in carotid arteries. Representative immunostaining for (A-B) 
3Me-K4-H3 and (E-F) hSet1 in cross-sections from apoE
+/-
 offspring from wild-type mothers (Mat WT) 
and apoE
-/-
 mothers (Mat apoE
-/-
). Scale bars: 20 µm. Percentage of (C-D) 3Me-K4-H3-positive and (G-
H) hSet1-positive EC and SMC in Mat WT and Mat apoE
-/-
 offspring. Note the significant reduction in 
3Me-K4-H3 staining, as well as in the accompanying lysine methyltransferase hSet1 in the SMC from 
Mat apoE
-/-
 offspring. Data are means ± SEM. Significant difference observed in (D) *P < 0.000 and (H) 





Figure 4. Ac-H3 and Ac-H4 staining in carotid arteries. Representative immunostaining for (A-B) Ac-H3 
and (E-F) Ac-H4 in cross-sections from apoE
+/-





). Scale bars: 20 µm. Percentage of (C-D) Ac-H3-positive and (G-H) Ac-H4-positive 
EC and SMC in Mat WT and Mat apoE
-/-
 offspring. Note the significant increase in Ac-H4 positivity in EC 
from Mat apoE
-/-






This study provides a first indication that epigenetic programming could be 
responsible for the long-term persistence of the effects of prenatal exposure to 
atherosclerotic risk factors. Tissue-specific alterations were detected in histone 
modification patterns in EC and SMC of apoE
+/-
 mice from apoE
-/-
 mothers relative 
to apoE
+/-
 offspring from wild-type mothers. This shift in histone modification 
patterns may explain the altered susceptibility for cardiovascular disease that may 
be acquired in utero and maintained throughout life.  
 The examination of global histone modifications, with emphasis on triple-
methylation of lysine residues in histone H3, through an immunohistochemical 
approach provided us with information on differences in levels of global histone 
modifications and their accompanying lysine methyltransferases between individual 
cells and cell types. The distinction in the proportion of positive EC and SMC 
between carotid arteries of apoE
+/-
 offspring from apoE
-/-
 mothers and those from 
wild-type mothers was used to assess the level of modification in a tissue-specific 
way. A striking observation was the general increase of the number of positively 
stained EC in carotid arteries of apoE
+/-
 offspring from apoE
-/-
 mothers compared 
with apoE
+/-
 offspring from wild-type mothers for all used markers. In SMC on the 
other hand, an overall decrease was detected. The observed changes in histone 
modification profiles indicate differences in the activation status of the vascular 
wall. They are the associated with exposure to the adverse maternal environment 
created by apoE-deficient mothers. It is not clear at the moment whether the 
altered profiles are the result of a direct effect of the microenvironment on the 
developing vessel wall in utero or a reflection of indirect influences of other affected 
or reprogrammed biological systems, as for instance the immune system. In both 
cases, the maternal apoE status is the cause of the observed histone modifications 
in the vessel wall of the adult offspring.  
 Few studies have been performed on the role of histone modifications in 
cardiovascular disease. It was demonstrated that athero-prone shear stress levels, 
an important risk factor of atherosclerosis characterized by low or oscillatory flow 
profiles, affected chromatin remodeling in cultured human SMC.
22
 Histone H4 
acetylation was reduced in the promoter regions of α-smooth muscle actin and 
smooth muscle myosin heavy chain in cultured human SMC thereby promoting 
SMC dedifferentiation. In vivo, in low-density lipoprotein receptor-deficient mice 
histone acetylation was associated with pro-atherogenic genes and in regulation of 
the oxLDL receptor.
23
 In contrast to the relative lack of data on the role of histone 
modifications in cardiovascular disease, histone modifications and their effects 
have already been extensively studied in cancer research. Many global changes in 
post-translational histone modifications have been found.  
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The presence of 3Me-K9-H3, 3Me-K27-H3 and EZH2 in promoter regions of tumor 
suppressor genes has been reported to induce vulnerability to aberrant de novo 
DNA hypermethylation in tumor suppressor genes.
24-27
 The global loss of 
acetylation at K16-H4 and trimethylation at K20-H4 has been associated with 
hypomethylation of DNA, an important feature of cancer cells.
28
 Besides their 
function in carcinogenesis, changes in expression profiles of histone lysine 
methyltransferases have been linked to disease risk. Overexpression of EZH2 
correlates with poor prognosis in various human cancer types.
29-33
 A particular 
combination of histone markers is predictive for risk of recurrence of prostate 
cancer and gastric adenocarcinomas.
34,35
 These data indicate that histone 
modifications play a key role in carcinogenesis and disease outcome. In our study 
we observed an increase in the number of cells with triple-methylation of K9-H3 
and of K27-H3. Furthermore, we also noted and enrichment of EZH2 which 
catalyzes 3Me-K27-H3 in EC of apoE
+/-
 offspring from apoE
-/-
 mothers. In addition, 
3Me-K27-H3 and 3Me-K4-H3 were significantly reduced in SMC. Together these 
alterations in global histone methylation modifications affect the cellular portrait of 
expressed genes ultimately providing and athero-prone environment. 
 No pathology was detected in the carotid arteries, as well as in the aortic 
arch of all apoE
+/-
 mice at age 20 weeks thereby indicating that the histone triple-
methylation modifications preceded any sign of atherosclerosis.
3
 Challenging of the 
carotid arteries with postnatal risk factors for atherosclerosis, such as induction of 
athero-prone low shear stress through collar placement and high-cholesterol 
feeding, resulted in accelerated neointima formation in the apoE
+/-







 offspring from wild-type mothers on the other hand, no 





 mothers the vascular wall is primed towards a pro-atherogenic 
phenotype.  
The DMH microarray analysis revealed trends of differentially methylated 
CpG islands in the vasculature of apoE
+/-
 offspring from apoE
-/-
 mothers compared 
with apoE
+/-
 offspring from wild-type mothers. The majority of these trends were set 
in the direction of hypermethylation of the CpG islands. We found no evidence of 
significant methylation differences when MT correction was applied. However, from 
these experiments we can not conclude that DNA methylation is not affected by 
maternal apoE-deficiency. When we take into account in terms of percentage the 
relatively small alterations in global histone methylation, DNA methylation most 
probably will also show subtle changes. From a technical point of view, the DMH 
microarray is probably not sensitive enough to pick up small changes. The DMH 
method is focused only on methylated regions, ignoring the possibility of the 




digestion. In that way it is feasible that a positive result is based on a minority of the 
total input material.  
DNA methylation plays a role in the tissue-specific transcriptional 
regulation of genes. Nonetheless, we did not distinguish between EC and SMC in 
our search to try to detect alterations in CpG island methylation between the 
apoE
+/-
 offspring from apoE
-/-
 mothers compared with apoE
+/-
 offspring from wild-
type mothers. With, for instance, laser dissection techniques EC could be 
separated from SMC. However, the yield of DNA of such small numbers of specific 
cells is far too low in order to detect differentially methylated regions by means of 
microarrays or bisulfite sequencing. Additional techniques will have to be used to 






It is becoming clear that DNA methylation is intimately linked to histone 
modification patterns. Genes marked by 3Me-K27-H3 and the EZH2, a subunit of 
the  polycomb repressive complex PRC2, may represent the main template for de 
novo DNA methylation in cancer.
24
 In this regard, it has been suggested that EZH2 
interacts with DNMTs thereby controlling DNA methylation.
26
 Methylation of K9-H3 
provides a binding platform for heterochromatin protein 1 to chromatin which 
subsequently facilitates recruitment of DNMTs.
37,38
 On the other hand, histone 
modifications have also been reported to precede alterations in DNA methylation 
and act independent of DNA methylation.
24,39
 The link between DNA methylation 
and post-translational histone modifications in our model remains to be 
established.   
  We realize that this study does not provide information on specific genes 
and their silencing, inactivation or activation as a result of exposure to maternal 
apoE-deficiency. Future research therefore is aimed at the identification in the 
different relevant cell types of the targets of the various histone methylation 
modifications investigated   
 In conclusion, epigenetic programming of susceptibility to adult 
cardiovascular disease is associated with the triple-methylation of several histones 
within vascular EC and SMC. These alterations may be acquired in utero and 
maintained throughout life and explain the increased atherosclerosis susceptibility 
of apoE
+/-
 offspring from apoE
-/-
 mothers as compared to apoE
+/-
 offspring from 
wild-type mothers. 
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Figure 1. P-plot of 88 significant differentially methylated clones. Data based on student’s t-test (not 





Table 1. Significant different methylated clones (not corrected for multiple testing) 
number Sequence 
Name 
Accession # Fold 
Change 
P-value selected 
1 MCPG2_50_G04 UHNmmcpg0012052 138,453 0,00000000030  
2 MCPG2_30_D12 UHNmmcpg0010104 163,494 0,00000020749  
3 MCPG2_72_E05 UHNmmcpg0014141 251,357 0,00000379349  
4 MCPG1_27_A02 UHNmmcpg0002313 193,665 0,00001000000  
5 MCPG1_64_G03 UHNmmcpg0005046 118,932 0,00001000000  
6 MCPG1_75_A12 UHNmmcpg0006489 245,650 0,00001000000 Gata2 
7 MCPG2_66_G11 UHNmmcpg0013595 225,774 0,00001000000  
8 MCPG2_75_C02 UHNmmcpg0014402 149,212 0,00001000000  
9 MCPG1_27_G11 UHNmmcpg0002613 154,663 0,00002000000  
10 MCPG1_54_D12 UHNmmcpg0004943 145,658 0,00002000000 Tnfrsf4 
11 MCPG1_57_G01 UHNmmcpg0004598 139,978 0,00002000000  
12 MCPG2_57_G12 UHNmmcpg0012732 118,405 0,00002000000 Ptgs1 
13 MCPG2_74_C05 UHNmmcpg0014309 130,797 0,00002000000  
14 MCPG1_63_B03 UHNmmcpg0005051 114,430 0,00003000000  
15 MCPG2_24_B05 UHNmmcpg0009497 262,656 0,00003000000  
16 MCPG1_3_C01 UHNmmcpg0000006 168,124 0,00004000000  
17 MCPG2_54_A04 UHNmmcpg0012364 127,008 0,00004000000  
18 MCPG2_49_H11 UHNmmcpg0011975 116,785 0,00004451960  
19 MCPG1_34_G12 UHNmmcpg0003030 173,253 0,00005000000  
20 MCPG2_12_C11 UHNmmcpg0008363 235,166 0,00005000000  
21 MCPG2_66_E03 UHNmmcpg0013563 115,813 0,00005000000  
22 MCPG1_1_A01 UHNmmcpg0000001 268,587 0,00006000000  
23 MCPG2_31_D06 UHNmmcpg0010194 133,033 0,00007000000  
24 MCPG2_75_H04 UHNmmcpg0014464 176,242 0,00008000000  
25 MCPG2_77_A03 UHNmmcpg0014571 210,428 0,00012000000  
26 MCPG2_42_A12 UHNmmcpg0011220 254,723 0,00015000000  
27 MCPG2_60_E07 UHNmmcpg0012991 205,232 0,00018000000  
28 MCPG2_77_E12 UHNmmcpg0014628 245,634 0,00019000000  
29 MCPG2_47_G03 UHNmmcpg0011763 189,447 0,00021000000  
30 MCPG1_20_D12 UHNmmcpg0001887 187,978 0,00022000000  
31 MCPG1_28_C11 UHNmmcpg0002621 234,325 0,00022000000  
32 MCPG1_3_G11 UHNmmcpg0000334 260,267 0,00024000000  
33 MCPG1_31_F03 UHNmmcpg0002739 -113,372 0,00025000000  
34 MCPG2_69_F05 UHNmmcpg0013865 176,464 0,00025000000  
35 MCPG2_43_D03 UHNmmcpg0011343 -114,147 0,00027000000  
36 MCPG2_63_F10 UHNmmcpg0013294 129,488 0,00027000000  
37 MCPG2_24_B11 UHNmmcpg0009503 186,135 0,00028000000  
38 MCPG2_75_E11 UHNmmcpg0014435 208,235 0,00029070900  
39 MCPG2_75_E06 UHNmmcpg0014430 145,076 0,00043000000  
40 MCPG1_22_B09 UHNmmcpg0001788 221,737 0,00050000000  
41 MCPG1_3_F10 UHNmmcpg0000300 -116,111 0,00053000000  
42 MCPG1_26_C03 UHNmmcpg0001982 134,913 0,00059591800  
43 MCPG1_71_B08 UHNmmcpg0005979 -112,195 0,00067000000  
44 MCPG1_47_F07 UHNmmcpg0004020 264,273 0,00079000000  
45 MCPG1_60_B09 UHNmmcpg0004860 148,055 0,00079000000  
46 MCPG2_47_B07 UHNmmcpg0011707 134,492 0,00086000000  
47 MCPG2_62_E06 UHNmmcpg0013182 331,391 0,00089965600  
48 MCPG1_13_H02 UHNmmcpg0000832 139,470 0,00092000000 IL12b 
49 MCPG2_18_C12 UHNmmcpg0008940 119,616 0,00092000000  
50 MCPG2_4_C02 UHNmmcpg0007586 212,782 0,00092000000 Cys1 
51 MCPG2_69_D02 UHNmmcpg0013838 146,787 0,00097000000  
52 MCPG2_77_B10 UHNmmcpg0014590 226,755 0,00118000000  
53 MCPG2_39_B01 UHNmmcpg0010933 224,492 0,00124000000  
54 MCPG2_32_B01 UHNmmcpg0010261 -112,576 0,00134000000  
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55 MCPG1_15_H07 UHNmmcpg0001362 134,237 0,00137000000  
56 MCPG2_66_D04 UHNmmcpg0013552 146,797 0,00141000000  
57 MCPG2_23_B3 UHNmmcpg0009399 183,980 0,00182000000  
58 MCPG2_29_G03 UHNmmcpg0010035 120,756 0,00184000000  
59 MCPG1_54_A07 UHNmmcpg0004777 140,258 0,00209000000  
60 MCPG2_24_A01 UHNmmcpg0009481 130,969 0,00221000000 Tubb2b 
61 MCPG2_73_F10 UHNmmcpg0014254 125,207 0,00240000000  
62 MCPG1_51_E02 UHNmmcpg0004257 193,678 0,00261000000  
63 MCPG2_77_D11 UHNmmcpg0014615 171,896 0,00270000000  
64 MCPG2_54_E03 UHNmmcpg0012411 161,266 0,00304000000  
65 MCPG1_13_H07 UHNmmcpg0000992 125,019 0,00309895000  
66 MCPG1_78_B07 UHNmmcpg0006700 129,139 0,00310000000  
67 MCPG2_77_H04 UHNmmcpg0014656 205,780 0,00312000000  
68 MCPG2_76_G06 UHNmmcpg0014550 121,173 0,00365000000  
69 MCPG2_51_D03 UHNmmcpg0012111 -112,158 0,00417000000  
70 MCPG2_77_E08 UHNmmcpg0014624 233,735 0,00417000000  
71 MCPG1_27_E11 UHNmmcpg0002609 199,450 0,00433000000  
72 MCPG2_68_B06 UHNmmcpg0013722 -107,028 0,00437000000  
73 MCPG2_28_B11 UHNmmcpg0009887 -107,517 0,00469000000  
74 MCPG2_15_F02 UHNmmcpg0008678 -113,385 0,00538711000  
75 MCPG2_77_H10 UHNmmcpg0014662 241,198 0,00551000000  
76 MCPG2_77_E02 UHNmmcpg0014618 344,360 0,00567988000  
77 MCPG1_78_B01 UHNmmcpg0006508 180,482 0,00581000000  
78 MCPG2_77_B08 UHNmmcpg0014588 200,676 0,00654000000  
79 MCPG2_77_F01 UHNmmcpg0014629 187,156 0,00699000000  
80 MCPG2_19_G08 UHNmmcpg0009080 110,772 0,00721000000  
81 MCPG2_31_H07 UHNmmcpg0010243 -114,692 0,00796000000  
82 MCPG1_43_H09 UHNmmcpg0003704 -107,260 0,00800000000  
83 MCPG2_24_F06 UHNmmcpg0009546 164,537 0,00838000000  
84 MCPG2_77_E09 UHNmmcpg0014625 132,943 0,00883000000  
85 MCPG1_74_G05 UHNmmcpg0006261 125,285 0,00917000000  
86 MCPG2_24_G06 UHNmmcpg0009558 212,329 0,00942000000  
87 MCPG2_18_C09 UHNmmcpg0008937 183,268 0,00957000000  


















The aim of this thesis was to investigate the role of environmental prenatal risk 
factors for atherosclerosis on the susceptibility for cardiovascular disease in adult 
life. Using two mouse models of atherosclerosis, we show that intrauterine 
exposure to several of these factors results in prenatal programming and 
subsequent accelerated neointima formation in the offspring. The major 
conclusions and implications of our findings presented in this thesis will be 
discussed in this chapter. 
 
Risk Factors of Intrauterine Programming of Adult 
Cardiovascular Disease 
Maternal hypercholesterolemia 
In this thesis we demonstrated in a murine model that maternal 
hypercholesterolemia most probably is not the most important trigger for 
intrauterine programming of atherosclerosis susceptibility and early manifestation 
of cardiovascular disease in the offspring. Profound maternal hypercholesterolemia 
did not induce fetal pathology in Ldlr
+/-
 offspring (Chapter 4). These data were 
substantiated by results from similar experiments performed in apoE
+/-
 mice 
(Chapter 2). Despite much lower cholesterol levels in apoE
-/-
 mothers compared 
with Ldlr
-/-
 mothers, we actually detected major endothelial damage in the 
vasculature of apoE
+/-
 fetuses. Together, these results indicate that other risk 
factors seem to be more important in the process of prenatal programming than 
solely maternal hypercholesterolemia.  
 Our data appear to conflict with the existing consensus that maternal 
hypercholesterolemia during pregnancy plays an important role in early stage 
atherosclerosis in the aortas of human and rabbit fetuses and neonates.
1,2
 
However, it has to be taken into account that humans, as well as New Zealand 
White rabbits are genetically susceptible to atherosclerosis and fatty streaks could 







 mice on the other hand, are relatively athero-resistant. Human 
lipoprotein metabolism is characterized by a high LDL fraction and in rabbits the 
lipid metabolism shows comparable levels of LDL, VLDL and HDL.
3,4
 Wild-type 
mice on the other hand, are highly resistant to the development of atherosclerosis 
due to intrinsic low levels of total serum cholesterol, a high HDL fraction and very 
low levels of LDL.
5-8
 Only when fed a Western-type diet containing cholate
9
 or 
genetic manipulation, such as deletion of the apoE or Ldlr gene, mice will develop 





humans, rabbits and mice may explain the discrepancy in intrinsic atherosclerosis 
susceptibility. Low shear stress is considered to be athero-prone
10,11
 and the 
average wall shear stress in human and rabbit carotid arteries is more than 6, 
respectively 3 times lower than in mice.
12
 So, in contrast to all studies performed in 
humans and rabbits in which a genetic component may contribute to the 
phenotype, we most probably studied solely the effects of the environmental risk 
factor maternal hypercholesterolemia.  
 In case of genetic susceptibility to cardiovascular disease, presence of 
maternal hypercholesterolemia appears to accelerate and aggravate the 
phenotype.
1,2,13
 We confirmed this observation. We found intimal thickening in the 
fetal aorta of genetic susceptible Ldlr
-/-
 fetuses exposed to maternal 
hypercholesterolemia, but not in Ldlr
-/-
 fetuses from normcholesterolemic Ldlr
+/-
 
mothers (Chapter 4). 
 As maternal hypercholesterolemia appears not to be the most important 
trigger for prenatal programming of atherosclerosis susceptibility, the 
consequences of hypercholesterolemia on programming probably are more subtle 
and comprise effects in regulation and modulation processes. For example, a 
recent study reported that intrauterine exposure to maternal hypercholesterolemia 
associated with Ldlr-deficiency affected the vascular responses to phenylephrine 
and Ca
2+








Postnatal diet-induced hypercholesterolemia 
Development of hypercholesterolemia in adult life is one of the major risk factors 
for cardiovascular disease. Therefore, we also investigated its contribution in 
manifestation of neointimal pathology in adult offspring. Our data showed that 
neointimal lesion initiation occurred independent of a high-cholesterol diet. Even 
without cholesterol feeding, neointimal lesions of considerable size developed in 
apoE
+/-
 offspring from apoE
-/-
 mothers (Chapter 3). A cholesterol-containing diet in 
these mice, however, severely accelerated and aggravated the phenotype 
(Chapter 2). Although diet-induced hypercholesterolemia is not the most important 
trigger for neointima manifestation in adult life, it exerts additional harmful effects 
on the development of cardiovascular disease.  
 
Oxidative stress 
Studies in rabbits in the early 1990s showed an association between 
hypercholesterolemia and oxidative stress.
15-17
 In addition, it has been reported that 
murine apoE-deficiency leads to high levels of reactive oxygen species (ROS) in 
the circulation and tissues
17
 and pregnancy itself
18





oxidative stress. Therefore, the effects of maternal oxidative stress also needed to 
be taken into account in our studies.  
 In an initial attempt to detect oxidative stress in the fetus, we examined the 
presence of endproducts of glycation and lipid peroxidation, CML and MDA-LDL 
respectively, in the vascular wall. We did not find any sign of deposition of both 
proteins (unpublished data). However, from these data we can not conclude that 
maternal oxidative stress does not affect oxidative stress processes the offspring. 
The data are too preliminary and incomplete. Further studies on ROS detection 
and intermediate and endproducts of oxidation in the fetal circulation and 
vasculature have to be performed to gain more insight into this matter.  
 In addition to the formation of oxidation products, maternal oxidative stress 
may affect gene expression patterns in the offspring. Maternal oxidative stress 
could influence intrauterine programming in two ways. Maternal ROS may 
permeate the placenta and through peroxidative chain reactions in the fetal 
circulation affect signaling processes and induce a molecular memory, through for 
example DNA methylation.
19-21
 Alternatively, maternal reactive metabolites can 
trigger the fetal tissues for elevated ROS formation, thereby initiating a harmful 
intrinsic response leading to epigenetic changes. Little is known about the 
capacities of embryos and fetuses to form ROS. Presence of MDA-lysine and 4-
HNE-lysine epitopes in fatty streaks in the human fetal aorta suggests that human 
fetuses themselves are capable of generating ROS.
1
 Indirect measurements of 
oxidative stress in rat embryos/fetuses demonstrated that from gestational day 10 
onwards oxygenation and dependence on oxidative metabolism increases.
22
 As 
early as gestational day 12-14 fetal rat tissues should have the capacity to form 
ROS.
19,22
   
 Another factor we have to consider is that mitochondria, known to be major 
sites of ROS production and subsequent oxidative stress,
23
 are maternally 
inherited.
24
 As a result, the source of the mitochondria of apoE
+/-
 offspring from 
apoE
-/-
 mothers and apoE
+/-
 offspring from wild-type mothers differs. Microarray 
and gene set enrichment analysis on adult carotid arteries showed that several 





 mothers compared with apoE
+/-
 offspring from 
wild-type mothers (Chapter 2). Oxidative phosphorylation, the Krebs cycle, and 
carbohydrate and fatty acid metabolism were affected. Whether these functional 
changes can be explained by the origin of the mitochondria remains to be 
established.  
 It has to be mentioned that mitochondria themselves can also be 
compromised by severe and/or prolonged oxidative stress.
25-28





observations we suggest that mitochondrial function in the offspring may be 
influenced by extensive exposure to maternal oxidative stress.  
 
Immune system 
When we evaluate the results of our studies in the apoE
+/-
 and the Ldlr
+/-
 mouse 
models (Chapter 2-4), we can conclude that the effects of maternal apoE-
deficiency on atherosclerosis susceptibility in the offspring are far more detrimental 
than those of maternal Ldlr-deficiency. The main functions of apoE and Ldlr involve 
lipid metabolism. The presence of apoE on VLDL, IDL, HDL and chylomicron 
particles facilitates rapid uptake from the circulation by high-affinity binding to the 
Ldlr and the Ldlr-related protein LRP. ApoE-deficiency results in accumulation of 
lipoproteins in the circulation because these particles cannot bind with high 
efficiency to either receptor.
5,6
 Ldlr-deficiency on the other hand, leads to impaired 
clearance of lipoproteins due to absence of one of the two receptors.
29,30
 
Deficiency for either apoE or Ldlr evokes profound (diet-induced) 
hypercholesterolemia associated with oxidative stress.  
 Besides a role in cholesterol metabolism and transport, apoE also has anti-
inflammatory properties,
31
 such as inhibition of expression of vascular cell adhesion 
molecules on endothelial cells,
32
 inhibition of lipid oxidation,
33
 suppression of type I 
inflammatory responses
34
 and regulation of clearance of apoptotic cells.
35
 Lack of 
apoE as a consequence, adds an inflammatory component to the maternal 
phenotype. 
 Increased inflammation in pregnant apoE
-/-
 mothers during pregnancy most 





 mothers severe damage to the endothelial cell lining was found 
whereas endothelial injury was neither seen in the vasculature of apoE
+/-
 fetuses 
from wild-type mothers (Chapter 2), nor in fetuses from immune competent Ldlr
-/-
 
mothers (Chapter 4). In adult carotid arteries of apoE
+/-
 offspring from apoE
-/-
 
mothers, which appeared normal at morphological examination, an upregulation of 
gene expression was found in genes involved in IL-12, IL-17 and T cell cytotoxicity 
pathways in comparison to apoE
+/-
 offspring from wild-type mothers (Chapter 2) 
suggesting a basic pro-inflammatory shift. 
 Maternal inflammation can adversely affect the fetal vasculature, but can 
also interfere with the construction of offspring immunity. A first indication of 
intrauterine programming of the immune system of the offspring was found when 







 offspring from wild-type mothers (unpublished 
data). Significant differences were found between both groups in bone marrow 









. Differences in bone marrow composition and peripheral 
blood constitution between apoE
+/-
 offspring from apoE
-/-
 mothers and apoE
+/-
 
offspring from wild-type mothers point toward an altered response in case innate or 
adaptive immunity is challenged. The role of programmed bone marrow in 
neointima formation remains to be established.  
 Several mechanisms can be proposed to explain the alterations observed 
in the immune system of apoE
+/-
 offspring from apoE
-/-
 mothers. Soluble factors, 
like cytokines in the maternal circulation, may pass the placenta and modulate fetal 
innate and adaptive immunity. Placental passage of maternal antigens could evoke 
autoimmune responses in the fetus. Furthermore, a number of studies have 
reported that maternal erythrocytes, platelets, granulocytes and lymphocytes, all 
cell types derived from the bone marrow, may pass the human placenta.
36,37
 They 
were detected in cord blood and in fetal blood samples obtained in the third 
trimester of pregnancy.
38
 In mice, in late fetal stages lymphocyte-like maternal cells 
were found in the bone marrow of immune competent mice.
39,40
 Appearance of 
maternal cells in the bone marrow coincided with the start of hematopoiesis at 
these sites. These data suggest that maternal cells have a functional role in the 
foundation of the immune system of the offspring. Remarkably, even at 12 weeks 
after birth maternal cells could be detected in the offspring.
40
 By exerting effects on 
the stromal microenvironment these cells could influence bone marrow composition 
and reactivity thereby contributing to the distinction in phenotype as observed 
between the apoE
+/-
 offspring from apoE
-/-
 mothers and those from wild-type 
mothers.  
   
Intrauterine Programming of Adult Cardiovascular Disease 
Post-translational histone modifications and DNA methylation 
In this thesis we demonstrated that intrauterine exposure to maternal apoE-
deficiency accelerated neointima formation in the offspring (Chapter 2,3). We 
conclude that the intrauterine environment in the apoE knockout mouse model 
poses a major risk for adult cardiovascular disease. Understanding of the 
underlying signals and epigenetic mechanisms through which prenatal 
programming is constituted is essential, especially for the development of 
prevention and treatment strategies. Recent literature governing these processes 
was reviewed in Chapter 6. Epigenetic memory is established by chromatin 
remodeling that can be initiated by among other things DNA methylation of CpG 
islands
41
 or post-translational modifications of the histone proteins of the 
nucleosome.
42




 In theory, every individual cell of the embryo/fetus can be exposed to the 
adverse intrauterine environment created by maternal apoE-deficiency. As a result, 
all cells of the offspring may contribute to the founding of the atherosclerosis 
susceptibility as seen in apoE
+/-
 offspring from apoE
-/-
 mothers. Examination of the 
involvement of each tissue type is an almost impossible task. We decided to focus 
on cell types known to be important in atherosclerosis development.  
 The process of atherosclerosis starts with endothelial dysfunction.
43,44
 In 
addition, we demonstrated that endothelial cells themselves can contribute to the 
initial lesion development (Chapter 5). Adverse influences exerted by maternal 
apoE-deficiency on the vasculature of the offspring therefore may have major 
consequences on the cardiovascular disease risk.  
 Examination of adult carotid arteries of apoE
+/-
 offspring from wild-type 
mothers and apoE
+/-
 offspring from apoE
-/-
 mothers revealed clear tissue-specific 
effects of maternal apoE-deficiency on the global histone triple-methylation 
patterns (Chapter 7). In endothelial cells a general upregulation in triple-
methylation and acetylation was observed whereas in smooth muscle cells an 
opposite response was found, namely an overall reduction in staining. The 
observed changes in histone modification profiles indicate differences in the 
activation status of the vascular wall. They represent alterations in chromatin 
structure and gene transcription control
42
 and are the resultant of a temporary 
exposure to the adverse maternal environment created by maternal apoE-
deficiency. It is currently not clear whether the altered profiles are the result of a 
direct effect of the microenvironment on the developing vascular wall in utero or a 
reflection of indirect influences of other affected or reprogrammed biological 
systems, as for instance the immune system. In both cases the maternal apoE 
status is the cause of the observed histone modifications in the adult. The effect of 
maternal apoE-deficiency on DNA methylation in the vasculature of apoE
+/-
 
offspring and the link between DNA methylation and post-translational histone 
modifications in our model remains to be established.   
 Prenatal programming by maternal apoE-deficiency can be induced 
between the time of conception and birth. During embryonic development multiple 
signaling pathways, including transcriptional and (post)translational interactions, 
have to be framed in exact spatiotemporal windows. A small deviation in one of 
these processes can influence cell lineage determination or cellular contribution to 
developing organs. Thus, timing and duration of exposure are of vast importance in 
establishing intrauterine programming. A recent study on the long-term 
consequences of prenatal exposure to famine as a result of the Dutch Hunger 
Winter (1944-1945) reported that very early mammalian development appears to 






 Until now, our research focused on late fetal stages only (Chapter 2). 
Because all organs and cell types are founded at this time point, the sensitivity of a 
fetus to an adverse intrauterine environment may be lower than during the 
embryonic period. Examination of embryos and fetuses at different and foremost 
earlier time points in gestation could provide more information about the critical 
time windows and the course of development in presence of maternal apoE-
deficiency. Furthermore, these studies may contribute to our understanding of the 
moment of the establishment of atherosclerosis susceptibility. Does an adverse 
intrauterine environment induce a memory that only manifests itself after being 
challenged by for example collar placement or an athero-prone diet? Or does it 
already during prenatal life result in changes in the regulation of many pathways 
and if so, can it be measured? Future efforts will focus on the specific genes that 
are affected by either DNA methylation and/or post-translational histone 
modifications to be able to answer above-mentioned questions. 
 
Genomic imprinting 
 Although we assigned the atherosclerosis susceptibility as observed in 
apoE
+/-
 offspring from apoE
-/-
 mothers to the adverse intrauterine environment 
created by maternal apoE-deficiency, we can not exclude that all, or part, of the 
effects are caused by genomic imprinting. In genomic imprinting, specific genes or 
loci show different epigenetic patterns depending on the parent of origin.
46
 In 
certain situations the inheritance of the maternal or paternal allele containing a 
mutation even determines the type of congenital disorder that will develop. For 
example, inheritance of the maternal chromosome 15 containing a partial deletion 
in the long-arm results in the development of the Angelman syndrome in the 
progeny, whereas transmission of the paternal allele containing this mutation leads 
to the Prader-Willi syndrome.
47
  
 In a recent study it was estimated that approximately 600 loci in the murine 
genome are potentially imprinted.
48
 If there exists a distinction in the epigenetic 
marks between the maternal and paternal apoE allele, and likely other loci as well, 





 mothers and those from apoE
-/-
 fathers (and wild-type 
mothers). The role of genomic imprinting in the induction of atherosclerosis 
susceptibility can be studied by embryo transfer experiments in which early apoE
+/-
 
blastocysts from wild-type mothers are transferred to apoE
-/-
 females and vice 
versa. If the apoE
+/-
 fetuses from wild-type mothers transplanted into apoE
-/-
 
recipients show vascular injury at E17.5 similar to that described in Chapter 2, an 
inheritable effect of the apoE allele most likely can be excluded. In case no 






 blastocysts from apoE
-/-
 mothers transplanted to wild-type 
recipients, we can conclude that genomic imprinting is responsible for induction of 
atherosclerosis susceptibility in apoE
+/-
 offspring from apoE
-/-
 mothers. Should the 
embryo transfer experiments prove that genomic imprinting is important, 
transgenerational inheritance should also be investigated.
49,50
 This could be done 
by assessment of cardiovascular disease risk in the second generation of apoE
+/-
 
progeny, obtained by intercrossing of the F1 generation of apoE
+/-
 offspring.    
 
Clinical Implications 
In this thesis we have reported that intrauterine exposure to maternal apoE-
deficiency, and to a lesser extent maternal Ldlr-deficiency, induces susceptibility for 
cardiovascular disease in mice that persists into adulthood. Even though the 
results are obtained in murine models of atherosclerosis, they can give rise, 
through interpretation and extrapolation of the data, to the development of 
treatment and prevention strategies in both pregnant women and offspring. 
 
Prevention and treatment mothers 
In fact, not many reports are available on the normal progress of, and fluctuations 
in, plasma cholesterol levels, and a degree of inflammation and oxidative stress 
markers during pregnancy, not to mention the consequences for the offspring. 
Plasma cholesterol levels during pregnancy increase between 25-50% and the 
majority of pregnant women develop gestational hypercholesterolemia.
51,52
 
Changes in maternal cholesterol metabolism are generally considered to be a 
natural phenomenon not directly posing a risk for cardiovascular disease in both 
mother and progeny. Cholesterol is an essential component for adequate 
development of the fetus, as it is an integral part of cell membranes. It is, however, 
not known at which threshold the effects of gestational hypercholesterolemia switch 
from being beneficial to the embryo/fetus to detrimental. This not only accounts for 
hypercholesterolemia, but also for hypocholesterolemia during pregnancy, which is 
associated with preterm delivery and reduced birth weight.
53-55
   
 Since we demonstrated in this thesis that maternal hypercholesterolemia 
most probably is not the most important trigger for intrauterine programming of 
athero-susceptibility and manifestation of pathology, (Chapter 3,4) the role of apoE, 
inflammation and oxidative stress on intrauterine programming should be 
investigated. In a recent study, a weak association between elevated maternal C-
reactive protein, an indicator of inflammation and oxidative stress, and 
atherosclerosis development in the offspring was found.
56
 Examination of other 




fibrinogen, and markers of endothelial cell function like sCAMs, may shed more 
light on the role of inflammation and oxidative stress on intrauterine 
programming.
57-59
 Altogether, we would like to recommend the initiation of an 
epidemiological prospective follow-up study in which, besides routine assessment 
of plasma cholesterol levels, a search for, and identification of, inflammatory and 
oxidative stress markers will be performed. This will increase our understanding on 
metabolic changes during pregnancy and the balance between maternal 
production and fetal needs. In addition, general monitoring may identify a high-risk 
population of women for which prevention and treatment strategies can be 
developed that benefit both mother and child. 
 In gestational hypercholesterolemia, the most conventional treatment 
strategy is dietary intervention.
60
 In spite of moderate cholesterol-lowering effects, 
the CARDIPP study showed that dietary intervention has limited effects on 
biomarkers for inflammation.
61
 Dietary intervention therefore appears not to be the 
most ideal method to reduce the maternal burden. Many lipid-lowering and anti-
inflammatory drugs exist that are prescribed in case of hypercholesterolemia or 
other metabolic disorders. However, they can not be safely prescribed during 
pregnancy.
62
 Statins, the most potent drugs that can be prescribed for cholesterol-
lowering are contraindicated during pregnancy. This is the result of limited and 
inconclusive experimental data. Studies on the incidence of congenital birth defects 
after use of statins in the first trimester of pregnancy revealed a limited numbers of 
abnormalities among live births.
63-65
 There is still debate about whether or not these 
abnormalities are the consequence of statin exposure. The involvement of statins 
in spontaneous abortions in early pregnancy has never been examined. 
Furthermore, resultant cholesterol lowering and other pleiotropic effects
66,67
 most 
probably exert more subtle effects than induction of congenital birth defects. These 
influences have not been identified thus far. Finally, we have to realize that 
cholesterol lowering may establish cholesterol levels below the threshold 
necessary to provide for the fetal needs thereby harming the unborn. The results of 
this thesis could be of interest for the pharmaceutical industry as we provide new 
perspectives on how intrauterine atherosclerotic risk factors possibly exert their 
effects (Chapter 6,7). 
 Many animal studies predicted a bright future for dietary or synthetic 
antioxidants. They not only affect LDL oxidation, but have many additional 
biological effects. Probucol for example has been reported to reduce 









Only in mice, atherogenesis was stimulated after probocul treatment.
72,73
 Clinical 
trials revealed that next to LDL lowering, probucol also reduced HDL levels.
74
 




inconsistent results in animals
2,75-78
 and clinical trials in human demonstrated no 
beneficial effects.
79-81
 Beta-carotene supplementation even significantly increased 
cardiovascular disease risk in humans.
82-84
 Overall, antioxidant treatment strategies 
are not as effective as expected and use in pregnant women therefore should not 
be recommended. 
 In addition to all the effort that has been put in studies on statins and 
antioxidants, progress has been made in the development of treatment regimes 
that act via anti-inflammatory effects. A growing body of evidence suggests a role 
for inflammatory pathways in adverse reproductive outcomes.
85
 The two main 
intervention strategies are immunosuppressive drugs and immunization by 
vaccines. As far as anti-inflammatory drugs are concerned, it is not known whether 
use has harmful effects on the mother and fetus. Future studies have to be 
performed to gain more insight. The development of many vaccines is still in the 
pre-clinical phase, but they seem very promising (reviewed by Riley and colleagues 
86
). In the setting of intrauterine programming of adult cardiovascular disease, 
Yamashita and colleagues performed maternal immunization studies with oxLDL 
and KLH before pregnancy.
87
 Atherosclerosis in the offspring was significantly 
reduced in case of maternal immunization with oxLDL. Whether vaccines in the 
future can be prescribed to pregnant women, without adverse effects on the mother 
and fetus, remains to be established. 
 
Prevention and treatment offspring 
In this thesis we demonstrated that intrauterine exposure to maternal apoE-
deficiency results in acquisition of a cardiovascular disease risk that persists until 
adulthood (Chapter 2,3,4). In addition, our data showed that the increased 
cardiovascular disease risk already manifested itself after a single challenge of the 
vasculature by collar placement. We postulate that intrauterine environment poses 
a major risk factor for adult cardiovascular disease in humans.  
 The prospective follow-up study as suggested for pregnant women to 
identify a high-risk group of women should be extended by life-long follow-up of the 
progeny. In this way it can be determined whether intrauterine exposure to an 
adverse intrauterine environment actually results in an increased number of 
cardiovascular events in the offspring, such as myocardial infarction and ischemic 
stroke. Cardiovascular disease risk over time in the offspring can be assessed by 
regular examination of the levels of cholesterol and inflammation markers in the 
blood. In addition, noninvasive techniques for visualization of development and 
progression of atherosclerosis could be used. Ultrasound is frequently used to 







 electon beam computerized tomography,
89
 and MRI could be 
applied for assessment of coronary artery disease. 
 The society we live in nowadays is not beneficial for our health, and that of 
our children. Risk enhancers for cardiovascular disease lie in wait everywhere. 
Since fast food is much cheaper than vegetables, and eating microwave pizza 
much less time consuming than cooking, the food that we consume it not well-
balanced. In addition, playing computer games and watching TV seems to be more 
attractive to children than playing outside or joining a soccer team. This may all 
sound a little bit far-fetched, but obesity in children age 2-19 years has increased 
over the last 20 years and only approximately 50% of children meet the Dutch 
standard for ‘gezond bewegen’ (CBS: Gezondheid en zorg 2007). Unfortunately, 
diet and physical activity are not the only risk factors. Since most of them are 
related to lifestyle, the primary goal for health care professionals should not be to 
keep cardiovascular disease risk low, but to get it low! Awareness on this issue 
needs to be achieved in parents, as well as children. In this way, the detrimental 
consequences of an adverse intrauterine environment on cardiovascular disease 
risk hopefully can be kept to a minimum. 
 The question arises to what extent children and adolescents that have 
been exposed to an adverse intrauterine environment can be treated. And where 
do we have to treat them for? In case children are diagnosed with 
hypercholesterolemia, mostly associated with heterozygous or homozygous familial 
hypercholesterolemia, statin treatment can be safely started.
90
 However, maternal 
hypercholesterolemia does not result in hypercholesterolemia in children.
91
 
Treatment with statins from an early age onwards for that purpose therefore seems 
not appropriate. When we consider the pleiotropic effects other than cholesterol-
lowering, such as the anti-inflammatory effects, treatment could be beneficial. We 
have to realize that children exposed to an adverse intrauterine environment do not 
have symptoms for the condition for which they are treated. Therapy adherence 
therefore will be a serious problem.
92
 A recent study reported that as many as 15-
60% of patients terminated statin treatment during the first 6 months after initial 
prescription.
93
 Long-term compliance for treatment strategies that comprises daily 
use of medication most likely can not be achieved.  
  
Conclusions 
In this thesis we demonstrate that susceptibility for adult atherosclerosis can 
already be programmed during embryonic development. The indication that an 
adverse intrauterine environment, that comprises hypercholesterolemia, increased 





progression of cardiovascular disease decades later hopefully triggers many 
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In this thesis, the long-term consequences of an adverse intrauterine environment, 
created by maternal apoE-deficiency or Ldlr-deficiency, on adult athero-
susceptibility in the offspring has been explored. In addition, the epigenetic 
mechanisms underlying the acquired susceptibility for cardiovascular disease were 
investigated.  
 
Chapter 1 provides a general introduction on cardiovascular disease and the major 
environmental risk factors involved in atherosclerosis. Furthermore, the possible 
fetal origin of cardiovascular disease and the role of epigenetic programming in this 
process are described.    
 
In Chapter 2, the effect of maternal apoE-deficiency, characterized by 
hypercholesterolemia, high oxidative stress and inflammation, on fetal vascular 
development and adult cardiovascular disease risk in apoE
+/-
 offspring has been 
investigated. In late fetal stages, a slight, but significant plasma cholesterol 
elevation was found in apoE
+/-
 fetuses from apoE
-/-
 mothers in comparison to 
apoE
+/-
 fetuses from wild-type mothers. In addition, morphological and 
morphometric analysis revealed profound vascular injury, characterized by a 
significant increase in loss of endothelial cell volume, in the carotid arteries of 
fetuses from apoE
-/-
 mothers. After birth, the damage to the endothelial cell lining 
was repaired and no pathology could be detected. Constrictive collar placement 
around the left common carotid artery of adult apoE
+/-
 offspring from apoE
-/-
 
mothers which were fed a cholesterol-containing diet, resulted in severe neointima 
formation in 9 out of 10 mice analyzed. In apoE
+/-
 offspring from wild-type mothers, 
we only detected minor lesion volume (2 out of 10). Since neointima formation in 
apoE
+/-
 offspring from apoE
-/-
 mothers was accelerated and aggravated in relation 
to genetically identical offspring from wild-type mothers, it can be concluded that 
maternal apoE-deficiency during pregnancy has adverse effects on cardiovascular 
disease risk in the adult offspring. 
 
Chapter 3 also concerned the apoE
+/-
 mouse model. Here we investigated whether 
adult apoE
+/-
 offspring from apoE
-/-
 mothers was also more susceptible to neointima 





 mothers, as well as apoE
+/-
 offspring from wild-type mothers 
were normocholesterolemic. The results showed that intrauterine exposure to 
maternal apoE-deficiency was sufficient to allow collar-induced neointima 






 offspring from apoE
-/-
 mothers were small, but present, sustaining the 
hypothesis that an adverse intrauterine environment provided by maternal apoE-
deficiency poses a major risk factor for adult disease.   
 
In Chapter 4 the role of maternal hypercholesterolemia in intrauterine 





 offspring, intrauterine exposure to maternal hypercholesterolemia 
resulted in fetal intimal thickening and profound spontaneous atherosclerosis in the 
adult stage. Maternal hypercholesterolemia appears to have limited effects on 
athero-susceptibility in Ldlr
+/-
 offspring. Analysis of the fetal vasculature and 





 mothers. In addition, collar placement in adult Ldlr
+/-
 offspring from Ldlr
-/-
 





 mothers. Here, no lesions could be induced at all. Solely in 
spontaneous atherosclerosis in Ldlr
+/-
 mice from Ldlr
-/-
 mothers, a difference in 
aortic medial hypertrophy was detected suggesting that maternal 
hypercholesterolemia is not the primary trigger for intrauterine programming. In 
conclusion, we can state that most likely maternal hypercholesterolemia has a 
more regulatory role in this process.  
 
In Chapter 5 the capacity of adult endothelial cells to undergo endothelial-to-
mesenchymal transformation in vivo was explored. Morphological analysis of 
femoral arteries of Tie2LacZ mice 3 days after nonconstrictive collar placement 
revealed endothelial detachment and proliferation. As early as 7 days after collar 
placement, β-galactosidase, which is endothelial cell-specific, could also be 
detected in the neontima. A number of these β-galactosidase-positive 
mesenchymal cells gained positivity for α-smooth muscle actin. The β-
galactosidase-positive, α-smooth muscle actin-positive mesenchymal cells most 
likely are of endothelial cell origin. The contribution of these cells to the developing 
neointima suggests a role for endothelial cell derivatives in the development and 
progression of cardiovascular disease.  
 
Chapter 6 is a review that focuses on the maternal signals that may cross the 
placental barrier and exert detrimental effects on embryonic and fetal development 
with a subsequent cardiovascular disease risk. Fetal undernutrition, maternal 
hypercholesterolemia and a number of other maternal factors all have been 
associated with an increased risk for cardiovascular events. Alterations in normal 
programming during sensitive embryonic or fetal developmental periods may result 




adult life. Growing evidence from animal studies indicates that the underlying 
epigenetic mechanisms comprise DNA methylation or histone modifications.  
 
Chapter 7 shows that profiles of histone triple-methylation modifications of lysines 
and the accompanying lysine methyltransferases in endothelial cells and smooth 
muscle cells were clearly differentially affected in apoE
+/-
 offspring from apoE
-/-
 
mothers in relation to apoE
+/-
 offspring from wild-type mothers. Thus, it seems that 
intrauterine programming of susceptibility for cardiovascular disease in adult life is 
(in part) established by adverse influences of maternal apoE-deficiency on 
chromatin remodeling in the vasculature of the offspring.  
 
Chapter 8 provides a general discussion of the data presented in this thesis. The 
role of maternal hypercholesterolemia, oxidative stress, and alterations in the 
immune system in prenatal programming of adult cardiovascular disease is 
discussed. In addition, the epigenetic mechanisms through which these risk factors 
may exert their effects are described. Finally, where possible, a link with the human 
situation is made and the implications of the data presented in this thesis on 
prevention and treatment strategies in pregnant women and offspring are 
presented.  
 
In summary, in this thesis it becomes clear that the intrauterine environment 
created by the mother during pregnancy not only has beneficial effects on the 
developing embryo / fetus. Although it is too early to draw definite conclusions, the 
first results of this research line show that maternal apoE-deficiency, in contrast to 
maternal Ldlr-deficiency, adversely affects the offspring, not only in late fetal stages 
but also in adult life. Our data indicate that the inflammatory status of the mother 
and the lack of maternal apoE itself may attribute to the increased cardiovascular 
disease risk observed in the adult offspring. Hypercholesterolemia and oxidative 
stress possibly play a more regulatory role. In a first attempt to elucidate the 
underlying mechanism we show that maternal apoE-deficiency leads to changes in 
the histone triple-methylation modifications in the vascular wall of the offspring. 
This can be considered an important lead that needs to be investigated further. It 
does not mean, however, that we are close to complete elucidation of the 
underlying mechanism. A lot of research is needed to accomplish this and it is 
needed. Why? The fact that a hit so early in life exerts negative effects on 
cardiovascular disease risk in adulthood is worrisome. If we could succeed in 
elucidating the exact role of epigenetics in this process and are able to translate 




















In dit proefschrift zijn de consequenties van een nadelige intrauteriene omgeving, 
gecreëerd door maternale apoE-deficiëntie of Ldlr-deficiëntie tijdens 
zwangerschap, op de gevoeligheid voor aderverkalking in de volwassen 
nakomelingen bestudeerd. Tevens zijn de epigenetische mechanismen die ten 
grondslag liggen aan de verworven gevoeligheid voor hart- en vaatziekten 
onderzocht. 
 
In Hoofdstuk 1 wordt algemene informatie gegeven over hart- en vaatziekten en 
de belangrijkste risicofactoren voor aderverkalking. Daarnaast wordt de mogelijke 
foetale oorsprong van hart- en vaatziekten en de rol van epigenetische 
programmering in dit proces beschreven. 
 
In Hoofdstuk 2 zijn de effecten van maternale apoE-deficiëntie tijdens 
zwangerschap in muizen, dat gekenmerkt wordt door hoog cholesterol, hoge 
oxidatieve stress niveaus en toegenomen ontsteking, op foetale 
bloedvatontwikkeling en het risico op hart- en vaatziekten in volwassen apoE
+/-
 
nakomelingen bestudeerd. Tijdens de laat foetale ontwikkeling werd een kleine, 





 moeders in vergelijking met apoE
+/-
 foetussen van wildtype 
moeders. Bovendien lieten morfologische en morfometrische analyses ernstige 
schade aan de vaatwand zien, gekarakteriseerd door een significante toename van 
verlies van endotheelcel volume in de halsslagaders van de foetussen van apoE
-/-
 
moeders. Na de geboorte is de schade aan de endotheelcellaag hersteld en werd 
geen aderverkalking gevonden. De apoE
+/-
 nakomelingen kregen een dieet dat 
cholesterol bevatte om het cholesterolniveau in het bloed te verhogen. Op een 
leeftijd van 16 weken werd een kokertje rondom de linker halsslagader van 
volwassen apoE
+/-
 nakomelingen geplaatst. Het kokertje vernauwt het bloedvat 





 moeders resulteerde in ernstige neointimavorming in 9 
van de 10 nakomelingen. In apoE
+/-
 nakomelingen van wildtype moeders werden 
kleine verdikkingen gevonden in 2 van de 10 nakomelingen. Neointimavorming in 
apoE
+/-
 nakomelingen van apoE
-/-
 was versneld en verergerd in verhouding tot 
genetisch identieke apoE
+/-
 nakomelingen van wildtype moeders. We concluderen 
dat maternale apoE-deficiëntie tijdens zwangerschap nadelige effecten heeft op 






In Hoofdstuk 3 werd ook het apoE
+/-
 muismodel gebruikt. We hebben onderzocht 
of volwassen apoE
+/-
 nakomelingen van apoE
-/-
 moeders ook gevoelig zijn voor 
neointimavorming in afwezigheid van een cholesteroldieet. Een normaal dieet 
zonder toevoeging van cholesterol resulteerde in normale cholesterolwaarden in 
apoE
+/-
 nakomelingen van zowel apoE
-/-
 moeders als wildtype moeders. De 
resultaten toonden aan dat blootstelling aan maternale apoE-deficiëntie tijdens de 
embryonale ontwikkeling voldoende was om neointimavorming op te wekken via 
cuff-plaatsing, zelfs zonder een cholesteroldieet. De neointima verdikkingen in 
apoE
+/-
 nakomelingen van apoE
-/-
 moeders waren klein, maar aanwezig. Dit 
bevestigt de hypothese dat een nadelige intrauteriene omgeving gecreëerd door 
maternale apoE-deficiëntie een belangrijke risicofactor is voor ziekte in het 
volwassen leven.  
 
Hoofdstuk 4 beschrijft de rol van maternaal hoog cholesterol in intrauteriene 
programmering van het risico op hart- en vaatziekten in volwassen nakomelingen. 
Hiervoor werd het Ldlr
-/-
 muismodel gebruikt. In Ldlr
-/-
 nakomelingen leidde 
intrauteriene blootstelling aan maternaal hoog cholesterol tot vorming van 
intimaverdikkingen in de bloedvaten van de foetus en ontwikkeling van 
aderverkalking in het volwassen leven. Maternaal hoog cholesterol lijkt weinig 
effect te hebben op de gevoeligheid voor aderverkalking in Ldlr
+/-
 nakomelingen. 















 moeders niet tot versnelde en verergerde 
neointimavorming. Neointimavorming kon zelfs niet opgewekt worden. Alleen in 
spontane ontwikkeling van aderverkalking werd een toename in hypertrofie van de 
mediale laag van de aorta gevonden in Ldlr
+/-
 nakomelingen van Ldlr
-/-
 moeders. 
Deze data suggereren dat maternaal hoog cholesterol niet de primaire veroorzaker 
is van intrauteriene programmering. We kunnen concluderen dat maternaal hoog 
cholesterol waarschijnlijk een regulatoire rol heeft in dit proces.  
 
In Hoofdstuk 5 is het vermogen van volwassen endotheelcellen om te 
transformeren van endotheelcel naar mesenchymcel onderzocht. In Tie2LacZ 
muizen, waarbij door genetische manipulatie de endotheelcellaag met een blauwe 
kleur gemarkeerd is, werden niet-vernauwende kokertjes rondom de 
dijbeenslagaders geplaatst. Drie dagen na cuff-plaatsing werd loslating van 
endotheelcellen zowel als proliferatie van endotheelcellen gevonden. Vanaf 7 
dagen na cuff-plaatsing kon de blauwe kleur behalve in de endotheelcellaag ook in 




positief voor de marker α-gladde spiercel actine. De dubbel-positieve 
mesenchymcellen zijn waarschijnlijk van endotheelcel oorsprong. De bijdrage van 
deze cellen aan neointimavorming suggereert een rol voor endotheelcel afgeleide 
cellen in de ontwikkeling en progressie van hart- en vaatziekten.  
 
Hoofdstuk 6 is een review over factoren van de moeder die via de placenta het 
kind kunnen bereiken en daar nadelige effecten op embryonale en foetale 
ontwikkeling kunnen uitoefenen. Dit kan vervolgens leiden tot een verhoogd risico 
op hart- en vaatziekten. Foetale ondervoeding, maternaal hoog cholesterol en een 
aantal andere factoren tijdens zwangerschap zijn geassocieerd met een verhoogde 
kans op manifestatie van hart- en vaatziekten in de nakomelingen, bijvoorbeeld 
hart- en herseninfarcten. Veranderingen in de normale programmering tijdens 
kritieke perioden van de embryonale of foetale ontwikkeling kan leiden tot de 
aanleg van een verhoogde gevoeligheid voor aderverkalking die blijft bestaan tot 
het volwassen leven. Toenemend bewijs uit dierstudies doet vermoeden dat DNA 
methylatie en modificatie van histonen epigenetische mechanismen zijn die ten 
grondslag liggen aan de aanleg van de gevoeligheid.  
 
Hoofdstuk 7 laat zien dat de profielen van histon triple-methylatie modificaties van 
lysines en de bijbehorende lysine methyltransferases in endotheelcellen en gladde 
spiercellen veranderd zijn in apoE
+/-
 nakomelingen van apoE
-/-
 moeders in 
vergelijking met apoE
+/-
 nakomelingen van wildtype moeders. Het lijkt waarschijnlijk 
dat intrauteriene programmering van een gevoeligheid voor hart- en vaatziekten in 
het volwassen leven (deels) wordt aangelegd door nadelige invloeden van 
maternale apoE-deficiëntie op de remodellering van chromatine in de bloedvaten 
van de nakomelingen.  
 
Hoofdstuk 8 geeft een algemene discussie over de data gepresenteerd in 
hoofdstuk 2-7. De rol van maternaal hoog cholesterol, oxidatieve stress en 
veranderingen in het immuunsysteem in intrauteriene programmering van hart- en 
vaatziekten wordt besproken. Daarnaast worden de epigenetische mechanismen 
via welke de risicofactoren hun effecten uitoefenen beschreven. Tenslotte wordt 
waar mogelijk een link gelegd met de situatie in de mens. De mogelijke implicaties 
van de data beschreven in dit proefschrift op preventie- en 
behandelingsstrategieën in zwangere vrouwen worden besproken.  
 
In samenvatting, in dit proefschrift wordt het duidelijk dat de intrauteriene omgeving 
gecreëerd door de moeder gedurende de zwangerschap niet alleen maar positieve 





definitieve conclusies te trekken laten de eerste resultaten van het onderzoek zien 
dat maternale apoE-deficiëntie, in tegenstelling tot maternale Ldlr-deficiëntie, een 
nadelige invloed heeft op de nakomelingen, zowel  in laat foetale stadia alsmede in 
volwassen leven. Onze resultaten suggereren dat de ontstekingsstatus en het 
gebrek aan apoE bij de moeder bijdragen aan het verhoogde risico op hart- en 
vaatziekten bij de volwassen nakomelingen. Hoog cholesterol en oxidatieve stress 
lijken een meer regulerende rol te spelen. In een eerste poging om het 
onderliggende mechanisme te ontrafelen laten we zien dat maternale apoE-
deficiëntie leidt tot veranderingen in de histon triple-methylatie modificaties in de 
vaatwand van de nakomeling. Epigenetische mechanismen spelen dus 
waarschijnlijk een belangrijke rol in het vastleggen van de gevoeligheid voor hart- 
en vaatziekten. Het betekent niet dat we al dichtbij de complete ontrafeling van het 
onderliggende mechanisme zijn. Veel onderzoek is nodig om dit doel te bereiken 
en het is hard nodig. Waarom? Het feit dat blootstelling zo vroeg in het leven 
tientallen jaren later negatieve effecten heeft op het risico voor hart- en vaatziekten 
is zorgwekkend. Indien we succesvol zijn in het ontrafelen van de exacte rol van 
epigenetica in dit proces en in staat zijn de gegevens te vertalen naar de humane 
situatie, is het wellicht mogelijk de incidentie van hart- en vaatziekten te 
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